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CHAPTER I 
INTRODUCTION 
A historical review 
A history of the serendipities 
and experiments of nature. 
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CHAPTER I 
INTRODUCTION 
A historical review 
Hepatitis B virus infection, which shares many epidemiological characteristics 
with the Human Immunodeficiency virus infection, represents a major worldwide 
public health problem. At least 176 but probably 300 million people in the world 
(± 6 per cent of the world population) are persistent carriers of the hepatitis B 
virus (HBV) (Sobelavsky, 1978; Beasley, 1985). Chronic carriership can cause 
chronic liver disease, including cirrhosis and in the long term hepatocellular 
carcinoma, in at least 50 per cent of the cases. Chronic hepatitis B infection 
represents one of the highest relative risks (more than 200) known for a human 
cancer (Beasley, 1984, 1988). 
This important pathogenic hepatitis virus was identified in 1968, when 
Blumberg's Australia antigen was by chance associated with hepatitis virus, type 
B. Before this discovery the distinction between at least two different types of viral 
hepatitis, currently designated as hepatitis A and B, was based on clinical 
observations (Findlay, 1939) and transmission studies of human volunteers only 
(MacCallum, 1944; Paul, 1945; Murray, 1954; Krugman, 1967). After it became 
possible to identify hepatitis type B, other cases of blood-borne hepatitis that 
could not be attributed to hepatitis B were detected. From this finding the exist-
ence of at least a third type of hepatitis virus (hepatitis non-A, non-B or hepatitis 
C) was presumed and, after a long search, recently verified (Houghton, 1988; 
Kuo, 1989; Choo, 1989) by a complementary DNA-hybridisation technique. 
In the past hepatitis A, on the one hand, and hepatitis Band C, on the other, 
have been given various names, which were based mainly on either the 
suspected mode of transmission of the infectious agent or the clinical signs and 
symptoms of each of these types of hepatitis, e.g .. "acute catarrhal jaundice", 
"short-incubation hepatitis", "infectious hepatitis" and "epidemic hepatitis" for 
hepatitis A and "long-incubation hepatitis", "serum hepatitis", "(post)transfusion 
hepatitis" and "postvaccinal hepatitis" for hepatitis B andjor hepatitis C. 
Hepatitis A was known to occur in wide-spread outbreaks and was common 
among troops (Soldatengelbsucht; jaunisse des camps; campaign jaundice) 
during the second world war as well as earlier wars (Siegmund, 1942; Spooner, 
1944). The disease was thought to be spread by droplets from the respiratory 
tract andjor food and water contaminated by excreta (Havens et al., 1945; 
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Findlay and Wilcox, 1945). Hepatitis B, on the other hand, was not recognized 
until more recent times although retrospectively it was probably first described 
by LOhrman (1885). He reported an outburst of hepatitis in subjects vaccinated 
against smallpox, using the fluid collected from vesicles on the arms of previously 
vaccinated individuals. Later on, the occurrence of hepatitis was noted in 
individuals who had been given injections or infusions of human blood or blood 
products contaminated with virus, e.g. prophylactic serum against measles 
(McNalty, 1938; Propert, 1938), mumps (Beeson et al., 1944) and yellow fever 
(Findlay, 1943 and 1944). In addition, the large-scale introduction of blood 
transfusions in medical practice during World War II led to an increase in the 
incidence of hepatitis (Bradley, 1946). From these observations it was concluded 
that this type of hepatitis is transmitted parenterally via blood or blood products. 
By this time there was enough evidence to support the idea that two distinct 
agents were involved in the occurrence of hepatitis. In order to avoid confusion 
MacCallum suggested in 194 7 that the two putative viruses should be called virus 
A, which gives rise to infectious hepatitis after a short incubation period, and virus 
B, which leads to serum hepatitis after a long incubation period. 
Although a viral pathogenesis was postulated for both hepatitis A and hepatitis 
B {Findlay et al., 1939), all attempts to isolate and culture the virus failed and, as 
a result of the lack of serological and virological parameters, hepatitis research 
was severely hampered. 
The studies of Blumberg and coworkers, however, resulting in identification 
of the "Australia antigen" {1965) and later the accidental discovery of its relation 
to viral hepatitis (1967), initiated extensive serological, epidemiological, 
virological, pathological and clinical research in the field of hepatitis. 
During the above-mentioned studies directed initially toward a earch for serum 
polymorphisms, Blumberg identified an antigen by testing sera from poly-
transfused patients against a panel of sera from healthy individuals from different 
geographical areas. Using the Ouchterlony immunodiffusion technique, one of 
the sera of this panel was found to give a single precipitation line with serum from 
a polytransfused American hemophilic patient. Since the serum that caused the 
precipitation reaction had been obtained from a healthy Australian aboriginal, the 
antigen involved was called the Australia antigen (Au-Ag). 
Early epidemiological studies on this mysterious antigen indicated a relatively 
high prevalence of Au-Ag in sera from Oceanic, Oriental and Mediterranean 
populations, sometimes with family clustering. However, the antigen could only 
rarely be identified in sera from inhabitants ofthe United States {Blumberg, 1966). 
Since a high prevalence of Au-Ag was noted for leukemia patients {Blumberg, 
1965) as well as those with Down's syndrome (Blumberg, 1967), who are known 
to have a high risk for leukemia (Miller, 1964), the hypothesis that Au-Ag was 
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causally related to leukemia was put forward. By that time the presence of the 
antigen was considered to be important for the early diagnosis of leukemia. 
A relationship between Au-Ag and hepatitis was first suspected when follow-
up studies of a patient with Down's syndrome demonstrated the appearance of 
Au-Ag in the serum shortly before the development of an acute hepatitis. Later on, 
studies by Blumberg (1967), Sutnick (1968) and Okochi and Murakam (1968) 
confirmed the association between Au-Ag and hepatitis. Until that time, Au-Ag 
was considered to be associated with both hepatitis A and hepatitis B. However, 
the studies of Prince (1968) proved that Au-Ag was restricted to cases of 
hepatitis, type B only. This finding was confirmed by many authors and Au-Agwas 
established as a serological marker for hepatitis type B (Krugman et al., 1970). 
In electron microscopical (EM) studies by Bayer et al.(1968), who investigated 
sera containing Au-Ag, particles with a diameter of about 23 nm were 
demonstrated. Originally considered to be similar to picornavirus or polioviruses, 
they were presumed to represent the morphological equivalent of the Au-Ag. 
Further EM studies of Au-Ag-positive sera, however, revealed the presence of 
three different types of particles (fig.l.1 ): 
1. Roughly spherical particles with a diameter of 16-25 nm. 
2. Filamentous particles with a diameter of 16-25 nm and varying lengths (up 
to 700 nm). 
3. Uniform, spherical particles with a diameter of 42 nm. 
These latter particles, first described by Dane ( 1970), have a complex structure 
with a lipoprotein outer coat that surrounds a particulate, slightly hexagonal, inner 
core with a diameter of 27 nm (Almeida, 1971 ). These viral-like particles are 
commonly referred to as "Dane" particles. All three types of particle share 
common antigens on their surface that are identical with the Au-Ag. Hence, Au-
Ag was renamed the "hepatitis B surface antigen" (HBsAg). 
The inner core of the "Dane" particles, however, contains a distinct antigen, 
designated as hepatitis B core antigen (HBcAg) (Almeida, 1971 ). 
Because of its ultrastructural architecture and the presence of a DNA 
polymerase (Robinson, 1974; Kaplan, 1973, 1974) and a small double-stranded 
circular DNA that serves as a primer template for the DNA polymerase (Robinson, 
197 4 ), the "Dane" particle was subsequently considered to be the complete virus. 
Studies by Summers (1975) further defined the structure of the viral DNA and 
the way in which endogenous DNA polymerase uses this molecule as a template 
for DNA synthesis. It was concluded that the viral DNA was not entirely double-
stranded but contained a large single-stranded gap of variable size. Thus, one of 
the two strands was complete whereas the other was, on the average, only half 
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complete; eventually endogenous DNA polymerase extends the incomplete 
strand, using the complete strand as a template. On the basis of the specific 
structure of the DNA genome (the smallest of all known DNA viruses) and the 
presence of an endogenous DNA polymerase, a new class of viruses was defined 
that were unrelated to any viruses previously described; they were called 
Hepadnaviridae (Marion, 1980). Despite evidence that the "Dane" particle 
represents the actual infectious virus of hepatitis B (HBV), all attempts to grow 
HBV in tissue culture systems have been unsuccessful and the upsurge in our 
understanding of the molecular biology of HBV resulted from Hepadnaviruses 
present in woodchucks (Summers), Beechey ground squirrels (Marion, 1980) 
and Peking ducks (Mason, 1980). 
In addition to the "Dane" particle which represents the complete virus there 
are two other particles. These small spherical and filamentous particles are 
surplus viral coat material, produced by infected hepatocytes. Production of 
HBsAg by the hepatocytes of the host is coded by the HBV genome. 
More detailed serological studies have resulted in the detection of several 
antigenic determinants of HBsAg, indicated as "a", "d", "y", "r" and "w", according 
to Le Bouvier (1971) and Bancroft (1972). While the "a" determinant is an 
obligatory group-specific determinant, the others represent two parts of mutually 
exclusive determinants: "d" and "y"; "r" and "w". Thus the following subtypes can 
be recognized: "adr", "adw", "ayr", "ayw". These subtypes define the HBV 
phenotypes and do not appear to be associated with intrinsic biological diffe-
rences in terms of infectivity, virulence and type of liver disease. These antigenic 
determinants of HBsAg are located on the central hydrophilic region of HBsAg. 
An additional antigen, designated as "e" antigen (eAg), was discovered by 
Magnius and Espmark (1972) in HBsAg positive sera. Although the precise 
characteristics were not yet known, eAg was not considered to be a subtype of 
the hepatitis B surface antigen. It differs in immunological properties as well as 
size and buoyant density (Magnius, 1975). Since the occurrence of "Dane" 
particles and eAg in serum seemed to be associated, it was initially suggested 
(Neurath, 1976; Okada, 1976) and later proven (Takahashi, 1979) that eAg is a 
component of the "Dane" particle. In accordance with this finding some authors 
(Okada, 1976) have demonstrated that HBV is transmitted by HBsAg seropositive 
patients with eAg more often than by HBsAg seropositive patients without eAg. 
As a result eAg is now considered a parameter for the infectivity of HBsAg positive 
serum. Moreover there appeared to be evidence that the presence of eAg may be 
associated with a more unfavorable type of hepatitis (i.e. chronic active hepatitis) 
(Nielsen, 1974; Trepo, 1976). 
Ultrastructural and immunofluorescence studies on liver tissue from HBsAg 
seropositive patients demonstrated the presence of± 27 nm particles in nuclei 
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of hepatocytes (Huang, 1971) and the occurrence of HBcAg in the particles 
(Brzoska, 1973), while HBsAg was discovered either in the cytoplasm or along 
the cellular membranes of hepatocytes (ten Kate, 197 4; Roos, 1976; Ray, 1976). 
Fig.l.1 Schematic drawing of the different hepatitis B viral particles and the local-
ization of the viral antigens on these particles and in the hepatocytes. 
Dane - particle 
42nm 
Round and filamentous particles 
<:::::; 
() 
L__j 
±23nm 
S = surface antigen C = core antigen 
Hepatocyte 
s 
c c 
..s e- antigen 
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Ultrastructurally the cytoplasm of the hepatocytes was found to contain 
filamentous and spherical particles in widened cisternae of the endoplasmic 
reticulum (Stein, 1972). These particles seemed to resemble the round and 
filamentous HBsAg particles in serum. Hepatocyteswiththese HBsAg-containing 
particles in the cytoplasm appear to be identical to the liver cells described as 
"ground-glass" hepatocytes in light microscopy. These ground-glass hepatocytes 
have special staining characteristics (Hadziyannis, 1973; Shikata, 1974). From 
immunofluorescence studies of liver tissue from HBsAg seropositive patients 
there is some evidence that eAg is present in the nuclei of hepatocytes (Arnold, 
1977). 
Studies of both experimentally infected monkeys (Barker, 1973) and human 
patients (Hoofnagle, 1973; Overby, 1982) revealed a complex pattern of ap-
pearance and persistence of HBV antigens and antibodies in serum following an 
HBV infection. After an infection HBsAg can be detected 5-24 weeks later in the 
serum of an infected individual. Four to ten weeks after the appearance of HBsAg, 
anti-HBcAg appears. This occurs about three weeks before onset of jaundice and 
at the height of liver dysfunction. HBsAg usually disappears slowly during 
recovery from hepatitis. The rate of disappearance of HBsAg may vary markedly. 
In patients who recover from acute hepatitis type B, a significant decrease in 
HBsAg titer can usually be observed within the first three weeks of clinical onset 
(Froesner, 1982). After the loss of HBsAg anti-HBs appears two to six weeks 
later, long after the appearance of anti-HBc. This HBsAg and anti HBs negative 
period is designated at the "window phase". Appearance of anti HBs indicates 
recovery from and immunity to HBV infection. However HBsAg antigenemia may 
persist for many years. After recovery from HBV infection anti-HBs usually 
disappears faster than anti-HBc. 
In the meantime a new chapter in the history of hepatitis B was started by the 
discovery of Rizzetto (1977) of another hepatitis B-associated antigen-antibody 
system, which he designated 6/anti-6. Initially this delta antigen was found by 
chance in the nuclei of hepatocytes when he was investigating the localization of 
hepatitis B antigens in frozen liver tissue from HBsAg positive patients by 
immunofluorescence methods. In this liver tissue HBcAg and delta antigen 
seemed to be present to the exclusion of the other in the nuclei of the 
hepatocytes. Subsequent studies of chimpanzees (Rizetto 1980) revealed that 
delta antigen was a component of a virus with unusual properties. The delta virus 
was unable to replicate autonomously; it could only replicate in the presence of 
the HBV virus. The delta virus is thus a defective virus that is dependent on helper 
functions provided by HBV. Its hybrid nature is reflected by the delta virion which 
is a particle composed of a RNA genome together with the delta protein surround-
ed by a shell of HBsAg derived from the HBV (Bonino 1984). This virus (500,000 
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dalton) is smaller than all known animal viruses, but its size is compatible with the 
dimensions of satellite viruses of plants, that are also unable to replicate 
autonomously.ln view of the need for help from HBV, delta viruses can thrive only 
in individuals infected with HBV. This infection can occur as a coinfection 
simultaneously with the HBV infection, or it can be acquired as a superinfection 
in individuals who already carry the HBV. The two modes of infection result in 
different clinical pictures. Coinfection usually presents as a moderate to severe 
acute hepatitis, that runs a self-limiting course followed by complete recovery. 
Rarely is a fulminant hepatitis with massive liver necrosis or transition to chronic 
hepatitis seen. In contrast superinfection leads to a carrier state of the delta 
infection in over 70 per cent of the cases and aggravates the preexisting HBV 
disease or results in a new liver disease in previously healthy HBV carriers 
(Rizzetto 1983). In general, chronic delta infection has a tendency to progress 
more rapidly than infections of HBV only. In liver tissue delta antigen is located 
mainly in hepatocytic nuclei without detectable HBcAg. 
The availability of serological markers for a hepatitis Band D infection, on the 
one hand, and the development of safe techniques for obtaining needle biopsy 
specimens (Knauer, 1978; Perrault, 1978) of the liver, on the other, have resulted 
in recognition of the wide range in the natural course of HBV with and without 
delta co/superinfection, both clinically and histologically (Peters, 1975; Ishak, 
1976; Phillips, 1981). 
, The study of liver biopsy specimens by light microscopy is now considered to 
be the best and most constant method for classification of liver disease. 
However, it has become evident that the value of the light microscopical study 
of liver tissue is limited, not only for determining the prognosis of the hepatitis, 
especially during the acute phase, but also for differentiating acute hepatitis from 
chronic hepatitis. 
The purpose of the studies reported in this thesis is to investigate whether 
immunohistochemical and electron microscopical techniques, when performed 
in addition to light microscopical studies of liver biopsy specimens: 
a. can contribute to a better understanding of the pathogenesis of hepatitis 
Band D. 
b. are valuable for staging and determining the prognosis of hepatitis Band D. 
c. are helpful in monitoring the effects of therapy. 
For this purpose, the relationships between clinical and histological findings, 
viral expression patterns in the liver and serological viral parameters in a series 
of hepatitis B and D positive patients were investigated. 
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Highlights in hepatitis B story_ 
1885 LOhrman: 
1939 Findlay: 
1940-1945 Findlay: 
Havens: 
Paul: 
First well-documented epidemic outbreak of a post-
vaccination hepatitis, probably caused by hepatitis 
virus. 
Circumstantial evidence that hepatitis can be 
caused by an infective viral agent. 
Evidence for the presence of two different types of 
infective hepatitis. 
1947 MacCallum: Suggestion to call the two putative viral agents: 
virus A and virus B. 
1965 Blumberg: Discovery of Australia antigen associated with 
leukemia and Down syndrome. 
1967 Blumberg: Australia antigen associated with hepatitis. 
1970 Prince: Australia antigen associated with hepatitis B. 
1972 Magnius and 
Espmark: Discovery of eAgjanti-e system. 
1974 Robinson: Demonstration of double-stranded circular DNA in 
the core of the "Dane"particles. 
1975 Feinstone: Proved evidence for the existence of at least a third 
1975-1976 · Purcell: 
Reesink: 
Buynak: 
1977 Rizzetto: 
1981 Beasly: 
1989 WHO: 
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hepatitis virus (non A- non B). 
Development of first safe hepatitis B vaccins. 
Discovery of the delta-antigen, the marker for the 
hepatitis delta virus. 
Strong epidemiologic evidence for a close relation 
between chronic hepatitis B infection and the 
hepatocellular carcinoma. 
Strategies for eradication of hepatitis B virus. 
CHAPTER II 
PATIENTS AND MATERIALS 
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CHAPTER II 
PATIENTS AND MATERIALS 
11.1 INTRODUCTION 
A total of 1850 conse-cutive liver biopsy specimens, received for histological 
examination in the years 1973-1977, comprise the material for this study. 
All 1850 liver biopsies were examined by light microscopy for evidence of 
hepatitis B infection. Those biopsies that exhibited light microscopical evidence 
for hepatitis B infection were further investigated. Of the 1850 biopsies, 252 
biopsies were proffered fresh so that one part of each biopsy could be snap-
frozen in liquid nitrogen and another part could be prepared for light microscopy 
studies. Both samples were investigated for the presence of HBV antigens by 
immunohistochemical methods. One of the major selection criteria for freezing 
part of a biopsy was a positive HBsAg serum reaction or clinical suspicion for a 
viral infection. 
In addition a sample of each of the 252 biopsies was fixed in glutaraldehyde 
for electron microscopical examination. 
In total, 165 of the 252 biopsies were obtained from 139 HBsAg seropositive 
patients and 87 from 84 HBsAg seronegative patients. The HBsAg seronegative 
patients represented a broad spectrum of liver diseases. 
11.2 HBsAg SEROPOSITIVE PATIENTS 
During the period of this study more than one biopsy was taken from several 
of the 139 HBsAg seropositive patients. The HBsAg seropositive patients can be 
divided into two groups: 
Group A 
Group B 
51 asymptomatic individuals who were found by chance 
to be HBsAg positive during a routine blood examination. 
88 patients who were found to be HBsAg positive during 
evaluation of liver disease. 
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11.2.1 GROUP A (ASYMPTOMATIC HBSAG CARRIERS) 
In this group 41 individuals were "healthy" volunteers who had donated blood 
·to the Red Cross Blood Transfusion Services of Rotterdam (Head: dr. Kothe) and 
were found to be HBsAg seropositive upon routine screening. Six other 
individuals in this group had visited an outpatient clinic for venereal diseases. In 
this clinic all patients are routinely checked for the presence of HBsAg in their 
serum. Two individuals were found to be HBsAg seropositive during a routine 
medical check-up and HBsAg was detected in the serum of two subjects when 
family members of HBsAg seropositive blood donors were screened. None of the 
. 51 subjects had a history of jaundice; most of them, however, had experienced 
a period of nausea, malaise andjor complaints of abdominal distress. Three 
patients developed jaundice some time after the detection of HBsAg in their blood 
which suggests that the HBsAg was detec-ted during the incubation of a hepatitis 
B infection. 
Volunteer blood donors 
During this study all volunteers who donated blood to the Red Cross Blood 
Transfusion Services of Rotterdam (ranging in age from 18 to 65 years) were 
screened at the time of each donation for the presence of HBsAg in the serum. 
Initially HBsAg screening was performed by means of an agar-immuno-diffusion 
technique and later by a radioimmunoassay technique (Ausria; Abbott). Each 
volunteer donated blood once or twice a year. 
Table 11.1 lists per year: 
a. the total number of blood donors tested for the presence of HBsAg. 
b. the number of blood donors tested for the first time for the presence of 
HBsAg. 
c. the number of blood donors found to be positive for HBsAg at the initial or 
a later screening. 
d. the calculated prevalence of HBsAg in this population of blood donors, 
which may cautiously be considered to be representative of the entire 
"healthy" population (between the ages of 18 and 65 years). 
The incidence of hepatitis B infection cannot be calculated from the number of 
blood donors with HBsAg positive serum following a negative test at the time of 
the previous donation. In fact, several blood donors proved to be positive for 
antibodies against HBsAg, whereas at the time of the previous donation neither 
HBsAg noranti-HBsAgwas detected. Because HBsAgantibody tests were not 
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Table 11.1 Volunteer blood donors 
total number blood donors HBsAg seropositive HBsAg seropositive prevalence 
of screened for blood donors blood donors per cent 
blood donors HBsAg for the detected at the detected at 
first time the first screening subsequent screening 
n n n n ~ 0 
1972 25.111 25.111 47 9 0.19 
d 17.621 9 7.490 d 38 9 9 d 8 Q 1 
1973 29.513 4.233 10 8 0.24 
d 20.615 Q 8.898 d 9 Q 1 d 4 Q 4 
1974 32.672 5.738 13 9 0.23 
6 22.476 Q 10.196 6 6 Q 7 6 8 Q 1 
1975 34.844 5.609 15 5 0.27 
6 23.640 Q 11.204 6 12 Q 3 6 4 Q 1 
1976 35.804 3.893 9 3 0.23 
1\) 6 24.095 Q 11.709 6 8 Q 1 6 3 Q 0 
c.n 
performed routinely in all cases, the exact number of patients who exhibited 
conversion from anti-HBsAg negative to anti-HBsAg positive cannot be calcu-
lated. In addition, studies of individuals who were experimentally or accidentally 
infected with HBsAg have suggested that only transient viremia can exist without 
the formation of antibodies. 
The annual prevalence of HBsAg positive blood donors in the years 1972/1977 
ranged from 0.19 to 0.27, which is in agreement with the prevalence of HBsAg in 
other West European countries (Denmark 0.18: Banke, 1971; Germany 0.2: 
Rittner; United Kingdom 0.1-0.2) and North America (Taswell, 1972). 
In the period 1973-1977 128 blood donors were found to be HBsAg positive. 
All of these 128 blood donors were referred to a physician for a medical check-
up; in 41 of these 128 cases a liver biopsy was submitted to our department. 
11.2.2 GROUP B (SYMPTOMATIC HBSAG CARRIERS) 
Included in this group are 88 HBsAg seropositive patients, who were admitted 
to the hospital with clinical signs of liver disease. Four of these patients were 
taking immunosuppressive drugs at the time of the liver biopsy. Two patients had 
undergone a renal transplantation and one had a lymphoproliferative malignancy. 
Follow-up 
Except in 12 cases, all HBsAg seropositive patients were followed clinically 
and biochemically as long as their liver enzyme levels were abnormal andjor 
HBsAg was detectable in the serum. 
During clinical follow-up a second, third and in some cases a fourth liver biopsy 
was obtained from 34 patients in the study period 1973-1977. However, only in 
18 out of the 34 cases was there sufficient material to perform light microscopical 
as well as immunofluorescence and electron microscopical studies. 
11.2.3 SEX AND AGE 
Sex 
In the group of HBsAg seropositive subjects included in this study, a striking 
preponderance of males is noted. 
Group A: of the 51 asymptomatic HBsAg seropositive individuals 10 were 
females and 41 males. The sex distribution in the group of 41 volunteer blood 
donors was 8 females and 33 males (table 11.2). Of the 7,490 female and 17,621 
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male blood donors screened in 1972 for the presence of HBsAg, 9 females and 
38 males were found to have HBsAg in their serum (the prevalence being 0.12 
and 0.22, respectively). Therefore the femalejmale ratio for the whole group of 
HBsAg seropositive blood donors is approximately equal to the female jmale ratio 
for the group of blood donors in this liver biopsy study. The 6 patients who were 
found to be HBsAg seropositive during a visit to a clinic for venereal diseases 
were all males. 
In group B (88 HBsAg seropositive patients) the liver biopsies examined came 
from 23 females and 65 males (table 11.2). The femalejmale ratio here is slightly 
altered in favor of the males. 
Table 11.2 Femalejma/e distribution in the different groups of HBsAg seropositive 
individuals 
Group A 10 41 
volunteer blood donors 8 33 
Group B 23 65 
Age 
The age of the 139 HBsAg seropositive individuals ranged from 4 months to 
81 years. No liver biopsies from HBsAg seropositive patients between the ages 
of 2 and 16 years were included in this study. 
The age of the volunteer blood donors (group A) ranged between 18 and 65 
years; only individuals in this age range are accepted by the blood transfusion 
services as blood donors. The ages (grouped in periods of 5 years) of the blood 
donors and the other 88 HBsAg seropositive patients are shown separately for 
females and males in figs.ll.1 and 11.2. The ages given in the figures are the ages 
of the patients at the time the liver biopsy was taken; when more than one bioprsy 
was taken, the age at the time of the initial liver biopsy was noted. 
11.2.4 MODE OF INFECTION/HIGH RISK GROUPS 
For approximately one-half of the 139 HBsAg seropositive patients included 
in this study, a possible cause of the HBsAg infection was found. For the other 
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Fig.ll.1 Age distribution of the symptomatic HBsAg positive patients for males and 
females. 
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half of the HBsAg seropositive patients, however, no risk factors or possible 
cause of the HBsAg infection could be established. 
As far as the mode of infection is concerned, parenteral exposure of blood and 
blood products is considered the most important, probably the only, route of 
transmission of the hepatitis B virus (blood transfusion, (self)injections with 
improperlysterilizedsyringes, tattooing, razor blades )(Sherlock, 1 975). However, 
many HBsAg seropositive patients, especially in the younger age groups, did not 
have a history of parenteral exposure or contact with other known hepatitis 
patients. Because HBsA!J has been demonstrated in urine (Heathcote, 1974; 
Hourani, 1978; Di Bisceglie, 1985), stools (Grob, 1971; Villerejas, 1974), saliva 
(Macaya, 1979), semen (Karayiannis, 1985), milk (Boxal, 1974) and the saliva of 
insects; other modes of infection have been suggested for lomg times (venereal, 
enteral, aerogenous; Hersh, 1971 ). 
Irrespective of the fact that the mode of transmission of the HB infection is 
uncertain in many cases, a high incidence of HBsAg has been found for special 
groups of individuals (high risk groups). In addition to immunologic deficiency, 
geography, ethnic factors and socio-economic status, several other factors 
appear to be associated with the ~isk of persistentHBsAg antigenemia, e.g. sex, 
age attesting, age atfirst exposure to infection, occupation, sharing a household 
with other carriers and sexual promiscuity (Szmuness, 1 975). 
Some of these groups consist of subjects who are more likely to become 
infected, e.g. doctors, nurses, laboratory technicians, hemophiliacs (exposed 
groups). In other groups close contact or socio-economic conditions may play 
a major role, e.g. people living in institutions (mentally retarded, prisoners, 
orphans),prostitutes and homosexuals. A variable, sometimes high, incidence 
of chronic hepatitis B infection has been reported for groups of patients with 
immune deficiencies (leukemia, renal transplant recipients) (Hersh, 1971; Grob, 
1971; Perillo, 1981 ). 
The numbers of patients belonging to the various high risk groups are shown , 
in table 11.3. It should be noted that some individuals belong to more than one 
high risk group (the number of such individuals is shown in parentheses). Twenty-
four of the HBsAg seropositive patients were foreigners, chiefly from Mediter-
ranean and South American (Surinam) countries where the incidence of HBsAg 
is known to be high. In the group of volunteer blood donors 14 (± 30 per cent) 
belonged to a high risk group: four were homosexuals (two of them had also been 
treated for a venereal disease and one was a drug addict), two were medical 
technicians, one had received a tattoo three months before and one had had a 
blood transfusion 5 months before. Three blood donors had undergone extensive 
dental treatment (3 to 5 months previously), one patient was under treatmentfor 
venereal disease and two patients had HBsAg seropositive individuals in their 
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Table 11.3 High risk groups 
total blood-donors 
n = 65 n = 14 
Professionals: doctors 
nursers, medical students 5 2 
butchers 3 
Hemophiliacs 
Patients who have had 
a major operation 8 (3) 
(Poly-)transfusions 
' 
Patients treated for 
- venereal disease 16 (2) 3 (2) 
Homosexuals 10 (3) 4 (3) 
Drug addi,cts 15 (3) 
Infection possibly 
related to dental 
treatment 4 3 
Individuals who 
have a tattoo 5 (1) 
Patients with 
leukemia 1 ( 1) 
Renal transplant 
recipients 2 
Individuals with HBsAg 
positive family members 7 2 
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family. Amongst the HBsAg seropositive volunteer blood donors eight were 
foreigners from Mediterranean or South American countries. 
From the available data, there is some evidence that sexual transmission is 
one of the most frequent routes of transmission of hepatitis B infection. 
11.3 HBSAG SERONEGATIVE PATIENTS 
From the 84 HBsAg seronegative patients {29 children and 55 adults) 871iver 
biopsies were taken and processed for light microscopical, electron micro-
scopical and immunofluorescence studies. HBsAg could not be detected in the 
sera of these patients by means of a radioimmunoassay technique (Ausria II, 
Abbott). 
All kinds of liver disease were encountered in these biopsies: alcoholic liver 
disease, chronic active liver disease, biliary cirrhosis, sclerosing cholangitis, 
neonatal hepatitis, congenital biliary atresia, pancreatic fibrosis, a, -antitrypsine 
deficiency, cholangitis, drug-induced liver disease, cy~omegaly and luetic 
infections. 
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CHAPTER Ill 
METHODS 
111.1 SAMPLING OF LIVER BIOPSIES 
The majority of liver specimens were obtained with a True-Cut needle 
(Travenol Laboratories, Dearfield, Illinois, U.S.A.). A small number of liver biopsy 
specimens was taken with the Vim-Silberman needle, while some wedge biopsies 
were obtained during surgical intervention. About one third of all True-Cut needle 
biopsies were taken under laparoscopic control. Out of a total of 1850 biopsy 
specimens 1598 were totally and 252 were partly prepared for light microscopy 
studies. The remaining material of the 252 liver specimens was divided into 
pieces, using a razor blade. One piece of this material was snap-frozen for immu-
nofluorescence studies, another was prepared for ultrastructural examination. If 
sufficient material was available, suspensions of isolated hepatocyteswere made. 
111.2 LIGHT MICROSCOPY 
The liver biopsy sample for the light microscopy studies was fixed in 4 per cent 
buffered formaldehyde for at least 12 hours. In some cases part of the biopsy was 
fixed in 2 per cent paraformaldehyde. The fixed tissue was dehydrated in a series 
of alcohol baths of ascending concentration and embedded in paraplast 
(Sherwood Medical Industries). 
After deparaffination serial 4,u-thick sections were sliced from the blocks and 
routinely stained using the following staining procedures: 
1. Hematoxylin and azophloxin (Hand A). 
2. Hematoxylin and azophloxin with saffron (HAS.). 
3. Periodic acid-Schiff (PAS). 
4. Periodic acid-Schiff after glycogen digestion by diastases. 
5. Lawson-von Giesen's technique for elastin (EG). 
6. Gomori's technique for reticulin. 
7. Aldehyde thionin (AT). 
8. Rubeanic acid for copper. 
9. Perls' stain for iron. 
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In addition Shikata's orcein staining method (Shikata, 1974) was used when 
the liver tissue came from HBsAg seropositive patients as well as those HBsAg 
seronegative patients with ground-glass hepatocytes on the hematoxylin-
azophloxin stained slides or a positive aldehyde thionin stain. 
Sections from most of the biopsies from the HBsAg seropositive patients and 
biopsies with ground-glass cells were used for the immunofluorescence studies 
as described below. The histopathological alterations present in the biopsies 
from the HBsAg seropositive patients were classified as described in chapter IV. 
The degree of fibrosis in the liver tissue was scored as -, +, + +, + + +; 
periportal fibrosis without the formation of porto-portal or porto-central septa 
was scored as +, periportal fibrosis with porto-portal or porto-central septum 
formation in some areas as + +, and peri-portal fibrosis with porto-portal or 
porto-central septum formation throughout the biopsy as + + +.The iron content, 
as determined by Perls' stain, was scored as -, +, + +.Liver tissue with stainable 
iron in only some scattered Kupffer's cells or hepatocytes was scored as +, 
storage of iron diffusely throughout the liver or in groups of Kupffer's cells or 
macrophages as + +. Copper pigment was scored as absent or present. 
111.3 IMMUNOHISTOCHEMICAL TECHNIQUES 
111.3.1 SPECIMEN SAMPLING 
From 252 needle biopsies one or two segments, at least 0.5 em long, were 
sliced with a razor blade onto a dental wax plate. The biopsy segments were put 
on a small piece of cork covered with filter paper or in gelatin capsules and snap-
frozen. The liver tissue was stored in aluminum film boxes in liquid nitrogen. 
111.3.2 SECTIONING 
Four j.l-thick sections were cut from frozen liver tissue at -20°C in a cryostat 
and airdried at room temperature. After drying,the sections were tested with 
antisera (see below) the same day or stored at -20°C for staining the next day. 
111.3.3 FIXATION 
A series of sections from each biopsy was incubated with antisera without 
pretreatment of the slides. Another series was tested with antisera after washing 
with buffered saline (PBS pH 7.2) and a third series was incubated after 
dehydration for 10 minutes in 100 per cent acetone. 
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Moreover after sectioning various fixative solutions (para-formaldehyde, 
glutaraldehyde, alcohol) were applied to slides of a selected group of biopsies 
to study the effect of these fixatives on the morphology and the results of the 
immuno-histochemical procedures. Similarly deparaffinated sections of the 
formalin and paraformaldehyde-fixed, paraffin-em bedded liver tissue were used 
for immunofluorescence staining. 
111.3.4 STAINING 
Direct and indirect immunofluorescence and immunoperoxidase staining 
techniques were applied. For the direct immuno-fluorescence and immune-
peroxidase techniques, the slides were first washed with phosphate-buffered 
saline (PBS pH 7.2) or fixed/dehydrated (see above). Subsequently the slides 
were incubated with labelled antisera for one hour, washed for 30 minutes in PBS 
at 20°C and mounted in a glycerin PBS mixture (9:1, pH 7.8). 
For the indirect immunofluorescence and immunoperoxidase techniques, the 
slides were first incubated with unlabelled primary antisera for 30 minutes and 
washed in PBS for 20 minutes. Subsequently the slides were incubated with FITC, 
TRITC or peroxidase-labelled antisera for 30 minutes, washed again in PBS for 30 
minutes and mounted in the glycerin PBS mixture. For immuno-fluorescence and 
immunoperoxidase staining of paraffin sections, the slides were deparaffinated 
and then incubated with the appropriate antiserum for one hour in a humid 
chamber at 37°C. 
The mounted slides were read directly or stored at -20° C and examined within 
24 hours using a fluorescence microscope. 
111.3.5 MICRO-WAVE-STIMULATED INCUBATION 
To shorten immunofluorescence and immunoperoxidase procedures, micro-
wave irradiation was used in some cases during incubation of the tJssue sections 
with the specific antisera (Hopwood, 1984; Chiu, 1987). Slides covered with 
excess of antiserum in usual dilutions were placed on the bottom of a commer-
cially available household microwave oven (Miele Electronic M696). Microwave 
irradiation was performed at 150 W for 3 to 1 0 minutes. 
111.3.6 FLUORESCENCE MICROSCOPE 
The slides were evaluated in a Leitz orthoplan or a Zeiss fluorescence 
microscope with incident illumination. as described byPioem (1967)and Hijmans 
et al. (1970). A Xenon lamp (Osram HBO 50W) was used for excitation. 
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111.3.7 ANTISERA 
1. Antisera against immunoglobulins/complement factors. 
For demonstration of lgG, lgM, lgA and complement, cryostat and paraffin 
sections of liver tissue were tested with commercially available anti-lgG, anti-
lgM, anti-lgA and anti-complement antisera raised in rabbits (Central Laboratory 
of the Netherlands Red Cross Bloodtransfusion services, Amsterdam, the 
Netherlands and Kallestad Diagnostic Incorporation, Austin, Texas, USA). 
2. Antisera against HBsAg. 
A commercial HBsAg (subtype "ad") antiserum raised in rabbits was obtained 
from Behring Werke, Frankfurt, FRG). This serum was used in combination with 
the FITC labelled horse anti-rabbit antiserum, according to the method described 
by The and Feltkamp (1970) (CLB, the Netherlands). 
A second HBsAg (subtype "ad") antiserum was raised in rabbits. These rabbits 
were hyperimmunized with HBsAg isolated from HBsAg positive human serum 
(Duimel, 1972). Complement in the antiserum was inactivated by heating (56°C) 
after incubation of the antiserum with human erythrocytes and sepharose beads 
coated with HBsAg-negative human serum (Avrameas, 1969). Neither hetero-
agglutinins nor antibodies against human serum proteins were detectable in this 
antiserum by immuno-electrophoresis and agar double immunodiffusion (Ouch-
terlony, 1973). 
lg fractions ofthe anti-serum were conjugated with fluorescein isothio-cyanate, 
according to The and Feltkamp (1970). The molar F /P ratio for this serum was 
2.3; it was free of I g proteins with an F /P ratio of less than 1 and more than 4. The 
titer of this HBsAg antiserum found by the Ouchterlony tech-nique was 1 :218; 
passive hemagglutination yielded a value of 1 :500,000. The final working dilution 
of the antiserum for cryostat sections was 1:50. 
A third antiserum against HBsAg (subtype "ad") was obtained from a patient 
who had recently recovered from a hepatitis B infection. This serum contained 
antibodies against HBsAg, at a titer of 1:125,000 according to the passive 
hemagglutination technique. The lg fraction of this serum was used for the indi-
rect fluorescence technique, in combination with a FITC labelled horse anti-
human immunoglobulin serum (CLB, the Netherlands) as secondary antibody.ln 
addition a mouse monoclonal HBsAg antibody, kindly provided by Organon, 
was used on a part of the biopsy material. 
All three polyclonal HBsAg (subtype "ad") antisera and the monoclonal (against 
determinant "a") antibody yielded a strong and identical fluorescence pattern for 
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liver tissue from HBsAg seropositive patients without a disturbing background. 
Minimal non-specific fluorescence of (eosinophilic) leukocytes in liver tissue from 
both HBsAg seropositive and HBsAg seronegative patients was abolished by 
absorption of the antisera with sonicated preparations of purified polymorpho-
nuclear leukocytes. After absorption of the antisera with HBsAg positive serum 
all fluorescence was abolished. The fluorescence was not influenced by 
absorption with HBsAg-negative serum. Preincubation of HBsAg positive liver 
tissue with unlabelled anti-HBsAg antisera abolished the fluorescence of the 
labelled antiserum. As negative controls for the indirect fluorescence technique 
rabbit serum and normal HBsAg-negative human serum were used. 
An antiserum against HBsAg (subtype "ay") was raised in guinea pigs hyper-
immunizedwith a purified HBsAg (subtype "ay"). This antigen was obtained from 
the serum of an HBsAg (subtype "ay") positive patient by absorption of this serum 
with sepharose beads coupled to the purified rabbit antiserum against HBsAg 
subtype "ad" (see above). The guinea pig antiserum against HBsAg (subtype "ay") 
was purified of spurs of antibodies against human serum proteins by absorption 
with sepharose beads coupled to normal HBsAg-negative human serum 
(Avrameas, 1969). 
The lg fraction ofthis anti-serum showed the same fluorescence characteristics 
as the antisera containing antibodies against subtype "ad" HBsAg. 
After incubation with this anti-serum, a FITC labelled horse anti guinea pig 
r-globulin (Hyland, Ontario, Canada) was used as second fluorescence layer. 
Antisera to viral coat determinants "d" and "y" were prepared by absorption of 
the HBsAg (subtype "ad") rabbit antiserum with human serum positive for HBsAg 
(subtype "ay") and by absorption of the HBsAg (subtype "ay") guinea pig 
antiserum with human serum positive for HBsAg (subtype "ad"). 
The antiserum against the "d" determinant induced a fluorescence pattern 
similar to that of HBsAg (subtype "ad") antiserum for liver tissue derived from a 
HBsAg (subtype "ad") seropositive patient, while this antiserum caused no fluor-
escence in a liver biopsy obtained from a HBsAg (subtype "ay") seropositive 
patient. Similarly the antiserum against the "y" determinant induced the same 
fluorescence pattern as the guinea pig antiserum against HBsAg (subtype "ay") 
in liver tissue from a HBsAg (subtype "ay") seropositive patient. No fluorescence 
was seen in liver tissue from a HBsAg (subtype "ad") seropositive patient. 
3. Antisera against HBcAg. 
An antiserum against the viral core determinant (HBc) was obtained from a 
patient with an acute self-limiting HBsAg positive hepatitis two days after the 
HBsAg level just exceeded background levels, using the radioimmunoassay 
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technique (Ausria II, Abbott Laboratories, IL, USA) (Hoofnagle, 1973); HBeAg, 
anti-HBe and HBsAg were negative. This serum produced positive fluorescence 
of liver cell nuclei in those biopsies in which nuclear core particles were de-
monstrated ultrastructurally. No specific fluorescence was seen in liver biopsies 
from HBsAg seronegative patients. FITC labelled horse anti-human antiserum 
(CLB, see above) or peroxidase labelled anti-human antiserum (Dakopatts, 
Denmark) were used as second layer. Secondly, a mouse mono-clonal anti-
HBcAg antibody was kindly provided by Organon. This antibody showed no anti 
HBs and anti HBe activity. 
4. Antiserum against HBeAg. 
A mouse monoclonal antibody against HBeAg was kindly provided by 
H.C.Thomas. 
5. Antiserum against Delta antigen. 
A monoclonal FITC and peroxidase labelled antibody against delta antigen was 
kindly provided by Rizzetto. This antibody showed no anti-HBe and anti-HBs 
activity. 
111.4 ELECTRON MICROSCOPY 
111.4.1 SPECIMEN SAMPLING 
One or two small pieces of each of the 252 liver specimens ( 1 mm3 ) were sliced 
(within 3 minutes of the biopsy procedure) onto a dental wax plate with a razor 
blade and placed in a Karnovski {1965) or glutaraldehyde fixative solution. 
111.4.2 FIXATION 
Fixation was carried out with 3 per cent glutaraldehyde in 0.1 mol. Na-
cacodylate and 0.05 mol. CaCI2 in distilled water (pH 7.4) or Karnovski's fixative 
at a temperature of 4°C. The specimens were kept in the fixatives for at least 
three days and then transferred for 24 hours to a buffer solution consisting of 
0.1 mol. Na-cacodylate and 0.05 mol. CaCI 2 in distilled water (pH 7.4) before 
postfixation for 16 hours in 1 per cent Os04 in 0.1 mol. Na-cacodylate (pH 7.3) 
to which 0.05 mol. K3Fe(CN)6 had been added (De Bruijn, 1973). 
40 
111.4.3 DEHYDRATION 
Dehydration was performed at room temperature in a series of acetone baths 
of ascending concentration, 2x1 0 minutes in 30 per cent acetone followed by 
2x1 0 minutes in 50 per cent, 2x1 0 minutes in 70 per cent, 2x1 0 minutes in 90 per 
cent and 2x1 0 minutes in 100 per cent acetone. 
111.4.4 INFILTRATION 
After dehydration the tissue was immersed in a solution of 1 .2 mmol epoxy-
propane for 2x1 0 minutes and then in a mixture of EPON 812 (Shell) and acetone 
(1 :1) for one hour at room temperature. 
111.4.5 EMBEDDING 
Embedding was carried out in gelatine capsules containing Epon-C. The Epon-
C mixture consisted of 38 ml Epon 812 (Shell), 26 ml dodecanyl succinic 
anhydride and 20 ml methyl nadix anhydride (FLUKA). 
111.4.6 POLYMERIZATION 
A suitable degree of hardness was achieved by keeping the capsule at 37°C 
for 18 hours and then at 60°C for 2x24 hours. 
111.4.7 SECTIONING AND MICROSCOPY 
One f-Lm thick survey sections of the liver tissue blocks were cut on a LKB 
pyramiton, equipped with glass knives. They were then stained with toluidine-
blue. Small areas (0.20x0.20 mm) of liver parenchyma were selected for further 
ultrathin sectioning. For this purpose, the blocks were trimmed into small 
pyramids and cut with an LKB ultramicrotome with glass knives. The sections 
were mounted on Formvar-coated copper grids and stained with uranyl acetate 
and lead citrate. The sections were examined and photographed with a Philips 
E.M. 200. 
111.5 DETECTION OF ANTIGENS ON THE CELL SURFACE OF HEPATOCYTES 
For the detection of Hepatitis B surface antigen, immunoglobulins and com-
plement factors on the surface of hepatocytes, sedimentation and suspension 
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preparations of isolated hepatocytes from 50 of the biopsies from HBsAg 
seropositive patients were prepared. 
111.5.1 ISOLATION OF HEPATOCYTES 
A piece of liver tissue, the mass of which depended on the quantity of available 
liver material, was stored immediately after the biopsy procedure in a 5 per cent 
serum albumin solution in PBS (according to Hijmans, 1970) at 0-20°C. Within 
three hours the material was gently divided into fine fragments in some drops of 
Hijmans' solution on a glass slide using two preparation needles (temperature 
4° C). The suspension was transferred with a plastic pipet into a plastic tube 
containing Hi jmans' solution. The larger fragments of the suspended liver tissue, 
consisting chiefly of fibrous tissue, were removed. If larger liver tissue specimens 
were available (from surgical biopsies) 1 mm cubes of liver tissue were 
fragmented in Hijmans' solution (using a Borel bore). The suspension of liver and 
isolated hepatocytes was washed twice by centrifugation for 10 minutes at 1000 
r .p.m. After the first washing in Hijmans' solution the resuspended liver cell pellet 
was divided into two equal portions. After centrifugation one portion was 
resuspended in 5 per cent bovine serum albumin for the sedimentation 
preparations and one portion was resuspended in 1 per cent bovine serum 
albumin for the suspension preparations of hepatocytes. 
111.5.2 IMMUNOFLUORESCENCE TECHNIQUE FOR SEDIMENTATION PREPARATIONS OF 
ISOLATED HEPATOCYTES 
Six sedimentation preparations were made from the suspension of isolated 
hepatocytes in 5 per cent Hijmans' solution. Firstly, five drops of .PBS (pH 7.4) 
were put in a sedimentation chamber (temperature 0°-2°C). A few minutes later, 
five to seven drops of the suspension were added to the sedimentation chamber, 
depending on the concentration of hepatocytes. The preparations were dried in 
the sedimentation chamber overnight. Two slides were incubated with a FITC 
labelled rabbit anti-HBsAg antiserum, one with FITC labelled anti-lgG (CLB) and 
another with a FITC labelled anti-complement antiserum (CLB); one slide was 
stained with Giemsa. The same day the slides were read under the fluorescence 
microscope. 
111.5.3 IMMUNOFLUORESCENT TECHNIQUE FOR SUSPENSION PREPARATIONS OF 
ISOLATED HEPATOCYTES 
The suspension of hepatocytes in a 1 per cent serum albumin solution was 
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divided into two portions, one for incubation with rabbit a-HBsAg, another for 
incubation with the FITC labelled a-lgG (CLB, the Netherlands). 
The concentration of the fluorescein labelled antisera was twice as high as that 
used for the fluorescence technique for slides. One hour after incubation at 4 ° C, 
the suspensions were washed twice by centrifugation (1 000 r.p.m.). The pellet 
was resuspended in a few drops of buffered glycerin solution (pH 7.8). This 
suspension was put on a glass slide and read immediately under a fluorescence 
microscope. 
111.6 SEROLOGY 
Patient sera were tested on the presence of HBsAg with standard radio-
immunoassay (Ausria II, Abbott laboratories, II, USA). The presence of HBeAg 
and anti-HBe in serum were measured by double immunodiffusion technique 
and later on by radioimmunoassay (Abbott, USA). For the measurement of 
HBeAg by radioimmunoassay a constant serum dilution was used. This dilution 
was chosen such that a P /N ( cpm patient sample/ cpm negative controle sample) 
ratio of approximately 12 ± 2 would be obtained in pretreatment sera. A P /N ratio 
of less than 2.1 in undiluted serum was considered HBeAg negative. 
DNA-polymerase activity was measured by the method of Howard as modified 
byFang(1981). 
Anti-delta agent antibodies were determined by Elisa (Abbott, laboratories, IL, 
USA). 
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LIGHT MICROSCOPY OF VIRAL HEPATITIS, TYPE B 
45 

CHAPTER IV 
LIGHT MICROSCOPY OF VIRAL HEPATITIS, TYPE B 
IV.1 INTRODUCTION 
Hepatitis, defined as a diffuse necrotizing inflammatory disease of the paren-
chymal cells of the liver, is known to have several etiological causes (e.g. drugs, 
c.lcohol, viruses) and multiple morphological variants. In man hepatitis of viral 
origin can occur as part of a systemic infection by herpes simplex virus type 1 
(Fiewett, 1969), Epstein-Barr virus, cytomegalovirus (Stern, 1972; Toghill, 1967; 
Snover, 1984) and Coxsackie virus (Sun, 1 966) or by specific hepatotropic 
viruses (viral hepatitis). 
Two types of viral hepatitis (hepatitis A and hepatitis B) are well known and 
can be distinguished by means of serological and epidemiological data 
(Krugman, 1976). The presence of one or more additional hepatitis viruses was 
implied by clinical and serological observations (Feinstone, 1975). In fact, after 
a long search, an additional virus is identified recently (Choo, 1989; Kuo, 1989; 
Houghton, 1988). However as long as tests for the presence of non-A, non-S virus 
infection are not available, the general term non-A, non-S hepatitis is to be 
preferred over a more definitive designation, such as hepatitis C. 
The introduction of the liver needle biopsy, as a safe method for evaluation of 
liver disease, together with the availability of markers to identify hepatitis B virus 
(HBV) infection resulted in detailed knowledge of the histopathological features 
of HBV infections, in both man and chimpanzees. By means of a liver needle 
biopsy it is possible to obtain information regarding stage and prognosis of the 
disease (Bianchi, 1971 ). 
With the development of a variety of serological markers for hepatitis A 
infection (Miller, 1975; Purcell, 1976), reliable data on histopathological changes 
and the natural course of hepatitis A could be obtained (Dienstag, 1981; 
Lindberg, 1978; Mathiesen, 1980). In contrast to hepatitis type A, which is 
generally considered to be an essentially benign and self-limiting disease, 
hepatitis B runs a complex natural course with a wide range of clinical 
symptomatologies and histopathological changes (table IV.1 ). 
Using chimpanzees experimentally infected with hepatitis type A or type B, 
Dienstag ( 1976) noted that the pattern of histo-pathological alterations in serial 
liver biopsies is basically the same for hepatitis A and hepatitis B. However, the 
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morphological changes are of shorter duration in hepatitis A; in hepatitis B they 
last much longer, showing fluctuations and slow regression. The location of 
parenchymal changes in hepatitis A is predominantly periportal in combination 
with a prominent portal round-cell infiltrate. In contrast, in hepatitis B the paren-
chymal alterations are found chiefly around the central veins while the portal 
infiltrate is less pronounced compared to that in hepatitis A. Later, another type 
of experimental hepatitis B was identified in chimpanzees; comparable with the 
manifestations ofthe carrier state in man. This infection has smoldering features, 
and is characterized histologically by a prominent portal inflammatory infiltrate, 
as seen in human chronic persistent hepatitis (Shikata, 1980; Shouval, 1980). 
In contrast to the results obtained for chimpanzees, no distinct constant 
diagnostic differences in the morphological changes characterizing acute 
hepatitis caused by hepatitis virus type B or type A could be found for man 
(Peters, 1975; Ishak, 1976; Ludwig, 1977; Phillips, 1981 ).In addition to the histo-
logical picture of an acute hepatitis a wide range of clinicopathological 
manifestations can be seen following an HBV infection (fig.IV.1 ). 
Fig.IV.1 Clinicopathological reaction patterns after a hepatitis 8 infection 
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Although the factors which determine the variable clinical and morphological 
aspects are not clearly understood, the interaction of the hepatitis B virus and 
the host produces roughly two clinico-histopathological types of lesion: 
a. acute hepatitis, which in general corresponds to the morphological picture 
of lobular hepatitis. 
b. chronic hepatitis, which in general has the morphological picture of a portal 
or periportal hepatitis. 
The histological definitions of classic acute and chronic hepatitis are rather 
simple and well defined (Bianchi, 1971 ). Nevertheless, the spectrum of the 
morphological pictures of both acute and chronic hepatitis B is broad and merge 
imperceptibly into one another. The morphological variations in acute and 
chronic hepatitis which are probably related to differences in the immune 
response of the host may cause diagnostic problems for the pathologist. 
Clinically the differentiation between acute and chronic hepatitis may also be 
difficult, sometimes impossible. Hepatitis is arbitrarily considered chronic when 
biochemical changes are present for at least 1 0 to 12 weeks (Summerskill, 1 97 4 ). 
However, some authors (Mistilis, 1970; Sherlock, 1974, 1976) demand a mini-
mum time limit of six months before calling a hepatitis chronic, since in some 
instances self-limiting acute hepatitis can last this long. 
These difficulties and the many efforts to create a single classification system 
that is both clinically and histologically valid have resulted (in the past) in an 
inextricable terminology (Conn, 1976). In addition, nomenclature is further con-
fused by the use of many undefined temporal connotations such as acute, sub-
acute (Boyer, 1970; Tisdale, 1963), subchronic (Bjorneboe, 1949) and chronic 
(Conn, 1 976). Because the terminology applied by various authors differed, 
earlier reports on hepatic disease are exceedingly difficult to interpret and 
compare. It should be stressed that a uniform and reproducible classification 
system is indispensable for a comparison of the various studies on hepatic 
disease and for appraisal of the effects of therapeutic agents on these liver 
disorders. Histological evaluation of the effects of therapeutic agents on hepatitis 
B is particularly important, since several clinical trials have suggested that 
immunosuppressive and antiviral therapies (prednisone, azathioprine, interferon, 
acyclovir)(Cook, 1971; Soloway, 1972; Schalm, 1 982; de Man, 1 988) can prevent 
or at least slow down the progression from severe chronic hepatitis to lethal liver 
disease. The outcome of more benign types of hepatitis is not influenced by such 
therapy. 
A newly introduced and widely accepted classification system for hepatitis has 
now led to considerable improvement in the sense that the same terminology is 
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Fig.IV.2 Representation of different histopathological expression patterns of hepatitis 8 infection and their mutual 
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now used throughout the world, although all semantic problems have not yet 
been solved. This classification is based chiefly on histopathological criteria 
together with some clinical implications. However, histo-pathological classifi-
cation is still prey to several everlasting difficulties (fig.IV.2) and so far, liver 
biopsies are only of moderate value for predicting the prognosis of the disease. 
This new classification system also uses temporal connotations such as acute, 
chronic and persistent. Because of the wide spectrum of histological changes in 
the various clinico-pathological categories, it would be of benefit to eliminate all 
temporal connotations in the histological description of liver disorders and to 
base classification on morphological changes only (lobular, portal, periportal 
hepatitis; Ludwig, 1977). The morphological alterations, supplemented with 
clinical, biochemical and pathogenetic information, should lead to the ultimate 
clinicopathological diagnosis. Therefore for a definite diagnosis, integration of 
clinical, biochemical, virological and (immuno )-histological data is indispensable 
(fig.IV.3). 
In this chapter the histological variants of hepatitis B infection are described, 
using in principle the terminology propagated by the International Association 
for Study of the Liver and endorsed by the World Health Organization. In chapter 
V the material investigated will be grouped according to this classification system 
and discussed. 
Fig.IV.3 Scheme showing the path leading to a final diagnosis based on changes in 
a liver biopsy 
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IV.2 CLASSIFICATION SYSTEM OF HEPATITIS. 
The various categories of (viral) hepatitis are discussed under the following 
headings: 
IV.2.1 
a. 
ACUTE HEPATITIS 
extent of necrosis 
acute hepatitis with focal necrosis 
acute hepatitis with bridging necrosis 
acute hepatitis with multilobular necrosis 
/ 
acute hepatitis with massive necrosis 
b. stage of development 
early stage 
fully developed stage 
late stage 
residual stage 
c cholestasis 
IV.2.2 
a. 
b. 
IV.2.3 
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acute cholestatic hepatitis 
CHRONIC HEPATITIS 
chronic persistent hepatitis 
chronic active hepatitis 
mild 
moderate 
severe, including bridging hepatic necrosis 
CIRRHOSIS 
IV.2.1 ACUTE HEPATITIS 
In acute viral hepatitis there are hardly any diagnostic morphological features 
which distinguish it from other types of acute hepatitis (e.g. drug-induced 
hepatitis). Histopathological examination therefore does not play a significant 
role in the separation of acute viral hepatitis from other types of acute hepatitis. 
However, it can be of importance in the differentiation of acute hepatitis from 
other liver diseases that clinically resemble acute hepatitis (e.g. drug-induced 
cholestasis, biliary obstruction, acute exacerbation of chronic hepatitis). 
The morphological picture of acute viral hepatitis, as described by many 
authors (Bianchi, 1971; Peters, 1975; Ishak, 1976; Phillips, 1981 ), is with rare 
exceptions (see below) predominated by changes in the hepatic lobuli. The 
characteristic light microscopic feature is that of a lobular hepatitis. In fact, from 
a functional point of view, acinar hepatitis would be a more appropriate desig-
nation (Rappaport, 1976) but, because it is not widely used, it will not be applied 
here. Although changes in the portal tracts are always present, they are in most 
cases far less evident than the changes in the lobuli. These lobular changes 
consist of: 
a. degeneration and necrosis of liver parenchymal cells. 
b. inflammatory infiltration. 
c. mesenchymal reaction. 
The mutual relationships and degree of these different aspects of acute 
hepatitis are related to the duration of the disease; they are helpful in roughly 
determining the stage of viral hepatitis (Bianchi, 1971 ). On the basis of these 
features we can distinguish an early, a fully developed, a late and a residual phase 
of acute hepatitis although delineation from one phase to the next is vague. In 
addition, based on the extent of necrosis of the liver parenchymal cells, some 
morphological variants of acute hepatitis are recognized: 
acute viral hepatitis with necrosis of solitary scattered hepatocytes. 
acute viral hepatitis with bridging necrosis. 
acute viral hepatitis with multilobular necrosis. 
acute viral hepatitis with massive necrosis. 
Thus, two factors can be considered for the subdivision of acute hepatitis: the 
extent of necrosis and the stage of development (duration). 
It will be clear that the degree of necrosis can determine the short-term 
prognosis of acute hepatitis as well as the post-hepatic sequelae.lt is doubtful 
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whether extensive necrosis of the liver parenchyma in acute hepatitis is in some 
way associated with conversion into chronic hepatitis (Boyer and Klatskin, 1970). 
On the contrary, Sherlock (1976) demonstrated that lobular hepatitis without 
jaundice, i.e. hepatitis with a low degree of necrosis, is related to the development 
of a chronic hepatitis. The natural course of lobular (acute) hepatitis is variable, 
as shown in fig.IV.4. 
The general morphological changes in acute viral hepatitis will be described 
separately for the lobules and portal tracks, followed by a short description of 
the various histopathological categories of acute hepatitis with respect to: 
a. the extent of necrosis. 
b. the stage of development. 
c: cholestasis. 
Fig.IV.4 Scheme illustrating the various courses of an acute hepatitis 8 
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Lobular changes 
a. Degeneration and necrosis of liver parenchymal cells. 
An increased mitotic activity with the appearance of numerous binucleate hepato-
cytes is considered to be the earliest light microscopic feature of viral hepatitis 
(Bianchi, 1971 ). 
Subsequently but preceding jaundice as a clinical sign of acute hepatitis, 
degeneration and necrosis of the liver cells dominate the morphological picture. 
Liver cell damage occurs partly in the form of hydropic swelling and partly in the 
form of eosinophilic shrinkage of hepatocytes. These changes are seen in all 
lobules, although to a variable degree. 
The hydropic swelling of hepatocytes, the most striking feature of classical 
fully developed acute hepatitis, is found particularly around the hepatic venous 
radicles. At low power magnification it causes a typical picture of extreme 
centrilobular anisomorphism of the hepatocytes (fig.IV.5). These swollen cells, 
which are sometimes two to three times larger than normal, contain a finely 
granular, almost homogeneous, pale eosinophilic cytoplasm and a large nucleus 
with a prominent nucleolus (fig.IV.6). This aspect of the hepatocytes is known as 
"ballooning". It is believed that these changes arise from imbibition offluid due to 
a disturbed membrane pump function and are, up to a point, reversible (Trump, 
1975). However, hydropic degeneration often causes disruption of the cellular 
membrane, resulting in spillage of cell organelles into Disse's spaces and the 
sinusoidal lumen. These ballooned hepatocytes must be differentiated from so-
called "feathery degenerated" hepatocytes (fig.IV. 7). This feathery degeneration 
is due to cholestasis and may be found also in viral hepatitis, especially the 
cholestatic variant. 
Eosinophilic degeneration, the other type of hepato-cellular damage, is charac-
terized by cell shrinkage and deeply eosinophilic aspect of the cytoplasm (Kerr, 
1971 ). In contrast to hepatocytes with ballooning degeneration, which are local-
ized predominantly around the venous radicles, hepatocytes with eosinophilic 
degeneration are dispersed throughout the liver lobule. They lose their position 
in the hepatic cord (apoptosis) and are found in the sinusoids or Disse's spaces, 
partly phagocytized by Kupffer's cells, as rounded deep eosinophilic structures 
with or without nuclear remnants. They are known as acidophilic, apoptotic or 
free hyaline bodies (fig.IV.8). These bodies were first described by Councilman 
( 1890) in livers from patients with yellow fever and since then often referred to as 
Councilman-like or Councilman bodies. Klion and Schaffner (1966) attributed 
these changes to dehydration and Trump ( 1976) explained them by loss of cel-
lular water due to selective loss of potassium in the event of excess sodium gain. 
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Fig.IV.5 Acute hepatitis in the fully developed/late stage. Note the essentially 
centrilobular changes with small foci of collapse, the round-eel/ infiltrate 
and the hepatocellular disarray (Hand A, 160x). 
Fig.IV.6 Acute hepatitis. Hepatocytes with ballooning degenerative changes.Nuclei 
are large and reveal a prominent nucleus (Hand A, 380x). 
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Fig.IV. 7 Liver tissue containingthree hepatocytes with feathery degeneration of the 
cytoplasm (Hand A, 380x). 
Fig.IV.S Acute hepatitis: scattered Councilman bodies (arrows) (Hand A, 380x). 
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Although most authors stress the frequent occurrence of Councilman bodies 
in acute viral hepatitis (Cavalli et al., 1968), they are not specific for viral hepatitis. 
However, the combination of Councilman bodies and hepatocytes with balloon-
ing degeneration around the venous tributaries in particular is highly indicative 
of viral hepatitis. The hydropic swelling and the necrosis together with the re-
generative activity of hepatocytes cause a distortion of the architecture of hepatic 
lobules due to loss of uniformity and thickening of the liver cell plates, particularly 
in the centrilobular regions. Often rearrangement of hepatocytes in acini can be 
found in these regions (fig.IV.9). In the event of necrosis of solitary hepatocytes 
minimal condensation of the reticulin skeleton occurs focally. 
Necrosis of groups of hepatocytes in a relatively short time interval results in 
collapse of the reticulin framework in these areas (fig.IV.1 0). The degree of liver 
cell necrosis has implications for the post-necrotic sequelae e.g. cirrhose. No 
relation has been demonstrated between the degree of liver cell necrosis and 
transition to chronic liver disease. 
b. Inflammatory infiltration. 
In acute hepatitis the infiltrate within the lobuli is usually mild to moderate and 
consists of small aggregates of lymphocytes and monocytes, especially in the 
centrilobular regions (fig.IV.11 ). Polymorphonuclear leukocytes are scanty, in 
contrast, for example, to the many seen in alcoholic and drug-induced acute 
hepatitis. In the event of confluent necrosis the inflammatory infiltrate is not 
impressive: it is usually less marked than that seen in classical lobular hepatitis 
(Peters, 1975). 
c. Mesenchymal reaction. 
In classical acute hepatitis, liver cell necrosis is followed by a significant mesen-
chymal reaction, which comprises activated macrophages, Kupffer's cells and 
endothelial lining cells. These cells occur as solitary elements or as aggregates 
together with some lymphocytes and polymorphonuclear leukocytes in the vicin-
ity of a collapsed reticulin skeleton. Both the enlarged Kupffer's cells and 
macrophages and the swollen endothelial cells may virtually occlude the sinus-
oidal lumen, thereby presumably causing changes in the microcirculation. The 
macrophages, situated chiefly in the centrilobular areas, are loaded with irregular 
granules of yellowish brown pigment, representing the desintegrated and phago-
cytized parts of necrotic liver cells (fig.IV.11 ). Sometimes necrotic hepatocytes 
or acidophilic bodies are seen in the cytoplasm of these macrophages. This 
pigment, one of the lipofuchsin pigments (glycoproteins ), is known as ceroid 
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Fig.IV.9 Acute hepatitis: centrilobular area with marked hepatocellular disarray; 
cytoplasmic and nuclear anisomorphism, multinucleation and acinar re-
arrangement; mononuclear infiltrate (Hand A, 380x). 
Fig.IV.1 OAcute hepatitis: centrilobular necrosis of hepatocytes. Note accumulation 
of ceroid-containing macrophages (PAS after diastase, 160x). 
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Fig.IV.11 Acute hepatitis in the fully developed/late stage. Note the large clusters of 
macrophages, Kupffer's cells loaded with ceroid pigment and lymphocytes 
(PAS after diastase, 380x). 
pigment. The periodic acid Schiff reaction after diastatic pretreatment and 
aldehyde thionin stain demonstrate the presence and quantity of this pigment 
very well. Under the fluorescence microscope this ceroid pigment exhibits a 
bright auto-fluorescence. At a later stage, pigment-loaded macrophages are 
believed to move from the site of liver cell necrosis to the portal areas, where they 
can be found in large quantities. 
The distribution and location of these pigment-loaded macrophages play an 
important role not only in determination of the stage of acute hepatitis but also 
in differentiation from so-called reactive hepatitis. Reactive hepatitis is believed 
to be the result of extra-hepatic events, in which the mesenchymal compartment 
of the liver (Kupffer's cells, endothelial lining cells) plays a role in the clearance 
and breakdown of necrotic material and polluting elements transported in the 
blood from outside the liver, especially from the intestinal tract. 
In cases of reactive hepatitis Kupffer's cells are diffusely scattered throughout 
the lobuli in contrast to acute viral hepatitis in which pigment macrophages occur 
in clusters (fig.IV.12). In acute viral hepatitis the macrophages may also contain 
some iron pigment in addition to the ceroid pigment. Although the presence of 
iron pigment is considered by some authors to be an essential feature of acute 
60 
Fig.IV.12Reactive non-specific hepatitis. Diffuse activation and swe/lingof Kuptrer's 
cells .Increase in i nf I ammatory i nf i It rate in sinusoid s. Only mini mal changes 
in hepatocytes (PAS after diastase, 380x). 
viral hepatitis (Scheuer, 1980), the quantity differs widely from case to case. In 
most cases of acute viral hepatitis in our series, no iron pigment could be 
detected at all. The number of activated macrophages in classic lobular hepatitis 
is striking, but the degree of hepatocellular necrosis is not always proportional. 
In some cases of extensive necrosis, relatively few pigment macrophages are 
seen. Probably the degree and rate of necrosis in the liver is so great that before 
the macrophages are sufficiently activated, the cell debris is carried off in the 
blood stream, which can be a factor in cerebral dysfunction. 
Portal changes 
In all types of acute viral hepatitis, portal changes are present but less 
prominent than the lobular changes. The portal tracts show some expansion due 
to edema of the portal connective tissue and the presence of an inflammatory 
infiltrate. This infiltrate consists of lymphocytes, histiocytes, some plasma cells 
and polymorphonuclear leukocytes. Eosinophilic granulocytes, which are con-
sidered by most authors to be an indication of drug-induced hepatitis, are 
sometimes present in strikingly large quantities. Although the bile ducts are 
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normally intact, changes in the epithelium of the interlobular bile ducts may be 
present as well (fig.IV.13). Poulsen {1969) pointed out changes in the bile ducts 
in some cases of viral hepatitis, which transform into chronic active hepatitis. 
These bile duct changes sometimes cannot be distinguished from the changes 
seen in early primary biliary cirrhosis. In contrast, Schmid ( 1972) noted bile duct 
changes resembling those of mechanical obstruction of the extra-hepatic bile 
ducts in nine of 109 cases of viral hepatitis with "submassive" necrosis. In acute 
cholestatic viral hepatitis (see below) marked proliferation of the cholangioles is 
sometimes seen. The lumen is often dilated and may contain bile, and the wall is 
infiltrated with neutrophils. 
In acute hepatitis the portal infiltrate can sometimes extend deep into the lo-
bular parenchyma which then exhibit the features of periportal (chronic) hepa-
titis (fig.IV.14). In these cases a diagnosis of chronic hepatitis can mistakenly be 
made by the pathologist. However, the simultaneous presence of lobular changes 
and the lack of portal fibrosis in these cases should prevent the pathologist from 
making this wrong diagnosis. In drug-abusers, in particular, a prominent portal 
infiltrate can be seen. 
Various categories of acute hepatitis 
IV.2.1.a Extent of necrosis 
The degree and rate of liver cell necrosis in acute hepatitis vary from patient 
to patient. The cause of this variability is not known exactly, but it may be the 
result of variations in either the virulence of HBVor immunological defense mech-
anisms against the virus or viral products. In general it appears that the stronger 
and faster a patient reacts to the virus or viral products, the faster the virus is 
eliminated with less chance of the development of a chronic hepatitis. On the 
other hand an explosive reaction to the virus infection, reflected in extensive 
necrosis and fulminant hepatitis, can result in life-threatening situations. More-
over the extent of necrosis is certainly of significance for the short-term prognosis 
which then depends on the regenerative capacity of the liver parenchyma. 
IV.2.1.a.1 Focal necrosis 
In focal necrosis, multiple small foci of liver cell necrosis are seen, usually 
concentrated around the central venous tributaries, with some condensation of 
the reticulin framework in this area. This type of acute hepatitis, together with the 
type in which necrosis of only scattered solitary liver cells is seen, is known as 
classical lobular hepatitis. This histological type of acute hepatitis usually runs a 
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favorable self-limiting course with few or no residual sequelae after recovery. 
Clinically this type of acute hepatitis will run an icteric or anicteric course. A 
small number of cases with icteric acute hepatitis turn into a chronic form of 
hepatitis (7-9 per cent; Redeker, 1975). The percentage of patients with acute 
anicteric hepatitis who develop a chronic form of hepatitis is unknown because 
anicteric or subclinical cases unusually remain unrecognized. Sherlock (1976), 
however, stressed that an anicteric acute hepatitis is more often followed by 
chronic hepatitis than an icteric acute hepatitis, and indeed many patients with 
chronic hepatitis have no history of jaundice. 
IV.2.1.a.2 Bridging necrosis 
In bridging necrosis, described by Boyer and Klatskin (1970) as subacute hepatic 
necrosis, the degree of confluent necrosis is such that portal tracts and central 
veins as well as mutual central veins are linked together by necrotic areas: septa 
of collapsed reticulin (so-called passive septa) run from central veins to portal 
tracts (central-portal bridging) and from central veins to central veins (central-
central bridging). Theoretically these septa of collapsed reticulin form a scaffold 
for the later development of fibrous septa. This histological type of hepatitis 
sometimes follows a fatal course, especially in older patients. In younger patients 
the outcome is usually quite favorable with or without so-called post-hepatic 
scarring or cirrhosis (Boyer and Klatskin, 1970). It should be mentioned that brid-
ging necrosis can also be a phenomenon of a severe type of chronic active hepa-
titis. In these cases the hepatitis generally follows an insidious clinical course. To 
differentiate between the collapse of liver parenchyma seen in acute hepatitis and 
the development of active septa with new fiber formation in chronic hepatitis, 
orcein and special collagen staining methods can be helpful (Scheuer, 1980). 
IV.2.1.a.3 Multilobular necrosis 
In multilobular necrosis all, or nearly all, hepatocytes in adjacent lobuli are 
destroyed (fig.IV.15). The reticulin skeleton in these lobuli is condensed but the 
architecture remains in principle intact. The condensed reticulin skeleton shows 
the location of the pre-existing liver cell plates and provides the framework for a 
complete regeneration of the lobulus. The portal tracts stand close together, 
separated by the collapsed lobuli that contain variable amounts of Kupffer's cells 
and macrophages. The portal tracts show changes, the degree of which depends 
on the rate of liver cell necrosis. The essentially intact liver architecture is best 
visualized by reticulin stains. In addition to hepatic lobuli with a complete absence 
of hepatocytes, lobuli with varying degrees of liver cell necrosis can be found. 
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Fig.IV.13Acute self-limiting hepatitis: portal tract with cholangiolitis and slight bile 
duct proliferation (Hand A, 380x). 
Fig.IV.14Acute self-limiting hepatitis: lobular changes and an unusual pronounced 
portal infiltrate (Hand A, 150x). 
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Fig.IV.15 Multilobular necrosis; architecture is in principle intact. Note porta/tracts 
with extensive periportal fibrosis; centrilobular collapse (Hand A, 60x). 
Fig.IV.16 Acute hepatitis (late stage): lobular changes with clusters of ceroid-
containing macrophages; portal tracts with lymphoplasmace!fular infil-
trate and ceroid-containing macrophages (Hand A, 150x). 
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Sometimes duct-like structures emanating from the portal areas in particular can 
be seen. They are regarded as proliferating bile ducts or as pseudobile ducts. 
Clinically the multilobular type of viral hepatitis often presents as a fulminant 
hepatitis. Fulminant hepatitis is a syndrome of hepatic failure and coma within 
eight weeks of the onset of the illness, as defined according to the criteria of the 
fulminant hepatic failure surveillance study (Trey, 1972). It must be stressed that 
most patients with fulminant hepatitis die from complications (hemorrhage, 
cerebral edema, sepsis) and that in only a minority of the cases death can be 
attributed solely to hepatic failure (Gazzard, 1975). A substantial proportion of 
all cases of fulminant hepatitis are non-A non-S hepatitis (Gimson, 1983). Acute 
fulminant hepatitis accounts less than 1 per cent of all cases of acute hepatitis 
caused by HBV and has a slightly better prognosis compared to both acute fulmi-
nant hepatitis caused by toxic dyes and hepatitis non-A non-S virus (Gimson, 
1983). In addition to a fatal outcome, cirrhosis is also frequently encountered 
(Redeker, 197 4 ). In this type of acute viral hepatitis the prognosis is slightly better 
for younger patients than for older patients. Peters ( 1975) stressed that younger 
patients who survive fulminant hepatitis rarely, if ever, develop cirrhosis or 
chronic hepatitis. Older patients appear to have an impaired regeneration. 
IV.2.1.a.4 Massive necrosis 
The differential diagnosis between acute hepatitis with multilobular necrosis and 
acute hepatitis with massive necrosis is based only on the number of lobuli with 
complete hepatocellular necrosis. Massive necrosis is not compatible with life. 
The diagnosis massive necrosis can be assumed on the basis of a liver biopsy but 
not established with certainty, because a liver with extensive pan-lobular necrosis 
may include some circumscribed areas that have remained intact. 
IV.2.1.b Stages of development of acute viral hepatitis 
This information is based on the presence and mutual relationships of liver cell 
necrosis and mesenchymal reaction. The histological pattern, can provide 
information on the stage of development of acute hepatitis (Bianchi, 1971 ). 
However, the stage of development cannot be translated into an exact duration 
of the acute hepatitis because the rate ot progression of hepatitis varies markedly 
between patients. Early, fully developed, late and residual stages of acute 
hepatitis can be distinguished. 
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IV.2.1.b.1 Early stages 
Early stages of acute hepatitis may be seen occasionally. The histological 
changes have been studied in experimentally infected monkeys (Dienstag, 1976) 
and are sometimes encountered in biopsies obtained from HBsAg seropositive 
individuals during the incubation period of hepatitis B, before the onset of clinical 
acute hepatitis (see chapter XI). Liver cell necrosis, especially around the central 
or terminal veins, together with some proliferation and swelling of sinusoid lining 
cells and Kupffer's cells are the hallmarks of this stage. 
IV.2.1.b.2 Fully developed stage 
Fully developed stage acute hepatitis is characterized by the simultaneous 
presence of liver cell necrosis and focal aggregations of macro-phages and 
Kupffer's cells loaded with ceroid pigment (pigment macrophages) within the 
areas of necrosis. 
IV.2.1.b.3 Late stage 
In the late stages the accumulations of swollen, pigment-loaded Kupffer's cells 
andjor macrophages are more impressive than the prevalence of necrotic liver 
cells, which are scarce. The Kupffer's cells and macrophages are seen both 
adjacent to earlier liver cell necrosis, as indicated by focal reticulin collapse, and 
in portal tracts (fig.IV.16). Later on, pigment macro-phages in the portal areas 
dominate the histological picture. During this stage the remaining inflammatory 
infiltrate is more impressive, partly due to the lack of necrotic hepatocytes and the 
decreased number of pigment macrophages in the lobuli. It must be noted that 
in acute hepatitis genuine piecemeal necrosis (see CAH) is a rare event and 
proliferation of fibroblasts is inconspicious. 
IV.2.1.b.4 Residual stage 
The residual stage is characterized by a slight round-cell infiltrate together with 
a few macrophages in the portal tracts. These changes persist for a long time, up 
to a year. Aspecific reactive hepatitis and sometimes chronic persistent hepatitis 
must be included in the differential diagnosis for this stage. If the portal infiltrate 
of the residual stage of acute hepatitis is marked, the possibility of transition to 
chronic hepatitis must be consiCfered and careful follow-up, eventually with a liver 
biopsy, is indicated. 
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IV.2.1.c Cholestasis 
Acute cholestatic viral hepatitis is in principle a clinical variant. Differences 
in cholestasis in liver biopsies are difficult to interpret and are dependent on the 
mode and duration affixation ofthe liver tissue. Moreover the severity of jaundice 
and the quantity of bile pigment in liver biopsies do not always run in parallel. 
However, cholestasis in liver biopsies is sometimes striking and biliary obstruc-
tion must be included in the differential diagnosis. As a rule, the diagnosis is not 
too difficult, because there are usually few pigment macrophages in biliary 
obstruction and bile ducts are more severely affected by polymorphonuclear 
leukocytes. In later stages of biliary obstruction extensive liver cell necrosis can 
also be caused by the storage of toxic bile pigments. In that case the number of 
macrophages is more striking. Differentiation of cholestatic viral hepatitis from 
drug-induced cholestasis may cause more often problems. Bile plugging in the 
canaliculi is more prominent in drug-induced cholestasis which may help in the 
differential diagnosis. 
The clinical symptoms of acute cholestatic hepatitis last in general much longer 
(up to 5 months) than those of classical acute hepatitis, sometimes causing the 
clinician to worry if he is not familiar with this type of hepatitis. Although 
cholestasis may be marked in the liver biopsy, the histological picture includes 
the features of classical lobular hepatitis. The prognosis for this type of hepatitis 
is good and transition to chronic hepatitis occurs only sporadically. 
Finally it must be stressed that simultaneous occurrence of acute viral hepatitis 
and other cholestatic liver diseases may be present; this event must be con-
sidered especially in liver grafts in hepatitis B positive recipients. 
IV.2.2 CHRONIC HEPATITIS 
Chronic hepatitis can be defined as an unresolved inflammation of the liver. 
This inflammation can be initiated by several processes, including a reaction to 
hepatitis viruses. The term chronic hepatitis covers a wide spectrum of clinical, 
morphological, etiological and immunological aspects. Lacking a better criterion, 
hepatitis is arbitrarily regarded as "chronic", when clinical andjor biochemical 
changes are presentfor more than six months (Sherlock, 1974). In the event 
of a hepatitis B infection the duration of the hepatitis can be determined by the 
presence of hepatitis B surface antigen (HBsAG) in serum. 
However, it is well known that HBsAg can persist in serum without the bio-
chemical changes and the clinical signs of a liver disease. In these cases the 
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Fig.IV.17 Chronic persistent hepatitis: dense compact portal infiltrate. Minimal 
lobular changes (Hand A, 90x). 
Fig.IV.18 Chronic persistent hepatitis; no fibrosis; spill-over (Hand A, 380x). 
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infection can be associated with two different microscopic features: 
a. Minimal lesions without an inflammatory reaction. 
b. A portal inflammatory infiltrate consistent with the diagnosis of aspecific 
reactive hepatitis or chronic persistent hepatitis. 
Chronic viral hepatitis (type B) may also be defined as an inflammatory liver 
disease with persistence of HBsAg in the serum for more than 6 months. This 
chronic inflammation can occur w!t1 or without biochemical changes. The defi-
nition of chronic hepatitis is easy to use when the illness starts with an acute 
attack but awkward when the onset is insidious. In these latter cases a careful 6-
month follow-up is indicated, especially because the morphological features of 
both the residual phase of acute viral hepatitis and acute viral hepatitis in drug-
abusers and children resemble those of chronic hepatitis in many aspects. 
In general, chronic hepatitis is regarded as a difficult disease entity. This 
difficulty is both indicated and partly caused by the complex and constantly 
changing terminology. Desmet (1972) listed, for example, 47 different terms 
related to chronic hepatitis. In the past each investigator in this field introduced 
his own nomenclature, based sometimes on special views concerning the 
etiology and pathogenesis of the disease and sometimes on special aspects of 
the clinical presentation. Classification systems and subdivisions are based on 
various concepts, using intermingling combinations of etiological, clinical, 
morphological anp immunological parameters. Most of these parameters are 
highly variable during the course of the disease and as a rule exhibit only a partial 
overlap. Therefore it will be impossible to create a single classification system 
that is valid for clinical, biochemical, etiological and morphological parameters. 
Although some authors therefore prefer not to split chronic hepatitis into 
subgroups, the variable natural course of chronic hepatitis and the resulting 
variations in the need for and type of therapeutic intervention make classification 
of chronic hepatitis inevitable. 
In 1968 a new, widely accepted and simplified classification system was in-
troduced by de Groote et al. Classification is based on morphological features 
as well as some clinical aspects and prognostic implications. 
Chronic hepatitis with its wide spectrum of morphological features is essentially 
divided into two categories: 
Chronic persistent hepatitis (CPH), which is characterized by portal 
inflammation (portal hepatitis). 
Chronic aggressive hepatitis (CAH), which is characterized by periportal 
inflammation (periportal hepatitis). 
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The prefix "aggressive" was later changed to "active", not least because of the 
anxiety which the term "aggressive" evoked in patients when they heard or read 
the diagnosis of their disease. Chronic active hepatitis in turn was subdivided 
into the moderate and severe types. Later Popper and Schaffner (1971) added 
another subgroup to the classification of chronic hepatitis also defined by its 
histological changes: chronic lobular hepatitis (CLH). This type of hepatitis is 
characterized by the same lobular changes seen in acute hepatitis but now on a 
chronic time-scale. Nevertheless the international group for standarization of the 
definitions, nomenclature and diagnostic criteria for liver disease (1976) did not 
include CLH in their classification scheme since they regarded CLH as a 
protracted acute hepatitis. This interpretation of CLH is however in conflict with 
the above-mentioned definition of chronic hepatitis, i.e. an inflammatory liver 
disease of more than 6 months duration. This definition must then be extended 
to include: "with the histological features of portal or periportal hepatitis". More 
recently, the importance of the presence of lobular changes, especially necrosis, 
for the prognosis of chronic hepatitis has been stressed (Sheuer, 1986). 
In contrast to acute hepatitis B, which exhibits no pathognomonic light 
microscopic features, chronic hepatitis caused by hepatitis B virus can be 
characterized by changes in the cytoplasm of hepatocytes known as "ground-
glass hepatocytes" ( se9 chapter VII) (Hadziyannis, 1973; Shikata, 197 4 ). Using 
immunochemical techniques these hepatocytes have been proven to contain 
abundant HBsAg (see chapter VI). The appearance of these "ground-glass" 
hepatocytes and their significance for the diagnosis of hepatitis B will be 
discussed in chapter VII. 
IV.2.2.a Chronic persistent hepatitis (portal hepatitis) 
Chronic persistent hepatitis (CPH) is characterized by an inflammatory 
infiltrate, usually confined to somewhat enlarged portal tracts (portal hepatitis, 
fig.IV.17). This infiltrate consists of lymphocytes and histiocytes, admixed with 
some plasma cells and eosinophilic and neutrophilic polymorphonuclear 
leukocytes. The degree of infiltration varies from portal tract to portal tract and 
when dense, extension of the inflammatory infiltrate into periportal liver 
parenchyma can be seen (spill-over, fig.IV.18). Although the boundary between 
portal areas and parenchyma is sometimes blurred by the overlying inflammatory 
infiltrate, the so-called limiting plate is basically intact. Periportal liver cell 
necrosis should not be present in CPH. Some macrophages, loaded with ceroid 
pigment, can be found in the portal tracts (Scheuer, 1986). Lobular changes are 
minimal and consist of some small foci of mesenchymal cells, including Kupffer's 
cells and macrophages loaded with ceroid pigment. Sporadically a degenerating 
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Fig.IV.19 Chronic active hepatitis: irregular boundaries of the enlarged portal tracts 
(Hand A, 380x). 
Fig.IV.20 Chronic active hepatitis: architectural distortion with active septum 
formation and porto-portal septa (Hand A, 60x). 
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hepatocyte can be seen. In general fibrosis is absent or minimal. The presence 
of a larger degree of fibrose indicates a more severe type of hepatitis in the past. 
The good prognosis for CPH is the justification for distinguishing it from CAH 
(Chadwick et all., 1979). The disease requires no therapeutic intervention. The 
lesion remains static over long periods; in many cases the inflammatory infiltrate 
subsides after HBe seroconversion (Sanchez-Tapias, 1984 ). Occasionally spon-
taneous transition to chronic active hepatitis has been reported. However, 
transition of liver abnormalities that resemble CPH during treatment (immuno-
suppressive; anti-viral) to those of chronic active hepatitis after withdrawal of the 
therapeutic agent often takes place (Vi do, 1969). Acute exacerbation of chronic 
HBV infections, with the histological features of chronic persistent hepatitis, can 
occur: 
1. during transition of a high to a low rate of viral replication with serum 
conversion from HBeAg to anti-HBe (Liaw et all., 1983; 1985; Sanchez-
Tapias, 1984.). 
2. during reactivation of hepatitis B infection (Davis and Hoofnagle, 1985). 
It must be stressed that the histological picture of portal hepatitis, as seen in 
CPH, covers several clinicopathological entities (table IV.1) (Ludwig, 1977). 
Table IV.1 Differential diagnoses for portal hepatitis. 
Morphological diagnosis Definite clinicopathological diagnosis 
- chronic persistent hepatitis 
- aspecific reactive hepatitis. 
portal hepatitis - residual of acute hepatitis 
- chronic active hepatitis (light) 
- primary biliary cirrhosis 
- lymphoproliferative malignancy 
The spectrum of liver changes in CPH, borders upon CAH on one side, on the 
other side upon reactive hepatitis and residual phase of acute hepatitis, which 
can be persist for long times (fig.IV.2). Differentiation between CPH and CAH, 
reactive hepatitis and residual phase of acute hepatitis may sometimes be 
difficult. This difficulty is aggravated by the occasional finding that some portal 
tracts or some areas of the liver show the typical histological features of CAH, 
whereas other portal tracts or other areas of the liver are characterized by the 
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the features of CPH (Dudley, 1972). Small liver biopsies in particular, can 
therefore give rise to sampling errors and may result in the wrong diagnosis. 
If specific features of hepatitis B (ground-glass cells) are lacking, leukemic 
infiltration and primary biliary cirrhosis stage I also have to be included in the 
differential diagnosis. 
IV.2.2.b Chronic active hepatitis (periportal hepatitis) 
On one side of the histological spectrum of chronic hepatitis, chronic active 
hepatitis (CAH) borders CPH and on the other side cirrhosis (fig.IV.2). Sharp 
demarcations between these various groups do not exist, leading to problems 
in diagnosis as well as differences in interpretation between different observers. 
CAH can be distinguished from CPH by the presence of "piecemeal necrosis", a 
widely accepted term introduced by Paronetto et al. (1962). The characteristics 
of this phenomenon are a periportal inflammatory infiltrate combined with 
periportal liver cell necrosis, resulting in erosion of the limiting plate. This 
periportal inflammatory infiltrate, which mainly consists of lymphocytes and 
plasma cells, bulges irregularly into the liver parenchyma and surrounds single 
and small groups of hepatocytes (fig. IV. 19). During this process hepatocytes may 
show eosinophilic and sometimes hydropic degeneration. The periportal areas 
also exhibit the aspect of a liver cell-"eating" infiltrate. This "piecemeal necrosis" 
is the hallmark for diagnosis of chronic active hepatitis. 
The term piecemeal necrosis was coined by Cohen ( 1960) in one of the first 
immunohistochemical studies on the liver in which <-globulin was visualized; he 
associated r-globulinwith the necrosis of single and small groups of hepatocytes, 
which were replaced by lymphocytes, plasma cells and histiocytes. In view of the 
composition of the infiltrate and the presence of <-globulins, Paronetto (1962) 
suggested that immunological processes caused the necrosis of the hepatocytes. 
In contrast to the inert infiltrate in CP H, the behavior of the inflammatory infiltrate 
in CAH towards the liver parenchyma is "aggressive" or "active". As a result, in 
CAH most of the inflammatory infiltrate is found at the boundary between the 
connective tissue of the portal tracts and the liver parenchyma. In the larger portal 
tracts in particular this typical localization is easily visualized because the central 
areas of these portal tracts are nearly free of infiltrate. However, sometimes 
lymphoid follicles may be present in these larger portal tracts. Following 
periportal liver cell necrosis, the necrotic areas are replaced by connective tissue. 
In this process, known as "active septum formation", portal tracts show irregular 
enlargement due to the newly formed periportal connective tissue which radiates 
out into the liver parenchyma, ultimately giving rise to pronounced architectural 
changes (fig.IV.20). During the periportal increaseofconnectivetissue, enlarging 
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the pre-existing portal tracts, solitary and small groups of anisomorphic hepato-
cytes may become isolated within this connective tissue. As a result of regenera-
tion these isolated groups of hepatocytes can form so-called regeneration nod-
ules. Together active septa formation, that links portal tracts together, and regen-
eration of groups of isolated hepatocytes initiate the process of cirrhotic trans-
formation of the liver. 
Although the periportal events are the most striking feature in CAH, centri-
lobular changes are always present to varying degrees. So far as, the outcome 
of chronic hepatitis is concerned the centrilobular changes in particular are 
assumed to be important (Popper, 1983). In the hepatic lobuli hepatocytes show 
cellular and nuclear anisomorphism and acinar transformation, mainly in the 
periportal areas. The liver cell plates become irregular and broadened.ln contrast 
to acute hepatitis only small numbers of pigmented macrophages are present. 
Distinction of subgroups of CAH is based on the spread of the inflammatory 
infiltrate into the hepatic lobuli and the degree of periportal and lobular liver cell 
necrosis. In rapidly progressing chronic hepatitis the formation of connective 
tissue does not keep pace with the rate of liver cell necrosis. In these cases 
marked periportal and lobular reticulin collapse can occur, sometimes in com-
bination with either porto-portal or porto-central bridging necrosis. In the event 
of necrotic bridge formation, known as "bridging hepatic necrosis" (BHN) or 
"subacute hepatic necrosis" (SHN), differentiation between chronic hepatitis with 
bridging necrosis and acute hepatitis with bridging necrosis is difficult. In such 
cases the diagnosis CA~ can only made when other features of chronic hepatitis, 
such as piecemeal necrosis and periportal fibrosis, are present. As a result of 
these problems indifferential diagnosis bridging hepatic necrosis has been 
considered a phenomenon of both acute and chronic hepatitis. While Boyer and 
Klatskin (1970) first described bridging necrosis as a feature of acute viral 
hepatitis in a series of patients with a poor prognosis (hepatic failure; cirrhotic 
transformation), bridging necrosis was later considered to be a feature of CAH 
(Baggenstoss, 1972; Boyer, 1976). 
A international working party on standardization of definitions, nomenclature 
and diagnostic criteria in liver disease included bridging necrosis in the entity 
CAH (US Government Printing Office 1976). Clinically, bridging necrosis· is 
associated with either overt liver disease with jaundice or insidious grumbling 
liver disease without jaundice. 
Categories of chronic active hepatitis 
In their report, de Groote et al. ( 1968) subdivided CAH into two categories, 
designated as moderate and severe. Later ( 1976) BHN was presumed to be a 
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feature of CAH and subdivisions were based on this: CAH with and CAH without 
bridging necrosis. On the basis of prognostic and therapeutic consequences, in 
this thesis CAH is divided into three categories: 
1. chronic active hepatitis (mild). 
2. chronic active hepatitis (moderate). 
3. chronic active hepatitis (severe) with or without bridging necrosis. 
It must be stressed that CAH runs an undulating course with transient marked 
changes in activity. Moreover different areas in the liver can show differences in 
CAH activity, resulting in underestimation or (less likely) overestimation ofthe real 
activity of the underlying chronic hepatitis. 
IV.2.2.b.1 Chronic active hepatitis (mild) 
In chronic active hepatitis (mild), there are few or no changes in lobular architec-
ture. However, in several places destructionand irregularities of the limiting plate 
are present. The periportal inflammatory infiltrate, consisting of plasma cells and 
lymphocytes, reaches not deeper into the liver parenchyma than five layers of 
hepatocytes. The portal tracts are slightly distended in a web-like manner due to 
periportal fibrosis. In many places the pattern of chronic persistent hepatitis can 
be seen. The hepatic lobuli exhibit only slight liver cell changes. Because of the 
mild degree of periportal liver cell destruction this type of CAH has a relatively 
good prognosis. The need for therapeutic intervention is disputable. 
Histological differentiation from CPH with spill-over is sometimes difficult but 
usually has no therapeutic consequences. Careful follow-up is indicated in such 
cases. 
IV.2.2.b.2 Chronic active hepatitis (moderate) 
In chronic active hepatitis (moderate), piecemeal necrosis is marked and present 
in almost all lobuli. Architectural changes exist and the inflammatory infiltrate 
penetrates deeper into the lobuli. Around all portal tracts there is formation of new 
connective tissue (collagen type Ill) which penetrates the liver lobuli in many 
places. In the newly-formed connective tissue irregular bile ductules may be 
found. It is disputable whether the genesis of these bile ductules can be attributed 
to hepatocellular transformation, proliferation of pre-existent bile ducts or both. 
Periportal hepatocytes can show acinar formation, the lumen of which may 
contain accumulation of bile pigment. The centrilobular hepatocytes usually show 
some cellular and nuclear anisomorphism. 
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The prognosis of this type of CAH may vary. The architecture alters slowly and 
cirrhosis develops late, if at all. Immunosuppressive treatment may be con-
sidered, although in cases of viral CAH the use of immunosuppressive treatment 
has proven to be of little benefit (Schalm, 1982). Specific antiviral treatment is 
preferable (de Man, 1988). 
IV.2.2.b.3 Chronic active hepatitis (severe) 
In chronic active hepatitis (severe), liver cell degeneration and necrosis are not 
confined to the periportal areas. Due to the degenerating and necrotizing hepa-
tocellular process collapse of the reticulin skeleton with or without bridging is 
initially more evident than increase of connective tissue (active septa formation). 
The inflammatory infiltrate extends throughout the liver lobuli. Reticulin and 
collagen stains sometimes visualize the contours of intact, pre-existing portal 
spaces. The presence of thick collagen type I fibers in these pre-existing portal 
tracks contrasts with the recently produced type Ill collagen. The pre-existing 
portal areas are surrounded by a rim of collapsed and fibrosed pre-existing 
parenchyma (Popper, 1977). There·is a marked pan-lobular anise-morphism of 
the hepatocytes with "ballooning" degeneration and acinar transformation. 
Cholestasis is sometimes pronounced. 
This type of CAH has to be distinguished from acute hepatitis with confluent 
necrosis. The presence of piecemeal necrosis and the use of orcein staining 
(Scheuer, 1980) for differentiation between active and passive septa is helpful. 
The prognosis for severe CAH is worse than that for acute hepatitis with bridging 
or confluent necrosis, which will often heal completely if the patient survives the 
acute episode (Peters, 1975). 
IV.2.3 CIRRHOSIS 
The question of the incidence of and pathways by which viral hepatitis will lead 
to cirrhosis remains controversial (Popper, 1983; Sherlock, 1974). 
Cirrhosis caused by viral hepatitis, which is often of the macronodular or mixed 
macro-micronodular type, is presumably the result of both active and passive 
septum formation. 
The incidence of cirrhosis after viral hepatitis varies in the literature from less 
than one to about three per cent (Bjorneboe, 1974). Some authors reported no 
evidence of cirrhosis after acute viral hepatitis (Beebe, 1970) in extensive follow-
up studies. However, others have presented evidence, documented by serial liver 
biopsies, that acute viral hepatitis can progress to cirrhosis. This is especially true 
for patients with extensive hepatocellular necrosis. Peters (1975) stressed that 
77 
cirrhosis rarely, if ever, develops in younger patients with acute viral hepatitis, 
even if extensive confluent necrosis is present. On the other hand in older 
patients acute hepatitis with extensive necrosis frequently leads to cirrhosis. If 
acute hepatitis progresses to cirrhosis, the latter will occur as a rule within 12 to 
18 months, sometimes even within 5 months (Krieg, 1969, this thesis chapter XI) 
after onset of the disease. However, in most cases, cirrhosis appears to develop 
slowly from chronic active viral hepatitis, whereby accompanying lobular events 
play a major role (Popper, 1983). Liaw (1988) reported on a cohort of 684 
patients with chronic hepatitis B who exhibited an annual incidence of cirrhosis 
of 2.4 per cent for HBeAg sero-positive patients and 1.3 per cent for anti-HBe 
positive patients. In addition to viral replication, reflected by the HBejanti-HBe 
and HBV-DNA status, age of the patient and the extent, severity, duration and 
frequency of lobular hepatic changes were importantfactorsfor the development 
of cirrhosis. In this study hepatitis delta superinfection was not directly related to 
the development of cirrhosis, in contrast to the results of the long-term follow-
up study of Fattovich (1988). He reported that cirrhosis developed in eight out of 
ten hepatitis delta-positive patients. 
In the course of cirrhosis there is a stage which separates the tendency toward 
morphological repair from progression to life-threatening disease; in this stage 
the differentiation between chronic active hepatitis and cirrhosis is difficult or 
even impossible (Scheuer, 1977) (fig.IV.2). Because, in these cases, cirrhosis is 
the scarred end-stage of chronic inflammation of the liver, it can be accompanied 
by features similar to those seen in chronic active hepatitis. This type of cirrhosis 
is interchangeable designated as "cirrhosis with features of chronic active 
hepatitis", "chronic active hepatitis with cirrhosis" or "active cirrhosis". The term 
"active cirrhosis" covers all types of cirrhosis with morphological signs of liver 
parenchyma damage from which the cirrhosis can be the end result. In contrast, 
inactive cirrhosis shows no signs of necrosis and inflammation. Although the 
pathogenesis pf cirrhosis remains an enigma, host factors appear to play an 
important role; studies on hepatic fibrogenesis may provide a contribution by 
solving some of the pathogenetic problems (Popper, Review 1977). 
In view of the prognostic and therapeutic implications, it must be stressed that 
restrictive histological criteria should be used for the diagnosis of cirrhosis. In this 
context Schlichting et al (1981) realized significant prognostic differences, sub-
dividing severe architectural changes in the liver biopsies in: 
a. a group with definite cirrhosis. 
b. a group with probably cirrhosis. 
c. a group compatible with but not diagnostic for cirrhosis. 
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IV.3 HEPATOCELLULAR CARCINOMA 
Epidemiological and clinical studies (Blumberg, Review 1982; Beasley, 1988) 
have provided a substantial body of evidence for the hypothesis that persistent 
hepatitis B virus infection is the main cause of the development of primary cancer 
of the liver. This cancer is probably one of the most common malignant tumors 
in the world. However, the relative frequency differs markedly in different parts of 
the world. This evidence is based on: 
1. the high incidence of hepatocellular carcinoma in areas of prevalent HBV 
infection, especially in sub-Saharan Africa and Southeast Asia, while 
hepatocellular carcinoma is a rare tumor in areas with a low prevalence of 
hepatitis B. 
2. the high incidence of hepatocellular carcinoma in HBV carrier families. 
3. the presence of HBsAg in many patients with hepatocellular carcinoma 
(Nayak et al., 1977). 
4. Infection of animals with their species-specific hepatitis B-like virus has 
been proven to cause hepatocellular carcinoma (Marion, 1986). 
In cases of hepatocellular carcinoma hepatitis B surface antigen and core 
particles can be found in non-cancerous areas of the liver, but only sporadically 
in malignant hepatocytes. However, integrated viral DNA can be detected in 
hepatocellular carcinoma cells (Prasanta et al., 1980; Brechot et al., 1980). This 
integration of viral DNA in the genome of the host cells is consistent with findings 
in animal virus models, in which this integration also takes place during 
oncogenic transformation. 
In a study by Beasley et al. ( 1981) it appeared that the relative risk of acquiring 
hepatocellular carcinoma is more than 250 times greater for HBV carriers than for 
non-HBV carriers. In this study a group of 3500 HBV carriers and 3500 non-
carriers, matched for age and place of origin, were followed for 2-4 years. During 
this period 41 subjects died from a hepatocellular carcinoma, 40 of whom be-
longed to the HBV carrier group. Thus, 98 per cent of the cases of hepatocellular 
carcinoma occurred in HBV carriers, which implies that chronic hepatitis B 
infection is probably the highest risk factor known for any of the more frequent 
occurring cancers. It is believed that the period between the occurrence of HBV 
infection and clinically demonstrable carcinoma is at least 20 years. The shortest 
well-documented period within which hepatocellular carcinoma occurred was 6 
years and 2 months; the patient was a 6-year-old child (Shimada et al., 1980). 
Histologically hepatocellular carcinoma (HCC) in HBV-positive patients does 
not differ from HCC in HBsAg-negative patients. As mentioned above only in 
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sporadic cases can HBsAG and HBcAg can be detected in the neoplasm. In 
nearly all cases the liver parenchyma outside the HCC shows cirrhotic trans-
formation. In this cirrhotic liver parenchyma the hepatocytes are usually charac-
terized by remarkable cellular atypia. From these observations hepato-cellular 
atypia is considered to be a pre-neoplastic feature in cirrhotic livers. 
IV.4 CONCLUDING REMARKS 
The histological definitions of the various categories of liver disease, as seen 
in HBsAg seropositive patients, are rather simple so that classification is rational 
and reproducible. Classification has prognostic implications as far as the devel-
opment of cirrhosis is concerned, particularly for chronic persistent and chronic 
active hepatitis. In contrast the prognostic value of the histo-pathological 
classification of acute hepatitis is, as far as the transition to chronic hepatitis is 
concerned, limited and at the least uncertain. In fact, multiple causes may give 
rise to difficulties in classification of the liver abnormalities, leading to an incorrect 
diagnosis. These difficulties can be grouped under the following headings: 
Difficulties in the delineation of the various categories of hepatitis 
(histopathological overlap) (fig.IV.2). 
Errors due to biopsy sampling. 
Clinicopathological liver diseases (entities) that resemble one of the 
histological types of viral hepatitis B. 
Interference in a liver disorder caused by the hepatitis virus by liver disorders 
of other etiologies (heterogeneity of liver disease). 
IV.4.1 HISTOPATHOLOGICAL OVERLAP OF THE VARIOUS CATEGORIES OF VIRAL LIVER 
DISEASE 
With regard to the separation of histological subdivisions of viral hepatitis 
problems are inevitable since the continuous spectrum of viral hepatitis has been 
subdivided artificially. Despite correct histological definition, the subdivisions 
exhibit a certain overlap, leading to inter-observer "errors" and, to a lesser degree, 
difficulties in reproducibility (intra-observer errors). 
Problems in the delineation of hepatitis are not confined to the subdivisions of 
the two basic groups, acute and chronic hepatitis, but also apply to the sub-
groups of acute and especially chronic hepatitis in themselves (fig.IV.2). A well-
known problem is bridging necrosis which is a feature of both acute and chronic 
hepatitis. Also differential diagnostic problems may arise between the diagnoses 
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of residual liver changes, acute hepatitis and chronic (persistent) hepatitis, and 
between acute hepatitis with pronounced portal inflammation (e.g. acute hepatitis 
in drug-abusers) and chronic active hepatitis. For the group of patients with 
chronic hepatitis differentiation between chronic persistent and chronic active 
hepatitis is based on the phenomenon of "piecemeal necrosis". So-called "spill-
over", seen in chronic persistent hepatitis, must not erroneously be interpreted 
as piecemeal necrosis. On the other side of the spectrum of chronic active 
hepatitis, it is sometimes difficult to separate chronic active hepatitis with 
extensive fibrosis from cirrhosis with features of chronic active hepatitis. To solve 
this problem the group with definite cirrhosis must be separated from those with 
"probable" or "compatible with but not diagnostic for" cirrhosis. 
IV.4.2 SAMPLING ERRORS 
Although all types of viral hepatitis can be considered basically as diffuse liver 
disorders, variations in the histopathological features from area to area and from 
lobule to lobule are not uncommon. When liver biopsy specimens are small, 
sampling errors due to these local differences will occur with increasing fre-
quency. Of all categories of hepatitis, chronic persistent hepatitis has the greatest 
chance of being diagnosed incorrectly or not at all. It has been shown that in 
wedge biopsies some portal tracts will exhibit the alterations typical of chronic 
persistent hepatitis while others will be characteristic of chronic active hepatitis; 
in many cases, the latter will be the ultimate diagnosis because of its less 
favorable prognosis. Similarly some areas of the liver may show changes 
consistent with aspecific reactive hepatitis, while others will be indicative of 
chronic persistent hepatitis. In acute hepatitis necrosis is not equally distributed 
throughout the liver and depends on local differences in the microenvironment. 
Therefore the degree of necrosis cannot always be determined exactly in needle 
or even wedge biopsies; for example, liver cell necrosis throughout a needle 
biopsy need not be representative of the entire liver. 
IV.4.3 CLINICOPATHOLOGICAL LIVER DISEASES RESEMBLING OR IDENTICAL TO ONE 
OF THE HISTOLOGICAL TYPES OF VIRAL HEPATITIS B 
On histological grounds alone acute hepatitis B cannot be distinguished easily 
and reliably from acute hepatitis with a different etiology. The ground-glass 
hepatocyte, typical for chronic hepatitis B infection, is usually notfound in acute 
hepatitis. As far as the hepatitis viruses are concerned, only hepatitis non-A non-
B causes features during acute hepatitis that are helpful in diagnosing this viral 
infection (Kuroo, 1980 and Popper, 1980). In hepatitis non-A non-B the reported 
81 
to give a markedly sinusoidal mononuclear infiltrate resembles that seen in 
patients with infectious mononucleosis. Early in the evolution of acute non-A non-
S hepatitis some accumulation offat can be seen in the hepatocytes. This feature 
is unusual in hepatitis A and hepatitis B. Proliferation of bile ductules covered with 
abnormal epithelium and a pronounced cholestasis are reported to be more 
frequent in non-A non-B viral infections. Acute hepatitis that is not caused by viral 
agents, such as drug-induced hepatitis, is the most difficult as far as differential 
diagnosis is concerned. Abundant eosinophils, bile duct lesions and fatty 
changes in the hepatocytes support a diagnosis of drug-induced acute hepatitis. 
Acute alcoholic hepatitis can be distinguished from acute viral hepatitis by the 
presence of extensive fatty changes, Mallory's hyaline bodies, giant mitochondria 
and a predominance of polymorphonuclear leukocytes. Moreover longstanding 
biliary obstruction may sometimes mimic the cholestatic type of acute viral 
hepatitis. Both chronic persistent and chronic active hepatitis can occur as 
reaction patterns in other liver diseases, for example hepatitis non-A non-B, the 
early stages of primary biliary cirrhosis, drug-induced liver disease and the 
residual stage of acute hepatitis. However, light microscopically hepatitis B 
infection can often be diagnosed by the presence of ground-glass hepatocytes 
(see chapter VII). Chronic active hepatitis is seen not only during a hepatitis B 
infection but also in the more advanced stages of primary biliary cirrhosis, 
Wilson's disease, a 1 antitrypsin deficiency, drug-induced liver disease, non-A 
non-B virus infection, hemochromatosis and "lupoid" hepatitis. In most of these 
diseases the chronic active hepatitis is accompanied by special concomitant 
histological features, which lead to the correct diagnosis. In a considerable 
number of biopsies (see chapter VII) chronic active hepatitis B was indicated by 
the presence of ground-glass cells. Since cirrhosis is usuallythe end-stage of 
chronic active hepatitis, in case of a chronic hepatitis B infection, the special 
histological features of this chronic active hepatitis B can also be found in this 
cirrhotic liver parenchyma. When cirrhosis develops from an acute hepatitis with 
extensive necrosis, it is often not possible to establish the etiology of the 
cirrhosis. After an acute hepatitis the cirrhosis may be of the incomplete septal 
type, whereby very slender septa incompletely surround liver parenchymal 
nodules (Vido and Wildhirt, 1969). 
IV.4.4 HETEROGENEITY OF LIVER DISEASE 
When more than one etiological factor is involved in a liver disorder, it is often 
very difficult or impossible to determine which changes are caused by which 
factor. May be more than in any other liver disease, patients with hepatitis B 
infection are exposed to other factors that complicate the viral liver disease, e.g. 
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venereal infections, alcohol abuse and other viral infections. The combination of 
several pathogenetic factors plays an important role especially in livers grafted 
in HBsAg positive patients e.g. recurrence of hepatitis B infection and rejection 
(see chapter XI). It should therefore be noted that not all liver changes in HBsAg 
seropositive patients are the result of infection with hepatitis B virus. 
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CHAPTERV 
RESULTS OF LIGHT MICROSCOPICAL ANALYSIS OF LIVER BIOPSIES 
FROM PATIENTS WITH HEPATITIS B VIRAL INFECTION. 
V.1 SUMMARY 
The histopathology of acute and chronic infections associated with viral 
hepatitis B was analyzed in a series of 165 consecutive liver biopsies from 139 
HBsAg seropositive subjects; special attention was focussed on the spectrum 
of the histo-pathologic changes and problems in their classification as well as 
the relation between the histological changes and the (longterm) prognosis. 
Out of 139 subjects 51 were asymptomatic HBsAg carriers identified by chance 
during routine screening, and 88 were patients with symptomatic liver disease. 
In these 88 cases HBsAg was detected during evaluation of the liver disease. 
Clinical and histopathological aspects of both groups were analyzed together 
and separately, and compared. In the asymptomatic HBsAg seropositive group 
most subjects were found to have persistent HBsAg serology. In 32 out of 51 
cases, the liver changes were classified as minimal changes ( 11 ), reactive hepa-
titis (8) and chronic persistent hepatitis (13). Eight subjects had a chronic active 
hepatitis, and one an inactive cirrhosis. Surprisingly in 1 0 cases the diagnosis 
was an acute hepatitis which, in seven cases (70 per cent), subsequently transit 
into a histologically proven chronic hepatitis. In 3 asymptomatic blood donors an 
acute self-limiting hepatitis was detected. 
In the group of patients with symptomatic liver disease a relatively large 
proportion had acute hepatitis (33), four of which transformed into chronic hepa-
titis: two had an anicteric course. A substantial proportion of the symptomatic 
patients with chronic HBsAg antigenemia had active liver disease (38), 17 with 
cirrhosis. 
It is concluded that: 
a. a substantial proportion oftheasymptomatic HBsAg seropositive individuals 
will exhibit quite severe liver changes. For these individuals abnormal liver 
tests are the criterion for careful evaluation, including a liver biopsy. 
b. an icteric acute HBV infection rarely transforms into a chronic HBV infection, 
which mainly develops from an anicteric acute infection. 
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c. piecemeal necrosis and bile duct lesions can be present in acute self-limiting 
hepatitis. 
d. the prognosis for hepatitis B seropositive individuals with minimal and 
aspecific liver alterations is excellent. 
e. HBV-associated cirrhosis, found mainly in the older age group, has a poor 
prognosis due to decompensation of liver functions and development of 
hepatocellular carcinoma in some cases. 
V.2 INTRODUCTION 
After discovery of the Australia antigen as a marker for hepatitis B infection 
many reports on the liver histology of the hepatitis B infection (HBV) were 
published (Peters, 1975; Ishak, 1976; Phillips 1981). The natural course of a 
hepatitis B infection was characterized by the wide range of light microscopical 
liver changes all with their own clinical and therapeutical implications. This fact 
and the broad acceptance of the liver biopsy as an safe and important tool for 
evaluation of liver disease, stimulated the development of a uniform classification 
system in which the same criteria and the same terminology would be used. 
Previously, as a result of the lack of uniform classification and because of the 
complex and confusing nomenclature, studies on liver disease and the effects of 
therapeutic treatment could not be compared. 
Now "The standardization of nomenclature, diagnostic criteria and methodo-
logy for disease of the liver and biliary tract", prepared jointly by the Fogarty 
International Center and the International Association for Study of the Liver, 
{1976) provides a basis for classifying liver disease. In this classification system 
liver histology plays a key role. 
Using the principles of this classification and the histological crit~ria given in 
chapter IV, a series of 1651iver biopsies, received over a five-year period (1973-
1977) was analyzed. Special attention was directed to problems encountered in 
the classification of the liver changes. The subsequent course of the disease in 
the different hepatitis groups was followed. 
V.3 RESULTS 
V.3.1 HISTOLOGICAL CLASSIFICATION 
The results of the classification of the histological changes present in 165 
biopsies from 139 HBsAg seropositive patients, using the criteria given in the 
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previous chapter, are listed in table V.1 and described below. The histological 
subdivision of the light microscopical liver changes seen in group A, those 
individuals in whom HBsAgwas found accidentally (e.g. volunteer blood donors), 
and group B, the patients with symptomatic liver disease, will be described 
separately. In this chapter "ground-glass" hepatocytes are not used for the classi-
fication of viral hepatitis. The role of these ground-glass cells in the classification 
of viral hepatitis is discussed in chapter VII. 
Table V.1 Results of the evaluation of the histological changes in 1651iver tissue 
specimens from HBsAg seropositive patients. 
acute hepatitis 47 
fully developed type 18 
with focal necrosis 16 
with passive septa 1 
with multilobular necrosis 
late-phase type 27 
with focal necrosis 26 
with bridging necrosis 1 
residual phase 2 
chronic persistent hepatitis 30 
chronic active hepatitis 43 
mild 30 
moderate 12 
severe 
cirrhosis 20 
active 17 
inactive 3 
minimal lesions 14 
aspecific reactive hepatitis 11 
V.3.1.1 Acute hepatitis 
The diagnosis of acute hepatitis was established for 4 7 liver biopsies. These 
47 biopsies were taken from 43 patients (15 females, 28 males), ranging in age 
from 16 to 70 years (mean: 32 years). 
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Early or fully developed type of acute hepatitis 
Early or fully developed acute hepatitis, characterized by the histological \ 
picture typical of lobular hepatitis, was demonstrated in 18 of 4 7 biopsies. These 
biopsies were taken from 18 patients {9 females, 9 males) with a mean age of 32 
years (range: 16-58 years). In 16 of these 18 biopsies only spotty necrosis was 
present. In one case this spotty necrosis was accompanied by passive septa; the 
biopsy came from a patient of the older age group {57 years). In all 18 biopsies 
moderate to large quantities of Councilman bodies were detected ( 1-3 Council-
man bodies per lobulus). There were numerous macrophages loaded with ceroid 
pigment lying mainly in clusters, especially in the centrilobular zones. Sometimes 
a few ceroid macrophages were also present in the portal triads. 
In all 18 biopsies the predominant lobular changes were accompanied by 
changes in the portal triads, consisting of some edema and inflammatory 
infiltrates that varied in density. In 3 out of 18 biopsies the portal infiltrate was 
pronounced and contained many lymphocytes and plasma cells. Locally the 
infiltrates extended into the surrounding liver parenchyma, blurring out the border 
between the liver parenchyma and the portal tract and mimicking the 
phenomenon of piecemeal necrosis. On the basis of this pronounced portal 
infiltrate the possibility of a transition to the chronic type of hepatitis was 
suggested. Periportal fibrosis was not present in any of the biopsies. The mean 
value and standard deviations of SGPT (serum glutamate pyruvate transaminase) 
and SGOT (serum glutamic oxaloacetic transaminase) levels (normal level both 
< 30 IU/L) in serum on the day the biopsy was taken are shown in fig.V.1. 
An epithelioid cell granuloma was present in one of the biopsies. In 7 biopsies 
eosinophilic granulocytes were frequently detected in the inflammatory infiltrates 
both in the portal tracts and in the liver parenchyma. In 12 biopsies bile pigment 
was seen, mainly in the centrilobular zones. This bile pigment was located in the 
cytoplasm of hepatocytes and macrophages as well as the somewhat dilated bile 
canaliculi. In 7 ?Ut of the 18 biopsies some irregularity andjor proliferation of the 
bile ductuleswas present. In 5 cases these biliary changes were accompanied by 
accumulation of bile pigment, mainly in the liver parenchyma. The amount of bile 
pigment accumulated did not correlate with the severity of the bile duct changes. 
In 5 out of 18 biopsies Perls' stain for iron revealed iron pigment, mainly in 
swollen Kupffer's cells and macrophages and always together with ceroid 
pigment. In 2 biopsies the iron deposits were minimal, in 2 slight and in one more 
pronounced. 
Fifteen of the 18 biopsies were taken 8 to 25 days after the onset of jaundice 
(average: 12 days). One biopsy was not taken until 8 weeks after the onset of 
jaundice. In none of these cases did the hepatitis follow an anicteric course. 
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One out of the 18 biopsies showed the picture of an acute hepatitis with multi-
lobular necrosis. Hepatocytes were not found in this biopsy. The reticulin 
skeleton had collapsed but was in principle intact (fig.V.2). The portal tracts were 
located close together, separated by the collapsed liver parenchyma which con-
tained only a milcl mixed polymorphonuclear and lymphoplasmacellular inflam-
matory infiltrate. In relation to the severity of the liver cell damage there was very 
little ceroid pigment. Macrophages and Kupffer's cells were inconspicuous. Iron 
pigment could not be demonstrated. This biopsy was taken from a 28-year-old 
woman, 5 weeks after the onset of jaundice. The patient survived and HBsAg 
cleared from the serum within 3 months. Follow-up by laparoscopy revealed a 
circumscribed area of liver parenchyma in the right lobe of a liver that had 
otherwise collapsed. 
Late-phase type of acute hepatitis 
The histological changes in 27 of the 4 7 biopsies classified as acute hepatitis 
were of the late-phase type. These biopsies were taken from 23 patients (5 
females and 18 males), ranging in age from 19 to 70 years (mean: 32 years). 
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Fig.V.2 Acute hepatitis with multilobular necrosis: portal tracts are located close 
together, separated by collapsed liver parenchyma, in which no hepatocytes 
are left (Hand A, 60x). 
In 9 patients the acute hepatitis was neither accompanied nor followed by 
jaundice (anicteric acute hepatitis). The other 14 patients were jaundice at the 
time of the biopsy. The duration of the jaundice before the biopsy was obtained 
varied considerably among these 14 patients, from 7 days to 7 weeks, with a 
mean of 23 days. 
During follow-up a second biopsy from 4 of these 23 patients !)till showed late-
type acute hepatitis. The time interval between the first and second biopsies 
ranged from 21h to 9 months. In all biopsies the histological picture was 
characterized by changes in the hepatic lobuli. The predominantfeature in these 
biopsies was a marked mesenchymal reaction as indication of liver cell necrosis 
which occurred some time ago; this mesenchymal reaction exceeded far the less 
frequent occurrence of necrotic hepatocytes and consisted of swollen macro-
phages and Kupffer's cells, both loaded with ceroid pigment. These ceroid-
loaded macrophages were scattered throughout the hepatic lobuli as solitary 
cells and small clusters, mainly in the centrilobular areas. In this phase of acute 
hepatitis the ceroid macrophages were also found in large quantities in the portal 
tracts. The number of necrotic hepatocytes varied from low in 18 (less than 1 
Councilman body per lobulus on the average) to moderate in 9 of the 27 biopsies 
( 1-2 Councilman bodies per lobulus on the average). In one of the 27 biopsies the 
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phenomenon of bridging necrosis was present. 
In all biopsies the lobular changes were accompanied by portal inflammatory 
infiltrates. These inflammatory infiltrates which were in general more pronounced 
than in the fully developed type of acute hepatitis, consisted mainly of lympho-
cytes and plasma cells and sometimes also eosinophilic leukocytes. Pronounced 
inflammatory infiltrates in the portal tracts were seen in 18 out of the 27 biopsies. 
These 18 biopsies were taken from 14 patients. In 7 of these 18 biopsies the in-
filtrate also extended into the surrounding liver parenchyma, exhibiting the fea-
tures of chronic active hepatitis. In all cases it appeared likely that the acute 
hepatitis would transform into a chronic type of hepatitis. 
In 2 biopsies lymph follicles had formed in some of the portal tracts. In several 
biopsies changes in the bile ductules were also present. In addition to erosion of 
bile ductules by the portal inflammatory infiltrates, proliferation of bile ductules 
was also seen in some biopsies. 
Iron pigment was found in 6 of the 27 biopsies: a small amount in 3 and more 
pronounced amounts in the other 3. The iron pigment was located mainly in the 
cytoplasm of swollen Kupffer's cells and macrophages. 
Fibrosis was not an important feature in these biopsies. However, in 9 out of 
the 27 biopsies some periportal fibrosis was detected; it was scored as mild in 7 
cases and as mild to moderate in 2 cases. The mean value with two-sided stan-
dard deviation of SGPT and SGOT levels are shown in fig.V.1. 
Residual phase of acute hepatitis 
An end-stage acute hepatitis was diagnosed in 2 out of the 47 cases. This 
diagnosis was based on the presence of numerous ceroid macrophages, where-
as degeneration and necrosis of the hepatocytes were rare. The macrophages 
loaded with ceroid pigment were present mainly in the portal tracts; only small 
scattered groups were detected in the hepatic lobuli. Indicating previous hepato-
cellular necrosis and subsequent regeneration, the plates of the hepatocytes 
showed a mild disarray and broadening. Frequently binucleated hepatocytes 
were seen. In addition the hepatocytes exhibit a mild nuclear and cytoplasmic 
an isomorphism. One patient underwent biopsy 4 weeks after onset of jaundice. 
The other patient revealed no jaundice at all. SGPT and SGOT levels were within 
normal limits. 
Iron deposition 
Of the 47 liver biopsies from patients with acute hepatitis, only 12 gave a 
positive iron stain. In 2 cases the amount of stainable iron was minimal, in 6 slight 
93 
to moderate (+).Only 4 biopsies contained more pronounced Fe deposits ( + + ). 
The iron pigment was located mainly in Kupffer's cells and macrophages, usually 
in combination with deposits of ceroid pigment in the same cells. Only a small 
amount of iron pigment could be detected in the cytoplasm of hepatocytes. 
Five of the 12 iron-positive biopsies exhibited the histological picture of a fully 
developed acute hepatitis. These biopsies were taken from 5 patients, all of whom 
had had icterus for a period of 3 to 14 days (mean: 9 days). 
The picture of late-phase acute hepatitis was seen in 6 of the 12 biopsies taken 
from 6 different patients. Five of these patients had icterus at the time of the 
biopsy. The icterus had been presenttor a period of 7 days to 6weeks (mean: 30 
days). The hepatitis in the other patient ran an anicteric course. This patient had 
undergone kidney transplantation, thus receiving many blood transfusions. 
Cholestasis 
Cholestasis was found in 26 out of 47 biopsies from patients with acute 
hepatitis. Of the 18 biopsies from patients with the fully developed type of acute 
hepatitis 12 (66 2/3 per cent) showed cholestasis; it was minimal in 2, mild to 
moderate in 9 and more extensive in 1 case. Of the group of 27 patients with late-
phase acute hepatitis 14 (52 per cent) exhibited cholestasis; it was minimal in 2, 
mild to moderate in 7 and extensive in 4 cases; in one case it was one ofthe most 
striking features of the biopsy. 
Bile pigment accumulation was visualized in the cytoplasm of hepatocytes 
partly as "feathery" or xanthomatous degeneration, partly as small droplets of 
greenish or brownish bile pigment. These cytoplasmic changes in the hepato-
cytes were seen in combination with varying numbers of dark-green bile thrombi 
in somewhat dilated bile canaliculi. Some bile pigment could also be found in the 
cytoplasm of Kupffer's cells, together with ceroid and sometimes iron pigment. 
A rough correlation existed between bile pigment accumulation in the biopsies 
and the level of bilirubin in serum. In only one case, the course of the acute 
hepatitis was anicteric; the other patients had icteric acute hepatitis. 
During follow-up 2 out of 26 biopsies, initially exhibiting cholestasis, underwent 
transition from acute hepatitis to chronic hepatitis; in the group of 21 biopsies 
without detectable cholestasis 13 from 9 patients transformed from acute hepa-
titis into a chronic type of viral infection. Clinically 8 of these 9 patients exhibited 
no icterus at all, whereas 1 patient had had icterus 3 months beforehand. 
Bile duct changes 
Although nearly all biopsies from patients with acute hepatitis showed focal 
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changes in the bile ductules, in most cases these changes were inconspicuous 
and consisted of some irregularity and disarray of the bile duct epithelium 
together with mild cellular and nuclear anisomorphism. The cytoplasm of the 
epithelial cells showed mild vacuolization. 
However, 18 out of the 47 biopsies exhibited more marked bile duct changes, 
which were always segmental in character and occurred in only a few of the portal 
tracts. These ductular changes could be subdivided into 2 groups: a cholan-
giolitis group and a group characterized by an increase in bile ductules (bile duct 
proliferation). Cholangiolitis was seen in 7 biopsies. The bile ductules in these 
cases were invaded focally by lymphocytes and plasma cells, which were found 
between the individual epithelial cells, of these bile ducts.ln 13 cases proliferation 
of irregular bile ductules had occurred. These bile ductules were found along the 
periphery of the, sometimes enlarged, portal tracts together with slightly irregular 
limiting plates (biliary piecemealing). In 3 cases the degree of bile duct 
proliferation was striking; in the rest (1 O) it was mild to moderate. In 2 biopsies 
bile duct proliferation was seen together with cholangiolitis. 
Cholestasis was seen in 11 of the 18 biopsies with bile duct changes, mild 
cholestasis in 7 biopsies and more marked cholestasis in 4 biopsies. Choles-
tasis was demonstrated in all but 1 of the 7 biopsies with cholangiolitis and in 7 
of the 13 biopsies with bile duct proliferation. 
Eosinophilic leukocytes 
In 27 out of 47 biopsies with the histological picture of acute hepatitis, 
eosinophilic leukocytes were detected in the inflammatory infiltrates. These 
eosinophils were localized mainly in the portal tracts. In 1 0 cases the number of 
eosinophils was marked. The inflammatory infiltrate contained only few eosino-
phils in the other cases. Four of the 10 patients with large numbers of eosinophils 
were drug-addicts. Thirteen of the 27 biopsies exhibited the picture of late-phase 
acute hepatitis, whereas 14 showed a fully-developed type of acute hepatitis. 
Steatosis 
Steatosis was detected in 7 of the 47 biopsies. These 7 biopsies were taken 
from 5 patients. The steatosis was of the coarse vacuolar type and was scored 
mild in 5 cases and moderate in the other 2. In all? cases the acute hepatitis was 
of the late phase type. None of the biopsies with the picture of a fully developed 
hepatitis exhibited steatosis. 
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Prominent portal inflammatory infiltrates 
Pronounced inflammatory infiltrates in the portal areas were seen in 21 out of 
the 47 biopsies with a histological picture of an acute hepatitis. These biopsies 
came from 17 patients (5 females and 12 males). In those cases (7 biopsies) in 
which the dense inflammatory infiltrates were accompanied by piecemeal 
necrosis, transition of the acute hepatitis to chronic hepatitis was considered a 
serious possibility. The histological changes in the 21 biopsies were classified as 
fully developed acute hepatitis in 3 cases, as late-phase acute hepatitis in 17 and 
as the residual-phase of acute hepatitis in 1 case. Jaundice was present at the 
time of the biopsy in 1 0 out of the 17 patients, including all 3 with fully developed 
acute hepatitis. One patient had suffered an icteric period 3 months before the 
biopsy was taken, while jaundice was not seen at all in 6 out of 17 patients 
(anicteric acute hepatitis). 
Follow-up 
All 43 patients with acute hepatitis were followed clinically. In 31 of the 43 
patients serum liver enzymes normalized and serum HBsAg disappeared spon-
taneously within 3 months of the biopsy. Out of this group of 31 patients, only the 
patient with acute hepatitis with multilobular necrosis was followed histologically. 
Repeat biopsies were taken 27 days and 61h months after the first biopsy. The last 
biopsy from this patient showed extensive post-collapse fibrosis and some 
circumscribed areas of intact liver parenchyma. Despite the fact that the HB virus 
markers had become negative and the serum liver enzymes had normalized a 
mild lymphoplasmacellular infiltrate was still present in the collapsed andfibrosed 
parts of the liver and in the portal tracts of the intact parts of the liver. 
In contrast .11 of the 43 patients remained HBsAg positive for many years. Two 
of these 11 patients no longer exhibited HBsAg 6 and 8 years after discovery of 
the acute HBV hepatitis. The other nine patients were still HBsAg-positive at least 
12 years after the initial biopsy. And yet 5 of these patients showed HBeAg sere-
conversion 4, 5, 5, 6 and 8 years (mean 5.8) after the first biopsy, respectively. 
One of the 43 patients died 5 weeks after the biopsy was taken; his liver 
enzyme levels were markedly elevated. The biopsy from this 70-year-old man 
showed late-phase acute hepatitis and extensive bridging necrosis. 
Various distinct histological and clinical features of the two biopsy groups (one 
with acute self-limiting hepatitis and the other with acute hepatitis with persistent 
HBsAg antigenemia) are analyzed in tables V.2, V.3 and V.4. 
Table V.2 shows the histological stages of acute hepatitis over the two groups. 
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Table V.2 Histological characteristics of biopsies from patients with acute self-
limiting hepatitis and acute hepatitis which transformed into chronic 
hepatitis. 
fully late type residual 
developed 
type 
n = 43 n = 18 n = 23 n=2 
acute self-limiting 
hepatitis n = 31 18/18 11/23 2/2 
acute hepatitis 
that transformed 
into chronic n = 11 0/18 11/23 0/2 
not evaluable n = 1 0/18 1/23 0/2 
Table V.3 Frequency of jaundice in patients with acute self-limiting hepatitis and 
acute hepatitis which transformed into chronic hepatitis. 
icteric anicteric 
n = 43 n = 34 n=9 
acute self-limiting 
hepatitis B 31/43 31/34 0/9 
acute hepatitis 
that transformed 
into chronic 11/43 2/34 9/9 
not evaluable 1/43 1/34 0/9 
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Table V.4 Portal infiltrate in biopsies from patients with an acute self-limiting 
hepatitis and acute hepatitis which transformed into chronic hepatitis 
pronounced pronounced portal inconspicuous 
portal infiltrate with portal 
infiltrate piecemeal necrosis infiltrate 
n = 17 n = 7 n = 26 
acute self-limiting 
hepatitis B 8/17 2/7 23/26 
acute hepatitis 
transformed into 
chronic 8/17 4/7 3/26 
not evaluable 1/17 1/7 0/26 
None of the patients with the fully developed type of acute hepatitis showed 
persistent HBsAg antigenemia.ln contrast 11 of the 23 patients with the late-type 
of acute hepatitis remained HBsAg-positive. Nine of the 11 patients in whom the 
acute hepatitis transformed into chronic hepatitis were anicteric. Only two 
patients had an icteric hepatitis (table V.3). A prominent portal infiltrate was seen 
in 8 of the 11 patients who developed chronic hepatitis, whereas 8 of the 31 
patients with an acute self-limiting hepatitis exhibited a dense inflammatory infil-
trate in the portal tracts (table V.4). Characteristics that mimic piecemeal necrosis 
were seen in 4 of the 11 patients who underwent transition of the acute hepatitis 
to chronic liver disease and in only 2 of the 31 with acute self-limiting hepatitis. 
V.3.1.2 Chronic persistent hepatitis 
The diagnosis chronic persistent hepatitis was established for 30 biopsies. 
These biopsies were taken from 29 patients (24 males, 5 females), ranging in age 
from 2 months to 57 years (mean 29 years). The age distribution pattern for these 
patients is given in table V.5. 
Portal hepatitis was the basis for diagnosis. In 10 of the 30 cases the diagnosis 
chronic persistent hepatitis was established only after extensive differential 
diagnostic considerations. For 8 of these 1 0 biopsies the problems consisted of 
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the differentiation between non-specific reactive hepatitis and chronic persistent 
hepatitis. Two of these biopsies showed some fibrosis, possibly a rest of a more 
severe liver disease (residual phase of an acute hepatitis). In 2 cases the 
differential diagnosis was chronic persistent or chronic active hepatitis. Six 
biopsies with chronic persistent hepatitis were one out of a series of follow-up 
biopsies. In 4 cases the other biopsies in the series showed chronic active 
hepatitis, while in 1 case the other biopsy showed aspecific reactive hepatitis. In 
1 case the biopsy with chronic persistent hepatitis was preceded by a biopsy 
with the features of the late-phase type of acute hepatitis. Two biopsies of chronic 
persistent hepatitis were taken from patients who were being treated with 
prednisone. The other patients were not being treated for their liver disease. 
Table V.5 Age distribution of patients with chronic persistent hepatitis. 
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Fibrosis 
Architectural changes were in general inconspicuous in 24 biopsies. In addition 
to the 2 biopsies mentioned above, fibrosis was seen in 6 other biopsies. The 
degree of fibrosis ranged from mild to severe: mild in one, moderate in one and 
severe in 4 biopsies. 
Iron deposition 
In 4 biopsies ion stain was positive. The amount of iron was slight in 2 biopsies 
and moderate in the other 2. Iron was present mainly in the cytoplasm of Kupffer's 
cells and macrophages. 
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V.3.1.3 Chronic active hepatitis 
Chronic active hepatitis was the diagnosis established for 43 biopsies. These 
biopsies were taken from 34 patients (30 males, 4 females), ranging in age from 
19 to 74 years, mean 33 years (table V.6). 
Thirty biopsies with chronic active hepatitis exhibited only mild activity. In 4 
cases, differentiation from chronic persistent hepatitis was difficult. Most of the 
30 biopsies exhibited mild periportal fibrosis. However, in 7 biopsies the fibrosis 
was marked with extensive porto-portal septum formation. In 2 biopsies the ex-
tensive fibrosis was accompanied by nodular regeneration. When cirrhosis could 
not be excluded, the liver changes in these cases were classified as "probable" 
cirrhosis. As a result of pronounced lobular changes with necrosis of hepatocytes 
in 2 of the 30 biopsies, problems in differentiation between prolonged acute 
hepatitis and exacerbation of chronic active hepatitis existed. 
Table V.6 Age distribution of patients with chronic active hepatitis. 
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In 12 biopsies the activity of the chronic hepatitis was moderate. In general 
the fibrosis in these biopsies was more marked; however none of the biopsies 
exhibited sufficient signs to be classified as cirrhosis. In 2 of the smaller biopsies 
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however cirrhosis could not be ruled out. As a result of a coexisting florid lobular 
hepatitis component in 5 of these 12 biopsies, acute exacerbation of the chronic 
active hepatitis was considered. In these cases prolonged acute hepatitis with 
transition to chronic hepatitis was the differential diagnosis. One biopsy showed 
a severe chronic active hepatitis with extensive active septum formation. 
Table V. 7 Relation between the severity of chronic active hepatitis and the degree 
of fibrosis and lobular changes. 
fibrosis probably lobular 
n mild marked cirrhosis changes 
CAH (mild) 30 23 5 2 2 
CAH (moderate) 12 3 7 2 5 
CAH (severe) 1 0 1 0 0 
V.3.1.4 Cirrhosis 
Cirrhosis was the diagnosis established for 20 biopsies taken from 18 patients 
( 17 males, 1 female). Th~ age of these patients ranged from 26 to 81 years with 
a mean of 51 years (table V.8). All patients had clinically established portal hyper-
tension with variable degrees of splenomegaly, esophageal varices and, in some 
cases, ascites. 
Table V.8 Age distribution of patients with cirrhosis. 
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In only 3 cases was the cirrhosis not accompanied by inflammatory infiltrates 
in the fibrotic septa; as a result the cirrhosis was classified as "inactive" in these 
cases. In one of the cases of "inactive" cirrhosis, the cirrhosis was of the 
"incomplete septal" type; this was the youngest patient in this group (26 years). 
The other 2 inactive cirrhosis were micronodular in one and mixed micro-macro 
nodular in the other. In 17 of the 20 biopsies the cirrhosis occurred together with 
inflammatory infiltrates in the fibrotic septa, thus resembling chronic persistent 
hepatitis or chronic active cirrhosis. In 6 of these 17 biopsies the chronic active 
hepatitis was even the more striking phenomenon. 
In most biopsies exhibiting active cirrhosis the hepatocytes in the cirrhotic 
nodules showed more of less severe cytoplasmic and nuclear anaplasia; these 
atypicalhepatocytesusuallycontainedabundantcytoplasmwithafinelygranular 
eosinophilic aspect (oncocytic change). Nuclei were prominent and hyper-
chromatic with prominent amphophilic nucleoli. The degree of atypia correlated 
with the severity of the accompanying chronic active hepatitis component. 
Follow-up 
During 15 years offollow-up 4 patients died due to concomitant diseases. One 
patient was no longer HBsAg positive 7 years after the biopsy which reveiled 
cirrhotic transformation. Three patients developed a hepatocellular carcinoma 4, 
5 and 15 years, respectively, after the biopsy which established the existence of 
a cirrhosis (in the mean time two died). 
TableV.9 Characteristics of patients and biopsies with cirrhosis. 
type of cirrhosis n hepato- died from loss hepato-
cellular concomitant of cellular 
atypia disease HBsAg carcinoma 
incomplete septal 1 - - - -
inactive cirrhosis 2 - - - -
cirrhosis with CPH 2 + - - -
cirrhosis with CAH 15 +I+++ 4 1 3 
+ = slight atypia + + = moderate atypia + + + = severe atypia 
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V.3.1.5 Minimal lesions 
Minimal histological changes were seen in 14 of the 165 biopsies. These 
biopsies were taken from 14 HBsAg seropositive patients ( 5 females and 9 males) 
ranging in age from 26 to 55 years (average: 33 years). Nine of the 14 patients 
were blood donors, accidentallyfound to be HBsAg-positive during routine blood 
screening. In some of these biopsies some scattered lymphocytes were found 
in a minority of the portal triads. On the basis of the presence of these lympho-
cytic infiltrates in one biopsy, the diagnosis of an aspecific reactive hepatitis was 
considered. The liver architecture in all biopsies was completely intact. No 
appreciable fibrosis was found in any of the biopsies. 
In most biopsies the hepatocytes showed mild cellular and nuclear anise-
morphism, and occasionally a slight disarray of hepatocyte plates. The most 
dominant feature in all biopsies was the presence of large irregular clusters of 
hepatocytes with the ground-glass appearance (see chapter VII). 
In one of the biopsies a mild coarse vacuolar steatosis and in another a small 
amount of hemosiderin pigment in Kupffer's cells were seen. 
V.3.1.6 Aspecific reactive hepatitis 
Aspecific reactive hepatitis was the diagnosis established for 11 of the 165 
biopsies. These biopsies were taken from 11 individuals ( 1 female and 1 0 males) 
ranging in age from 1 9to50years (average: 30years). Seven of these 11 patients 
belonged to the group of blood donors who were found by chance to have 
HBsAg. 
As the diagnosis indicates, the generally mild changes were aspecific and did 
not fit under the heading of one of the more definite types of hepatitis. The overall 
picture was that of a "restless liver". In most biopsies mild inflammatory infiltrates, 
composed mainly of lymphocytes, were found scattered throughout the portal 
tracts and in some places in the liver parenchyma. Throughout the liver paren-
chyma Kupffer's cells were slightly swollen and contained small amounts of 
ceroid pigment. Also some ceroid-loaded macrophages were seen in the portal 
tracts. The histological architecture ofthe liver was intact. Slight irregular fibrosis 
was seen in 5 of the 11 biopsies. In 2 cases the residual phase of acute hepatitis 
was included in the differential diagnosis. In 1 biopsy mild and in another more 
pronounced deposits of hemosiderin pigmentwere seen, mainly in the cytoplasm 
of Kupffer's cells. In this group of 11 biopsies larger clusters of ground-glass 
hepatocytes were also an important feature. 
103 
V.3.2 ASYMPTOMATIC HBSAG-POSITIVE SUBJECTS (GROUP A) 
This group of HBsAg seropositive individuals was composed chiefly of 
voluntary blood donors (41), together with: 
1. asymptomatic contacts of HBsAg-seropositive individuals (2). 
2. individuals who were found by chance to be HBsAg-positive during routine 
medical examination (2). 
3. patients found to be HBsAg-positive at routine screening by a clinic for 
venereal diseases (6). 
V.3.2.1 Blood donors 
For the group of 41 voluntary blood donors (8 females and 33 males) the 
results of the histological classification are given in table V.1 0. 
Table V.1 0 Histological liver changes, age and sex of 41 voluntary blood donors. 
age 
n males females range mean 
acute hepatitis 9 (22%) 9 0 22-50y 34y 
-self-limiting 3 3 0 22-43y 32y 
- transition 
into chronic 6 6 0 29-50y 36y 
chronic persistent 
hepatitis 10 (241h%) 8 2 22-49y 29y 
chronic active 
hepatitis 5(12%) 4 1 21-32y 25y 
active cirrhosis 0 ( 0%) 0 0 
inactive cirrhosis 1 ( 21h%) 1 0 26y 26y 
minimal lesions 9 (22%) 5 4 26-55y 33y 
aspecific reactive 
hepatitis 7 (17%) 6 23-50y 29y 
total 41 (100%) 33 8 
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During clinical follow-up of the hepatitis B infection, one or more biopsies were 
taken from 8 blood donors in the 5 years time period of this study. Between the 
first and second biopsies the time interval ranged from 5 to 13 months. On long-
term follow-up, after the 5 years time period of this study, several addi_tional 
biopsies were taken. The histological diagnose established for the initial and 
follow-up biopsies are given in table V. 11. Clinical follow-up of the voluntary blood 
donors ranged from 8 months to 15 years. 
Table V.11 Histological diagnosis and degree of fibrosis for initial and follow-up 
biopsies from 8 seropositive blood donors 
patients 
1 
hist 
fibrosis 
CAH 
++ 
biopsies 
CAH 
+++ 
2 
hist 
fibrosis 
CAH 
+ 
CAH 
+/++ 
CAH 
+/++ 
3 
4 
5 
6 
7 
8 
hist 
fibrosis 
hist 
fibrosis 
hist 
fibrosis 
hist 
fibrosis 
hist 
fibrosis 
hist 
fibrosis 
AH AH 
+ 
CAH CAH 
+ + 
AH 
AH 
AH 
+I-
CAH 
+ 
AH CPH 
+ 
AH 
time in months ----~~>-
CAH 
++ 
CAH 
++ 
CAH 
+ 
0 2 4 6 8 10 12 
hist = histological diagnosis 
R.H. =reactive aspec1fic hepatitis 
CPH 
+ 
18 
CAH 
++++ 
CAH 
++ 
CAH 
++ 
CAH 
+/++ 
CAH 
++ 
CAH 
+++ 
CAH 
++ 
CAH 
+++ 
CPH RH 
++++ ++++ 
CAH CAH CAH 
+++ +++ ++ 
CAH 
++ 
CAH 
+++ 
2y 3y 4y 5y 6y 7y 8y 
- HBs and HBe pos1tive 
~ HBs and anti-HBe positive 
Table V.11 shows the initial and follow-up biopsies, the respective histological 
diagnose and the degree of fibrosis for 8 blood donors, followed because of the 
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Table V .1 0 shows the initial and follow-up biopsies, the respective histological 
diagnose and the degree of fibrosis for 8 blood donors, followed because of the 
finding and persistance of a hepatitis B viral infection. The ordinate represents the 
months after the first biopsy. A.H.: acute hepatitis; C.A.H.: chronic active 
hepatitis; C.P.H.:chronic persistent hepatitis. 
Eight biopsies were taken as part of a series of follow-up biopsies. In a series 
of 4 biopsies from 1 patient 2 biopsies showed chronic persistent hepatitis, while 
the other 2 showed chronic active hepatitis. 
V.3.2.1.1 Acute (lobular) hepatitis 
Acute (lobular) hepatitis was the diagnosis established for the initial biopsy 
from 9 blood donors. In this group 3 individuals had self-limiting hepatitis, i.e. 
HBsAg had disappeared from the blood within 6 months of the accidental dis-
covery of HBsAg. The other 6 remained HBsAg-positive for at least 6 years. 
The 3 blood donors with self-limiting acute hepatitis exhibited the histological 
picture of classical fully developed acute hepatitis. In these biopsies marked 
ballooning degeneration and focal, mainly centrilobular, necrosis of hepatocytes 
were present; no bridging or confluent necrosis was seen. The 3 patients devel-
oped jaundice 50, 40 and 14 days, respectively, after the discovery of HBsAg in 
the serum by the blood transfusion services. Obviously the HBV infection in these 
individuals was detected during the incubation period. In these cases the liver 
biopsy was performed 8 days before and 8 and 9 days after the onset of jaundice. 
Before the jaundice they had complained of fatigue and general distress; one had 
arthralgia and a dermal rash. The patient with acute hepatitis who developed 
jaundice 8 days after the liver biopsy, had complained of fatigue and distress in 
the right upper abdominal region four weeks before the liver biopsy. At the time 
of the liver biopsy SGPT was elevated 1 00-fold and SGOT 50-fold. In contrast 
bilirubin was only mildly elevated as was alkaline phosphatase. Cholestasis was 
not seen in the biopsy of this patient, in contrast to the marked cholestasis with 
bile plugs in bile canaliculi in the other 2 cases. The portal tracts in all 3 patients 
exhibited edema and mild inflammatory infiltrates, composed of polymorpho-
nuclear leukocytes, lymphocytes and plasma cells. In addition some portal tracts 
showed mild bile duct proliferation. In 1 patient an epithelioid cell granuloma was 
present in one of the portal tracts. In all 3 cases the serum was free of HBsAg 1 
to 3 months after jaundice started. The peak of the SGPT values during the 
disease in these patients was 1740 IU/L on the average; the average value of 
SGOT on the day of the biopsy was 950 I U fL. 
The other 6 individuals with lobular hepatitis exhibited in general the histo-
logical picture of a more advanced stage of acute hepatitis. Swelling and 
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proliferation of ceroid-loaded macrophages and Kupffer's cells were found in all 
biopsies, mainly centrilobular. In some biopsies numerous macrophages were 
also present in the portal areas. In contrast to the extensive mesenchymal 
reaction the number of Councilman bodies was small. Ballooning degeneration 
and mitotic activity was less evident than in the first 3 patients. In only 1 of the 
biopsies was mild cholestasis seen. None of the 6 blood donors had ever had 
jaundice and during follow-up jaundice also did not develop. Five of the 6 had 
complained 1 week to 3 months before the biopsy of general distress andjor 
arthralgia. One donor with severe arthralgia was positive for both HBsAg and anti-
HBs. Only 1 of the 6 had no special complaints. Three of the 6 had donated blood 
about 6 months before the time HBsAg was found accidentally but had not been 
HBsAg-positive at that time. The other 3 subjects were donating blood for the first 
time. During clinical follow-up the course of the disease in 5 of the 6 donors was 
also evaluated histologically. The follow-up biopsies from these donors showed 
the histological features of a chronic hepatitis (table V.1 0). 
The liver tissue from 8 of the 9 donors with the histological picture of acute 
hepatitis did not contain hemosiderin or copper deposits. In 1 case the biopsy 
revealed a minimal amount of hemosiderin pigment in the Kupffer's cells. All 
biopsies contained small (6) or moderate (3) quantities of eosinophilic 
leukocytes, mainly in the portal tracts. 
V.3.2.1.2 Chronic persistent hepatitis 
Chronic persistent hepatitis was the histological diagnosis established for the 
initial biopsy from 1 0 volunteer blood donors (8 males, 2 females ranging in age 
from 22 to 49 years). All biopsies showed prominent round-cell infiltrates, con-
sisting mainly of lymphocytes and some plasma cells, in more than one of the 
portal tracts. Only 1 biopsy revealed "spill-over" ofthe infiltrate. In the other 
biopsies the infiltrates were restricted to the portal tracts. There was no evidence 
of piecemeal necrosis in any of the biopsies. In 2 biopsies most of the portal 
tracts contained a mild infiltrate; these cases provided diagnostic difficulties; 
differential diagnosis included aspecific reactive hepatitis and residual phase of 
acute hepatitis. 
Lobular changes in all biopsies were restricted to scattered small foci of 
proliferated macrophages and/or Kupffer's cells mixed with some lymphocytes. 
In these foci degenerating hepatocytes, sometimes with the features of a 
Councilman body, were seen sporadically. All biopsies contained groups of 
hepatocytes with little or moderate anisocytosis and anisokaryosis. In 4 of the 
10 biopsies marked fibrosis was present, sometimes with porto-portal septum 
formation which caused focal parcelling of the liver parenchyma. These fibrotic 
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septa contained no or only minimal inflammatory infiltrates. In 4 biopsies foci of 
hepatocytes contained intracytoplasmic fat vacuoles. Hemosiderin pigment, in 
both Kupffer's cells and hepatocytes, was seen only in one biopsy. 
The serum SGOTvalues, seefig.V.3, ranged from 22 to 721Ujlwith an average 
of 33 at the time of the biopsy. With respect to the serum SGOT levels, the serum 
SGPT levels, ranging from 14 to 92 I U /L with an average of 38, were higher in 6, 
similar in 2 and lower in 2 cases. 
In all1 0 cases the serum bilirubin levels were within the normal limits. None of 
the patients had a history of jaundice. Five individuals had complained of general 
distress and nausea 4 to 12 months before the finding of HBsAg; the other 5 
never experienced signs or symptoms suggesting the presence of a subicteric 
acute hepatitis. 
Fig.V.3 Serum transaminase levels measured in sera from 10 blood donors taken 
at the time of the liver biopsy, which was indicative for chronic persistent 
hepatitis. 
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All donors were followed clinically and biochemically. During follow-up the 
course of the liver enzyme tests justified histological follow-up in only 1 case 
(patient 8, fig.V.3). The biopsy was taken five years after the initial biopsy and 
showed chronic active hepatitis with marked fibrosis. 
V.3.2.1.3 Chronic active hepatitis 
The initial biopsyfrom 5 volunteer blood donors ( 4 males, 1 female) showed the 
histological picture of chronic active hepatitis. In all biopsies all portal tracts 
contained marked round-cell infiltrates, consisting of lymphocytes and plasma 
cells. In general the infiltrates were concentrated on the interface between the 
portal tracts and the liver parenchyma. In several places the parenchyma was 
invaded by the inflammatory infiltrate with destruction of the limiting plate. In 
these areas degenerating hepatocytes, sometimes with the aspect of Councilman 
bodies, were present. In 2 of the biopsies the inflammatory infiltrates were inter-
mingled with a marked quantity of eosinophilic leukocytes. The activity of the 
chronic hepatitis varied from mild (3) to moderate (2). In all biopsies periportal 
fibrosis was present, together with the formation of some porto-portal septa in 1 
biopsy, and with extensive porto-portal septa and nodular regeneration of the 
liver parenchyma in another. 
In 2 of the 5 biopsies a small amount of hemosiderin pigment was--present. The 
serum SGOT values for this group ranged from 32 to 86 I.U./L with an average 
of 56. The SGPT values, which with one exception were higher than the SGOT 
values, ranged from 30 to 120 I.U.jL with an average of 70 (fig.V.4). 
Follow-up 
During clinical and biochemical follow-up, repeat biopsies were taken from 3 
of the 5 patients during the five year study time: 3 from 1 patient, and 2 from 2 
patients. On the long-term follow-up biopsies were taken from all 5 patients. Four 
of the 5 donors reveiled HBe seroconversion after 3, 6, 6 and 10 years, respect-
ively. Subsequently 2 of these 4 also became HBsAg seronegative. 
V.3.2.1.4 Cirrhosis 
Cirrhosis was found in one volunteer blood donor. The cirrhosis was from the 
incomplete septal type. There were only minimal inflammatory infiltrates in the 
gracile fibrous septa. 
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V.3.2.1.5 Minimal lesions 
Minimal lesions (9 donors: 5 males, 4 females) or an aspecific hepatitis (7 donors: 
6 males, 1 female) were the diagnosis established for 16 of the 42 volunteer blood 
donors. 
Fig.V.4 Serum transaminase levels measured on the day of biopsy in 5 blood donors 
with chronic active liver disease. 
The changes in the biopsies from blood donors with aspecific hepatitis 
comprised focal anisocytosis and anisokaryosis of the hepatocytes, numerous 
binucleated hepatocytes, activation of scattered Kupffer's cells which contained 
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some ceroid pigment and inconspicuous inflammatory infiltrates in the portal 
tracts: the latter were too small for a diagnosis of chronic persistent hepatitis. 
Differentiation form chronic persistent hepatitis was difficult in 1 of the 7 cases. 
End-stage of acute hepatitis was included in the differential diagnosis for another 
biopsy, which showed fibrotic septa and many swollen macrophages loaded with 
ceroid pigment. Two biopsies exhibited mild fibrosis together with scattered 
hepatocytes with intracytoplasmic fat vacuoles (steatosis). Iron pigment was not 
found in any of the 7 biopsies. 
Periodic acid-Schiff-positive globules in the cytoplasm of hepatocytes, charac-
teristic of a1-antitrypsin, were seen in 1 biopsy. Proliferation of bile ductules was 
evident in another biopsy. 
For the group of subjects with aspecific reactive hepatitis the SGOT levels in 
sera taken at the time of the biopsy ranged from 16 to 26 with a mean value of 
21. The SGPT levels ranged from 18 to 25 (mean value 22). Six of 7 donors with 
an aspecific hepatitis were found to be HBsAg-positive at the time of their first 
visit to the blood transfusion services. However, 1 patient had been HBsAg-
negative at the time of a blood donation 1 year before. 
The 9 biopsies with histological changes scored as minimal lesions showed 
no inflammatory infiltrates. In 1 biopsy moderate and in another biopsy minimal 
steatosis was present. Fibrosis was not seen in anyofthese biopsies. No iron and 
copper pigment could be demonstrated. 
Both the liver biopsies with minimal lesions and those with aspecific hepatitis 
contained large numbers of "ground-glass" cells (see chapter VII). 
At the time of the biopsy the serum SGOT levels for the minimal lesion group 
ranged from 14 to 33 (mean: 22); the serum SGPT levels ranged from 12 to 32 
(mean: 28). The bilirubin levels were all within the normal limits. 
Seven of the 9 aspirant donors were found to be HBsAg-positive during their 
first medical examination which included routine screening of the blood for the 
presence of HBsAg; 2 of the 9, however, had been active donors, for 10 and 2 
years respectively. Their blood had been HBsAg-negative at the times of 8 and 
3 previous donations, respectively, the last being only 6 months earlier. 
V.3.2.2 Asymptomatic hepatitis B positive subjects, except blood donors 
The histological diagnosis for the 6 patients, found to be HBsAg positive by 
chance, during a visit to an outpatient clinic for venereal disease, are: 
chronic persistent hepatitis (2 patients); chronic active hepatitis (2 patients); 
minimal lesions (1 patient); aspecific reactive hepatitis (1 patient). 
From the two subjects found HBsAg-positive by screening of family contacts 
of known HBsAg carriers one had chronic persistent hepatitis, the other had 
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aspecific reactive hepatitis. The 2 patients found HBsAg .seropositive on routine 
medical examination reveiled chronic active hepatitis in one and acute hepatitis 
in the other. 
From 6 out of the 1 0 cases follow-up biopsies were available. The results are 
given in table V.11. 
Table V.11 Histological diagnosis and degree of fibrosis for initial and follow-up 
biopsies from 6 asymptomatic HBsAg-seropositive subjects 
Patient 1 
Patient 2 
Patient 3 
Patient 4 
Patient 5 
Patient 6 
biopsies 
! ! 
hist CAH CPH 
fibrose +++ ! +++ + 
hist AH CAH + fibrose ~ 
hist CAH 
fibrose ++ + 
hist CPH + fibrose ~ 
hist AH 
fibrose ~ 
hist CAH 
fibrose + 
CAH ! ++ 
CPN 
++ 
CAH 
++ 
CAH CPH 
+++ ++++ 
CPH 
+ 
CAH 
++ 
0 2 4 6 8 10 12 18 2y 3y 4y 5y 6y 7y 8y 
time---~ 
hist = histological diagnosis 
AH = acute hepatitis 
- HBs and HBe positive 
CPH = chronic persistent hepatitis 
CAH = chronic active hepatitis 
E::3HBs and anti-HBe positive 
V.3.3 SYMPTOMATIC HBSAG SEROPOSITIVE PATIENTS (GROUP B) 
The classification of the histological changes in the biopsies from 88 
symptomatic HBsAg seropositive patients are given in table V.12. 
Most of all acute hepatitis cases in this study, belonged to the group of 
symptomatic hepatitis B infections (33 of 43 cases). From the 33 acute hepatitis 
cases, 31 were accompanied by jaundice. Transformation into chronic hepatitis 
occurred in four, including the two anicteric cases. From the symptomatic 
hepatitis B patients± 13 per cent had chronic persistent hepatitis, compared to 
± 25 per cent in the asymptomatic hepatitis B subjects. 
As could be expected, most of the patients with chronic active hepatitis and 
cirrhosis had symptomatic liver diseases, i.e. 21 of 29 and 17 of 18, respectively. 
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On the other hand hepatitis B infection with minimal histological changes and 
aspecific hepatitis were relatively more frequent in the asymptomatic hepatitis B 
carriers. 
Table V.12 Histological classification of liver changes for 88 symptomatic HBsAg 
carriers 
acute hepatitis 33 
chronic persistent hepatitis 11 
chronic active hepatitis 21 
cirrhosis active 15 
cirrhosis inactive 2 
minimal lesions 3 
reactive hepatitis 3 
V.4 DISCUSSION 
A wide range of liver changes was found in the liver biopsies from the 139 
HBsAg-seropositive patients. The histological changes in all biopsies fitted one 
of the histological categories of the hepatitis B reaction pattern. However, despite 
exact definition of the histological criteria for the various categories of hepatitis, 
problems in classifying the liver changes were encountered in a large number of 
cases. These problems are inherent to all classification systems, where a con-
tinue spectrum of a disease is splitted artificially in categories. 
As far as the group with acute hepatitis is concerned the most serious problems 
occurred when there were prominent portal infiltrates, which sometimes invaded 
the surrounding liver parenchyma. When there were signs of a subsiding lobular 
hepatitis component, as seen in late-phase acute hepatitis, these prominent por-
tal infiltrates suggested in all cases a transition from acute hepatitis to chronic 
hepatitis. In this study an acute hepatitis with a prominent portal infiltrate was 
seen in 21 of the 47 biopsies (48 per cent); on the basis of this histological 
aspect, acute hepatitis, suggestive for transition to chronic hepatitis, was the 
diagnosis in these cases (table V .13). Three of these 21 biopsies revealed a fully 
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developed acute (lobular) hepatitis and 18 a late-phase acute hepatitis. Thirteen 
of these biopsies were taken from 9 patients, who ultimately developed a histo-
logically proven chronic hepatitis, while 8 biopsies came from 8 patients with a 
proven self-limiting acute hepatitis. Of the last group of 8 patients, 5 were 
(however) drug-addicts and the prominent portal infiltrates in these drugaddicts 
may be explained to be caused by other pathogenetic factors than the hepatitis 
B infection. In contrast only 3 out of 26 patients with an acute hepatitis without 
prominent portal inflammatory infiltrates developed chronic hepatitis. So, a 
prominent portal infiltrate, sometimes with the features of piecemeal necrosis had 
some but slight prognostic value, in predicting the transition of acute hepatitis to 
chronic hepatitis. All other light microscopic aspects seen in acute hepatitis are 
shown to have less prognostic value. 
Histological stages of acute hepatitis (fully developed, late and residual 
stages), correlated well with clinical and biochemical findings. Biopsies with the 
histological picture of an acute fully developed hepatitis were found to be taken 
meanly 12 days after jaundice started, whereas the biopsies with the histological 
picture of a late stage of acute hepatitis were taken 23 days after jaundice started 
and were accompanied by significant lower transaminase levels as compared 
with fully developed acute hepatitis. Most of the acute hepatitis cases which 
transformed in chronic hepatitis were the late-stage types. Probably this is the 
result of low rate of liver cell necrose on a protracted time-scale which will in-
fluence in the liver tissue the relation between necrotic hepatocytes and ceroid 
macrophages in favor of the ceroid macrophages. 
Presence of iron-pigment in the biopsy series of acute hepatitis was incon-
spicuous. In only 12 out of 47 cases(± 21 per cent) iron pigment was detected. 
This is in contrast to the studies of Hengeveld ( 1979) who found in 12 out of 20 
patients (60 per cent) iron pigment, partly in macrophages, partly in sinusoidal 
lining cells and in all biopsies ( 1 0), taken more than 2 weeks after jaundice 
started, he detected iron pigment. Eosinophilic granulocytes were found in 27 of 
the 47 biopsies with acute hepatitis, in large numbers in 10 cases. From this 
finding it is shown that eosinophilic leukocytes may not be used to discreminate 
between an acute viral hepatitis and an acute drug-induced hepatitis. 
In this study the differentation between CPH and CAH was not only justified 
by the differences in transamines in both groups but also by differences in 
architectural disturbances of the liver parenchyma and prognosis. Nevertheless 
pronounced fibrosis was found in some biopsies with the histological picture of 
a chronic persistent hepatitis. Obviously in these cases the CPH must be con-
sidered as a temporaly state of a basically more severe liver disease or as a state 
after a more severe liver disease e.g. status after severe acute hepatitis or after 
HBcAg seroconversion. The relatively good correlation between disturbances in 
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liver enzymes and histological liver changes are in contrast with the study of Seef 
1975, who found a poor correlation between clinical and histological diagnosis. 
Ages of patients with acute hepatitis, chronic persistent hepatitis and chronic 
active hepatitis differed not significantly, whereas cirrhosis was found in older age 
groups. This finding can be explained by the time period, necessary for the 
evolution of cirrhosis from a chronic (active) hepatitis. However a more agressive 
course of a hepatitis B infection in older age individuals cannot be excluded in 
this study. 
Of the 43 patients with a histologically classified acute hepatitis, 11 developed 
a chronic hepatitis. In 9 of these 11 patients, the acute hepatitis ran an anicteric 
course, which fits with the finding of Sherlock ( 1975) who stated that most cases 
of chronic hepatitis start as a grumbling subclinical acute hepatitis and that icteric 
acute hepatitis rarely transforms into a chronic liver disease. Moreover most of 
the patients with chronic hepatitis in this study do not reveal an anamnestic 
period of jaundice. 
Table V.13 Clinical and histological aspects associated with the course of an acute 
hepatitis with prominent port"al infiltrates. 
course of biopsies patients jaundice fully late phase 
hepatitis n n + - developed type of 
hepatitis hepatitis 
self-limiting 8 8 8 0 3 5 
transition into 
chronic 13 9 1 12 0 13 
From this study it is concluded that the presence of a prominent portal infiltrate, 
sometimes with the characteristics of piecemeal necrosis is not always a sign for 
transition to chronic hepatitis. For asymptomatic HBsAg seropositive subjects the 
wide spectrum of histological changes in liver biopsies is described by several 
authors (Klinge, 1973; Feinaro, 197 4; Woolf, 197 4; Villeneuve, 1976; Lok, 1988). 
However, there are discrepancies between these reports as far as the incidence, 
nature and severity of the liver abnormalities are concerned. These discrepancies 
could be explained by differences in the populations studied by the various 
authors (Feinman, 1975). In the studies on asymptomatic blood donors, some 
investigators excluded asymptomatic HBsAg-positive donors with abnormal liver 
function tests (Reinicke, 1972; Shrago, 1977), while others analysed all HBsAg 
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blood donors, irrespective of their liver function tests (Griffin, 1973; Villeneuve, 
1976). 
Table V.14Results of histological analysis of liver biopsies from healthy 
asymptomatic HBsAg-seropositive subjects in several studies. 
Series Total Normal Abnormal 
n or Asp. CPH CAH Cirrh. AH 
Prince 1969:bl 1 0 1 0 0 0 
Klinge 1971 :bl 21 10 11 0 0 0 
Singleton 1971 :bl 10 2 3 2 1 2 
lworson 1972:bl 21 10 11 0 0 0 
Reinicke 1972:bl 24 6 17 0 1 0 
Griffin 1973:bl 12 5 7 0 0 0 
Simon 1974:bl 9 6 0 2 0 1 
lchida 1975:bl 20 19 0 0 0 1 
Feinman 1975:bl 29 17 10 0 1 0 
Woolf 1975:bl 36 19 11 5 1 0 
Villeneuve 1976:bl 31 5 24 0 2 0 
Shrago 1977:bl 26 11 13 0 0 0 
Wesdorp 1979:bl 12 4 1 4 3 0 
Dormeyer 1981 :bl 88 78 6 4 0 0 
Feinman 1982:bl 36 21 15 0 0 0 
This serie 1989:bl 41 16 10 5 1 9 
bl = blooddonors 
Table V.14 shows the results of the histological evaluation of biopsies, taken 
from asymptomatic HBsAg seropositive individuals in several studies. The spec-
trum of lesions reported by the different investigators, varied from predominantly 
"normal liver histology" to serious lesions such as cirrhosis or chronic active 
hepatitis. However, in most studies the majority of liver biopsies revealed no or 
slight changes; chronic active hepatitis and cirrhosis were rare findings. As in the 
presentstudythe more severe liver changes were always accompanied byabnor-
malliver function tests. However, subjects with chronic persistent hepatitis may 
reveal normal or partly abnormal liver function tests. The relatively severe liver 
changes found in blood donors in the study ofWesdorp (1979) can be explained 
by abnormal liver enzymes as the selection criterium for the performance of a 
116 
liver biopsy. Also Singleton (1971) found in 9 out of 10 asymptomatic blood 
donors proportionally many severe liver changes: hepatitis, with chronic active 
hepatitis in 1, acute hepatitis in 2 and active cirrhosis in 1 and inactive cirrhosis 
in another case. However in contrast with the studies of Reinicke and lworson, 
which reported on volunteer blood donors, the study of Singleton concerned a 
group of payed donors, with a high incidence of intraveneus drug abusers. 
In contrast to the findings of others this present study of volunteer blood 
donors showed a striking incidence of lobular (acute) hepatitis. In three blood 
donors HBsAg was detected in the pre icteric period and acute hepatitis was self-
limiting. Six patients however were detected with an anicteric acute hepatitis 
which transformed into a chronic type of hepatitis. Within ten years four of these 
blood donors showed HBe seroconversion and one lost HBsAg subsequently. 
As to be expected liver biopsies with minimal lesions or compatible with the 
picture of "aspecific reactive hepatitis" are encountered more often in the group 
of asymptomatic HBsAg seropositive subjects ( 19 of the 51 : 39 per cent) than the 
group of symptomatic HBsAg seropositive patients (6 of the 88: 6,5 per cent). 
Among the symptomatic HBsAg seropositive patients acute hepatitis, including 
acute hepatitis that is likely to transform into chronic hepatitis, and active 
cirrhosis were the most common diagnosis ( 41 and 20 of the 89 patients, 
respectively). 
117 

CHAPTER VI 
DETECTION AND LOCALIZATION OF HEPATITIS BAND DELTA 
ANTIGENS AND IMMUNOGLOBULIN IN LIVER TISSUE 
An immunochemical study 
119 

CHAPTER VI 
DETECTION AND LOCALIZATION OF HEPATITIS BAND DELTA 
ANTIGENS AND IMMUNOGLOBULIN IN LIVER TISSUE 
An immunpchemical study 
Vl.1. SUMMARY 
The presence and localization of hepatitis B and D antigens were investigated 
in 165 biopsies from 139 HBsAg-positive patients. 
The mutual relationships between these antigens and the concomitant histo-
logical changes in the liver parenchyma were studied. 
In fresh frozen liver tissue three distinct patterns, based mainly on the dis-
tribution of HBsAg in the liver tissue, were distinguished. These patterns correlate 
well with, and provide additional diagnostic and prognostic parameters for, the 
light microscopical diagnosis: 
a. solitary pattern: expression of HBsAg in only an occasional macrophage 
and degenerating hepatocyte. This pattern correlates with acute self -I imiting 
hepatitis. 
b. diffuse or honeycomb pattern: all hepatocytes exhibit linear to finely granu-
lar deposits along the cell membranes, particularly on the outer surface. The 
pattern may be combined with the presence of scattered hepatocytes with 
intracytoplasmic HBsAg (ground-glass hepatocytes). Moreover, HBcAg 
andjor HDV may be present. On the basis of the presence and localization 
of HBcAg the pattern is subdivided: 
1 . no HBcAg or HBcAg confined to the nuclei. 
2. combined nuclear and cytoplasmic HBcAg localization. 
The diffuse HBsAg pattern correlates with chronic persistent and chronic 
active hepatitis while progression of chronic hepatitis is determined by the 
presence and localization of HBcAg. 
c. focal pattern: large groups of hepatocytes contain abundant intracyto-
plasmic HBsAg. These hepatocytes correspond in general with the ground-
glass cells seen in light microscopy. HBcAg is not present. Light micros-
copy shows minimal changes or slight aspecific hepatitis. 
The results suggest that a combination of immune mechanisms, determined by 
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HBsAg and possible HBcAg localization along hepatocytic membranes and direct 
cytopathogenic effects related to cytoplasmic HBcAg localization, plays a role in 
the pathogenesis of hepatitis B. Ground-glass cells are supposed to be a sign of 
integration of HBV-DNA in the host cell genome. The presence of immunoglobu-
lins in the nucleus and the cytoplasm of hepatocytes correlated with the presence 
and localization of HBcAg andjor HDV and is the result of adherance of intrinsic 
anti-HBc andjor anti-delta antibodies present in serum to HBcAg andjor HDV 
during the immuno-histochemical procedures. This phenomenon provides the 
means for finding other (viral) antigen/antibody systems in (liver) tissues. 
Vl.2 INTRODUCTION 
After the discovery of hepatitis B antigen (HBAg), then known as Blumberg's 
Australia antigen ( 1965), several immunofluorescence studies on the demon-
stration and localization of HBV- and later HDV- in liver tissue were published. 
In the early investigations various types of hepatitis were studied by means of 
the direct or indirect fluorescence technique, using both heterologous and hom-
ologous antisera to HBAg but the exact localization of HBAg in hepatocytes re-
mained controversial. Some authors found HBAg chiefly in the nucleus (Millman, 
1969; Coyne, 1970; Nielsen, 1970; Nielsen, 1971 ), others only in the cytoplasm 
(Edgington, 1971; Hadziyannis, 1972), while still others found HBAg in both the 
nucleus and the cytoplasm in variable patterns and quantities (Nowoslawski, 
1970; Kater, 1972; Gerber, 1972; Krawczynski, 1972; Hadziyannis, 1973). 
Most of the controversy was resolved when it became clear that HBAg is 
composed of at least two distinct components with well-defined morphological 
and antigenic correlates (Almeida, 1971; Brzoska, 1973; Huang, 1973). These 
components are hepatitis B core (HBcAg) and hepatitis B surface (HBsAg) anti-
gen, both defined by their own antibody system (anti HBsAg and anti HBcAg, 
respectively). In a patient's serum these antigens can appear together in one 
particle (Dane particle) as a complete virion, but in infected liver cells the two 
antigens have distinct localizations. 
Immunofluorescence studies, using specific antisera against core antigen, 
have shown that HBcAg is found mainly in the nuclei of hepatocytes and that the 
expression of this antigen correlates microscopically with the presence of 21-25 
nm particles (Huang, 1971 ). HBsAg could only be demonstrated in the cytoplasm 
andjor along the cell membranes of hepatocytes (Edgington, 1971; ten Kate, 
1974; Roos, 1975; Gudat, 1976). In ultrathin sections intracytoplasmic HBsAg 
was associated with 20 nm spherical or tubular particles located predominantly 
in the rough and smooth endoplasmic reticulum (Stein, 1971 ). 
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As a rule H8 antisera obtained from hyperimmunized animals appear to contain 
high levels of antibodies againstthe surface antigen whereas those obtained from 
H8sAg seropositive patients contain antibodies directed exclusively against the 
core antigen and those from convalescent hepatitis 8 patients contain variable 
amounts of H8c and H8s antibodies. The differences in the expression of H8sAg 
in the cytoplasm and H8cAg in the nuclei of hepatocytes led to the suggestion by 
Gudat et al. ( 1975) that these expression patterns could be related to the immune 
responsiveness ofthe patient and could therefore have diagnostic and prognostic 
implications. Indeed morphological and immuno-fluorescence studies by ten 
Kate ( 197 4 ), Akeyama ( 197 4) and Ray ( 1976) suggested that H8c, and especially 
H8s, fluorescence patterns correlate with stage and prognosis of the liver 
disease. 
Several authors compared the sensitivity of H8sAg serology with that of H8sAg 
fluorescence in liver tissue. Edgington ( 1971 ), Krawczynski (1972) and Ray et al. 
( 197 4, 1976) demonstrated positive fluorescence of H8Ag antigens in liver tissue 
from H8sAg-negative patients. Krawczynski, however, compared the immuno-
fluorescence patterns found for liver tissue obtained at autopsy with the findings 
of the H8sAg assays performed with sera and pericardia! fluids, using the 
insensitive immunodiffusion technique. The studies of Ray et al. (1974, 1976), 
who used a modified fluorescence method, also demonstrated positive H8sAg 
fluorescence in livers from H8sAg-seronegative patients. Serological detection 
in these studies was performed with radioimmunoassays. This latter study 
suggested that immunofluorescence studies of liver tissue are a more sensitive 
technique than radioimmunoassays of serum for the detection of hepatitis 8 
antigens. 
In the liver H8Ag has been detected not only in hepatocytes but also in 
Kupffer's cells and endothelial lining cells as well as macrophages in the portal 
tracts (Coyne, 1970; Edgington, 1971; Hadziyannis, 1974). Outside the liver, 
e.g. in bone marrow, testis, spleen or mesentery, deposition of H8Ag was rare 
(Coyne, 1970). The presence of H8Ag in vessel walls in H8sAg seropositive 
patients with polyarthritis nodosa (Prince and Trepo, 1971; Cocke, 1971; 
Nowoslawski, 1972; 8rzosko, 1974) and in glomeruli (de Man, 1989) is highly 
suggestive of immune complex deposits (Steffelaar, 1977). 
lmmmunoglobulins have been demonstrated in the liver along sinusoids (Kater, 
1972) and on surface membranes as well as in the nuclei of liver cells (Gerber, 
1972; Hadziyannis, 1973; ten Kate, 1974; Roos, 1975). The deposits of immuno-
globulin along liver cell surface membranes are thought to be caused by viral-
induced changes in the composition of the cell membranes which are responsible 
for destruction of the hepatocytes. The localization of immunoglobulins in 
hepatocytic nuclei is a subject of controversy. 
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In this chapter the localization of HB antigens (HBsAg, HBcAg and HBeAg), 
Delta antigen and immunoglobulins in liver tissue and liver cell suspensions is 
described. The variation in the appearance of HBc in the nuclei and HBsAg in 
the cytoplasm led to the recognition of several viral expression patterns; these 
patterns could be correlated with light microscopical findings (see chapter IV). 
Most of the patients were followed clinically, biochemically and in some cases 
morphologically in order to study the course of the disease. The significance of 
the various fluorescence patterns as a tool for histological staging and deter-
mination of the prognosis of the disease is discussed. 
Vl.3 RESULTS 
Vl.3.1 HBAG IN LIVER TISSUE AND ISOLATED LIVER CELLS 
Of 2521iver biopsies subjected to immunofluorescence to detect the presence 
of HBAg, 165 were obtained from HBsAg-seropositive patients and 87 from 
HBsAg-seronegative patients. 
Except in one case, none of the 87 liver biopsies from seronegative patients 
showed specific fluorescence with either anti-HBsAg and anti-HBcAg antisera. 
The one positive case in the group of HBsAg seronegative patients exhibited 
HBc fluorescence but no HBsAg fluorescence. 
In total161 of the 165Iiver biopsies obtained from HBsAg seropositive patients 
showed positive HBsAg fluorescence. HBsAg was found chiefly in hepatocytes, 
but sometimes also in the cytoplasm of Kupffer's cells and endothelial lining cells 
as well as the walls of vessels in the portal tracts. Of the 161 biopsies with a 
specific HBsAgfluorescence, 43 also showed positive HBcAgfluorescence (table 
Vl.1 ). 
Table Vl.1 Results of HBsAg and HBcAg fluorescence studies of 252 biopsies from 
HBsAg-seropositive and HBsAg-seronegative patients. 
HBsAg + HBcAg + 
n n n 
liver tissue from HBsAg 
seronegative patients 87 0 1 
liver tissue from HBsAg 
seropositive patients 165 161 43 
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The results of the HBs and HBc fluorescence studies of liver tissue specimens 
were compared with the results found for isolated hepatocytes in suspension 
and for sedimentation preparations made from the liver biopsies of 45 patients 
Vl.3.2 LOCALIZATION OF HBSAG IN LIVER CELLS 
Immunofluorescence studies, using monospecific HBsAg antisera, revealed 
that HBsAg appears within the hepatocytes only in the cytoplasm or along the 
cell surface. Nuclear localization of HBsAg was never seen. 
Within the cytoplasm of the hepatocytes some distinctive HBsAg distribution 
patterns were identified: 
1. hepatocytes with a diffuse granular, almost homogeneous, bright HBsAg 
fluorescence in the cytoplasm, leaving the nucleus and a small part of the 
biliary pool of the cytoplasm free of fluorescence (homogeneous fluores-
cence hepatocytes-HFH) 
.:;:::!.~- 8 A 
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Fig.VI.1 
homogeneous 
fluorescence 
hepatocyte (HFH) 
These HFH appeared in liver biopsies in large clusters or as solitary cells 
scattered throughout the liver tissue. In sedimentation preparations of 
isolated hepatocytes these cells were also detected, but the granular 
fluorescence then overlapped the nucleus. Suspensions of isolated hepato-
cytes contained only a sporadic HFH. These HFH corresponded with the so-
called ground-glass hepatocytes in light microscopy (Hadziyannis, 1973) 
(see chapter VII). This was confirmed by subsequent histochemical staining 
of slides containing HFH cells with hematoxylin azophloxin or aldehyde 
thionin (fig.VII.6). 
2. hepatocytes with a varying bright rim of granular fluorescence along the 
periphery of the cytoplasm, leaving the nucleus and the perinuclear parts 
of the cytoplasm free of HBsAg fluorescence (buttonhole fluorescence 
hepatocytes-BFH). These cells were almost always found in small or large 
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clusters. In light microscopy these cells were sometimes faintly recog-
nizable on hematoxylin azophloxin-stained slides; depending on the quantity 
of HBsAg they were visualized fairly easily with the aldehyde thionin and 
Shikata stains. 
Fig.VI.2 
buttonhole 
hepatocyte (BFH) 
3. hepatocytes which exhibit a fine granular almost linear fluorescence along 
the cell surface, not only along the sinusoidal parts but also along the 
intercellular parts of the cell membrane (cell surface fluorescence hepato-
cytes-SFH). Cells with this type of fluorescence were encountered as a rule 
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Fig.VI.3 
hepatocyte with 
cell surface 
fluorescence (SFH) 
throughout the entire liver biopsy in all liver lobuli. Although the intensity of 
the fluorescence of these SFH did vary only slightly within a biopsy, the 
difference between various biopsies may be marked. In sedimentation 
preparations of isolated hepatocytes these cells showed a fine granular 
fluorescence which also covered the nucleus (fig.VI.4). 
Similarly, suspensions of isolated hepatocytes exhibited a fine granular 
fluorescence along the cell surface, indicating that the HBsAg had been 
exposed to the outer surface of the liver cells. The fluorescence granules 
usually were not distributed as uniformly over the cell surface as in frozen 
sections, since they tended to form aggregates on the former (fig.VI.5). 
Sometimes a "capping" phenomenon was seen. Light microscopically no 
features corresponding to these SFH were seen. 
Fig.VI.4 Suspension preparation of two hepatocytes with HBsAg located on the cell 
surface (direct immunofluorescence method, anti-HBsAg 600x). 
Fig.V1.5 Sedimentation preparation of hepatocytes showing HBsAg deposits, 
irregular distributed on the outer surface (direct immunofluorescence 
method, anti-HBsAg 600x). 
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Vl.3.3 INFLUENCE OF FIXATIVES AND FLUORESCENCE TECHNIQUES ON HBSAG 
FLUORESCENCE 
The HBsAg-positive hepatocytes with bright homogeneous fluorescence or 
the buttonhole aspect could also be detected in sections of paraffin-embedded 
liver tissue by means of immunofluorescence and immunoperoxidase methods. 
However, the hepatocytes with cell membrane-bound fluorescence could 
generally not be demonstrated in formalin-fixed paraffin-embedded material. 
HBsAg fluorescence staining of frozen sections was only slightly affected by prior 
fixation with 2 per cent paraformaldehyde, alcohol or acetone as well as by 
heating during incubation with antisera. On the other hand prior fixation with 4 per 
cent formaldehyde or 1 per cent glutaraldehyde induced a strong background 
fluorescence, which masked the specific fluorescence. 
Incubation of sections with anti HBsAg antisera for less than one hour 
diminished the intensity of fluorescence (table Vl.2). Using microwave irradiation 
during incubation period within 5 minutes optimal fluorescence results were 
obtained. 
Table Vl.2 Effects of varying treatments of frozen liver tissue sections on HBsAg 
fluorescence results 
slide aHBs HBsAg fluorescence results 
pretreatment incubation cytoplasmic membrane background 
dried unfixed 1 hour 2o·c ++/+++ ++/+++ + 1-
dried unfixed !h hour 2o·c + + + 1-
dried unfixed 1 hour 4o·c +++ +++ + 
dried unfixed !h hour 4o·c ++ ++ . + 1-
PBS 15 min 1 hour ++/+++ ++ ++ 
acetone 1 0 min 1 hour +++ ++/+++ + /-
ethanol 15 min 1 hour +I++ 
formaldehyde 
15 min 1 hour + +/+ + ++ 
paraformaldehyde 
2% 15 min 1 hour +++ +++ ++ 
glutaraldehyde 
1% 15 min 1 hour ++ +/+ + ++ 
sublimate 15 min 1 hour + 1- + /- ++ 
aceton 1 o min 5 min micro +++ +++ + /-
- = negative + = slight + + = moderate 
+ + + = clear ;severe micro = microwave irradiation 
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Vl.3.4 LOCALIZATION OF HBCAG IN LIVER CELLS 
With the fluorescence technique, using a homologous antiserum, HBcAg was 
found to lie in most cases almost exclusively in the nuclei of hepatocytes. 
However in some cases· nuclear localization occurred together with localization 
in the cytoplasm: in particular patients with active liver disease and cirrhosis and 
patients undergoing immunosuppressive therapy sometimes exhibited large 
amounts of HBcAg in the cytoplasm (chapter XI). HBcAg could be detected in 
varying percentages of the nuclei, ranging from a sporadic nucleus to neariy all 
nuclei. No specific localization of HBcAg-positive hepatocytes was found within 
the hepatic lobuli. Within the nuclei HBcAg caused a fine granular pattern of 
variable intensity. The granules were usually scattered diffusely throughout the 
nucleus. Sometimes, however, these granules had accumulated near the nuclear 
membrane. The often pronounced nucleoli did not seem to contain HBcAg. 
Cytoplasmic HBsAg fluorescence in general occurred together with nuclear 
HBcAg, localized in several scattered or small groups of hepatocytes. 
Light microscopy did not reveal nuclear features consistent with the presence 
of HBcAg. With the double labelling immunofluorescence technique using FITC 
and TRITC-Iabelled antisera against HBsAg and HBcAg, it was shown that HBcAg 
is nearly always present in hepatocytes exhibiting cell membrane-bound HBsAg 
fluorescence (fig.VI.6). 
In sedimentation preparations of isolated hepatocytes HBcAg was also found 
in the nuclei of the hepatocytes. In suspensions HBcAg fluorescence could not 
be detected. Hepatocytes with bright homogeneous HBsAg cytoplasmic fluores-
cence, indicating impressive quantities of HBsAg, rarely contained HBcAg 
(fig.VI.6). 
Vl.3.5 LOCALIZATION OF EAG 
The localization of eAg in general was identical to that of HBcAg (chapter IX). 
Vl.3.6 LOCALIZATION OF DELTA ANTIGEN 
Only one of the 165 liver biopsies revealed delta antigen. Delta antigen was 
found in the nucleus of a small percentage of hepatocytes, together with HBsAg 
along the cell membranes. No HBcAgwasfound. The nuclear localization of Delta 
antigen in a small percentage of hepatocytes was also found in biopsies from 
later dates. 
In liver grafts, transplanted in HBV -positive, HDV-positive patients, HDV-antigen 
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was detected together with HBcAg, both in the nucleus and the cytoplasm of 
hepatocytes (see chapter XI). 
Vl.3.7 HBSAG AND HBCAG IMMUNOFLUORESCENCE PATTERNS IN LIVER TISSUE 
On the basis of the distribution of HBsAg and HBcAg in liver tissue, distinct 
patterns can be distinguished: 
1. the solitary pattern. In this pattern only a few scattered cellular elements 
in the liver tissue are positive for HBsAg. HBcAg is rarely found in these 
cases. The HBsAg-positive cells in the liver tissue are usually Kupffer's cells 
or macrophages with a coarse granular cytoplasmic fluorescence. These 
cells are situated within the sinusoidal spaces or lie within the portal tracts. 
Sporadically, a HBsAg-positive degenerating hepatocyte (Councilman body) 
may be found, but no vital HBsAg-positive hepatocytes are seen. 
2. the diffuse pattern. Classically this pattern is characterized by a fine cell 
membrane-bound fluorescence of all hepatocytes in the liver tissue, yielding 
a honeycomb-like fluorescence aspect (fig.VI.6, page 145). In addition to 
this cell membrane-bound fluorescence pattern, scattered hepatocytes 
exhibit a bright homogeneous fluorescence. The number of these latter 
hepatocytes differs from one patient to the next and probably to some extent 
within one and the same liver. Sometimes small groups of buttonhole 
fluorescence hepatocytes are present. In liver tissue exhibiting this diffuse 
HBsAg pattern, HBcAg is frequently found in the nuclei of the hepatocytes, 
sometimes in combination with cytoplasmic localization. The number of 
HBcAg-positive cells can range from sporadic to almost all hepatocytes. 
High percentages of HBcAg-positive hepatocytes are found especially in 
livers from patients on immunosuppressive therapy. The HBcAg-positive 
hepatocytes are distributed in foci. This focal distribution is not related to 
a specific area within the lobulus. The localization of HBcAg is nearly always 
restricted to hepatocytes with cell membrane-bound fluorescence, while 
hepatocytes with intracytoplasmic HBsAg fluorescence are often negative 
for HBcAg (fig.VI1.9, page 160). 
3. the focal pattern. This pattern is characterized by coherent groups of 
hepatocytes with a bright intracytoplasmic HBsAg fluorescence (fig.VI.7, 
page 145). In addition, groups of hepatocytes with buttonhole fluorescence 
andjor cell membrane-bound fluorescence may also be found. The groups 
of HBsAg-positive hepatocytes have no specific location within the hepatic 
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lobulus and can cover more than one lobulus. This HBsAg pattern never 
included HBcAg. The inhomogeneous distribution of HBsAg-positive 
hepatocytes may cause a false-negative fluorescence finding. 
According to the above-mentioned criteria most of the biopsies can be classified 
under one ofthe three fluorescence patterns. Sometimes, however, a pattern may 
be found with intermediate features. Cirrhotic livers in particular may exhibit 
different patterns in different nodules. 
The incidence and distribution of the solitary, diffuse and focal patterns over 
the 165 liver biopsies are given in table Vl.3. 
Table VI. 3 Incidence of HBcAg in the different HBsAg fluorescence patterns 
with HBcAg without HBcAg 
n n n 
solitary pattern 28 0 28 
diffuse pattern 100 36 64 
focal pattern 22 0 22 
negative 4 3 
intermediate pattern 11 6 5 
total 165 43 122 
None of the biopsies with the solitary or focal pattern contained HBcAg. HBcAg 
fluorescence was seen in 36 of the 1 00 biopsies {36 per cent) with a diffuse 
pattern. The number of nuclei positive for HBcAg ranged from sporadic to more 
than 80 per cent (table Vl.4). 
Eleven biopsies exhibited a fluorescence that did not fit one of the three 
fluorescence patterns. In 6 of these 11 biopsies cell membrane-bound fluores-
cence occurred only within groups of hepatocytes (not diffuse); 3 of these 6 
biopsies were also HBcAg-positive. The other 5 biopsies were characterized by 
foci of bright homogeneous cytoplasmic HBsAg fluorescence together with 
hepatocytes that produced a cell membrane-bound HBsAg fluorescence. Three 
of these biopsies exhibited HBcAg fluorescence. Four out of the 165 biopsies 
were negative for HBsAg, one of which contained HBcAg. 
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Table Vl.4 Estimated percentage of HBcAg-positive hepatocytes in biopsies with a 
diffuse HBsAg fluorescence pattern 
no fluorescence 
sporadic 
between 5 and 20 per cent 
between 20 and 50 per cent 
50 per cent and higher 
total 
n 
63 
5 
20 
6 
6 
100 
Vl.3.8 IMMUNOGLOBULIN AND COMPLEMENT DEPOSITS IN LIVER TISSUE AND 
ISOLATED LIVER CELLS FROM HBSAG-POSITIVE PATIENTS (table V1.5) 
The direct or indirect immunofluorescence technique for frozen sections 
revealed that all biopsies from HBsAg-positive as well as HBsAg-negative patients 
contained diffuse deposits of immunoglobulin and complement in varying quan-
tities in the sinusoidal spaces. These deposits were localized in particular in 
Disse's spaces (fig.V1.8). Biopsies from patients with inflammatory liver disease 
generally produced a more intense fluorescence than those from patients without 
inflam-matory liver changes. The immunoglobulin isotypes found were lgG and, 
to a lesser extent, lgM and lgA. Moreover the titer of complement factors in the 
sinusoidal spaces was low. 
Deposits of lgG or lgM were detected along the cell membrane of hepatocytes 
in 98 of the 165 liver biopsies from HBsAg seropositive patients and in 43 of the 
87 liver biopsies from HBsAg seronegative patients. This lgG and lgM fluores-
cence pattern was identical to the honeycomb-like fluorescence pattern found 
for HBsAg. Deposits of complementwere never found in this honeycomb-like cell 
membrane-bound fluorescence pattern. 
Immunoglobulin deposits were detected in the nuclei of hepatocytes in 42 of 
the 165 liver biopsies from HBsAg seropositive patients and 1 of the 87 biopsies 
from HBsAg seronegative patients. In the biopsies from HBsAg seropositive 
patients nuclear immunoglobulin fluorescence was always localized in groups of 
scattered hepatocytes (fig.VI.9). In the same biopsies HBcAg fluorescence exhi-
bited an identical distribution pattern. Only 1 biopsy with HBcAg fluorescence 
lacked immunoglobulins; this biopsy came from a renal transplant recipient on 
high-dose immunosuppressive therapy. This was also the only one of the 43 
patients with HBcAg fluorescence who exhibited minimal anti-core activity in the 
serum. 
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Fig.V1.8 Normal lgG sinuso Tdal fluorescence pattern in a section of frozen iiver 
tissue (320x). 
Fig.V1.9 Perisinuso Tdal lgG deposits together with bright fluorescence of lgG 
deposits in a nucleus indicatingthe presence of HBcAg ( anti-lgG, direct one-
step fluorescence method, 600x). 
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Electron microscopy showed core particles in the nuclei only in those cases 
in which nuclear immunoglobulin and/ or HBcAg fluorescence staining had been 
demonstrated (see chapter X). All biopsies with nuclear deposits of immuno-
globulin also exhibited deposition of immunoglobulin along the cell membrane 
of the hepatocytes. 
Table Vl.5 Deposits of immunoglobulins in liver tissue 
n 
liver tissue from 
HBsAg-positive 
patients 165 
liver tissue from 
HBsAg-negative 
patients 87 
cell membrane 
bound 
sinusoidal lgG lgM 
165 98 39 
87 43 29 
nuclear 
lgG lgM 
42 2 
0 
In 40 of the 42 biopsies the nuclear immunoglobulin deposits were of the lgG 
class; the other two contained both lgG and lgM deposits. None of the biopsies 
showed deposition of lgA or complement in the nuclei. The biopsy with nuclear 
deposits of immunoglobulin from the patient without HBsAg-positive serology 
showed granular lgG fluorescence of all hepatocytic nuclei. The biopsies with 
nuclear immunoglobulin deposits from HBsAg-positive patients as well as the 
above-mentioned HBsAg-negative patient acquired nuclear complementfixation 
after incubation of the slides with fresh human serum. 
Eluates of the liver tissue showed anti-core activity in biopsies from HBsAg 
seropositive patients. Eluate of the liver tissue from the HBsAg seronegative 
patient showed antinuclear activity. The latter patient was known to have lupus 
erythematosus. 
Vl.3.9 RELATION BETWEEN (HBSAG AND HBCAG) FLUORESCENCE PATTERNS AND 
LIVER HISTOLOGY 
Table Vl.6 gives the relation between the HBsAg fluorescence patterns 
described above and the histological changes in the liver biopsies from HBsAg-
seropositive patients. 
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Table Vl.6 Relation between HBsAgfluorescence pattern and histological diagnosis 
histological 
diagnosis n sol 
HBsAg fluorescence patterns 
diff focal interm neg 
acute 
hepatitis 47 26 15 0 5 
chronic 
~ersistent 
epatitis 30 0 28 2 0 0 
chronic 
active 
hepatitis 43 1 38 0 3 1 
cirrhosis 
active 17 12 1 3 0 
cirrhosis 
inactive 3 0 1 2 0 0 
minimal 
lesions 14 0 3 11 0 0 
aspecific 
reactive 
hepatitis 11 0 3 6 0 2 
total 165 28 100 22 11 4 
sol = solitary diff = diffuse interm = intermediate neg = negative 
More than 50 per cent of the liver biopsies graded histologically as acute hepa-
titis yielded a solitary pattern, a pattern that is seen only sporadically in the other 
histopathological categories of liver changes for the group of HBsAg seropositive 
patients. Approximately 30 per cent of the biopsies of acute hepatitis exhibited 
a diffuse fluorescence pattern, while an intermediate fluorescence pattern was 
seen in 5 patients (± 10 per cent). Three of the latter showed cell membrane-
bound HBsAg not as a diffuse pattern but in groups of hepatocytes. The liver 
biopsies from the other two patients yielded a fluorescence pattern intermediate 
between the diffuse and focal HBsAg fluorescence patterns. Biopsies graded 
histologically as chronic persistent hepatitis gave a diffuse fluorescence pattern 
in all but two cases. The two exceptions exhibited a focal fluorescence pattern. 
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Table VI.? Relation of HBcAg with histological diagnosis and HBsAg fluorescence 
patterns. 
histological HBcAg 
diagnosis n diffuse 
HBsAg 
intermediate 
acute 
hepatitis 6 4 2 
chronic 
~ersi~t~nt 
epat1t1s 9 9 
chronic 
active 
hepatitis 22 20 2 
cirrhosis 5 3 2 
minimal 
lesions 1 1 
aspecific 
changes 0 0 
total 43 37 6 
In chronic active hepatitis too the diffuse fluorescence pattern prevailed (88 
per cent); in only one case was a solitary and in three cases an intermediate 
fluorescence pattern seen, while no fluorescence could be detected in one 
biopsy. In 2 out of the 3 cases with an intermediate fluorescence pattern only 
small groups of hepatocytes showed cell-membrane bound fluorescence; in the 
other one, the fluorescence pattern was intermediate between the focal and 
diffuse patterns. One of the patients with chronic active hepatitis and cell 
membrane-bound HBsAgfluorescence in some groups of hepatocyteswasfound 
to exhibit extensive HBcAg fluorescence. 
Liver biopsies with cirrhosis gave a wider variation in the fluoresence pattern; 
in most cases the diffuse pattern predominated. 
About 70 per cent of the liver biopsies showing minimal or aspecific liver 
changes exhibited the focal pattern. A relatively large percentage (20 per cent) 
of biopsies with aspecific liver changes was negative for HBsAg. 
HBcAg was found exclusively in biopsies with a diffuse or intermediate 
fluorescence pattern and was associated with nearly all types of histological 
changes (table Vl.7). 
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Vl.3.1 0 FOLLOW-UP STUDIES OF PATIENTS WITH HISTOLOGICALLY GRADED ACUTE 
HEPATITIS 
The 43 patients graded histologically as acute hepatitis were followed clinically. 
In 31 of these 43 patients HBsAg was cleared from the serum and the elevated 
levels of transaminase normalized within eight months. No histological follow-
up of these patients is available. 
B.iopsies of the 31 patients with self-l.imiting acute hepatitis gave a solitary fluor-
escence pattern in 26 cases, a diffuse fluorescence pattern in 1 and a partial cell 
membrane-bound fluorescence of groups of hepatocytes in 3 cases. One biopsy 
was completely negative for HBsAg and HBcAg. 
Eleven of the 43 patients remained HBsAg seropositive for at least 4 years. 
One patient died 5 months after the biopsy was taken with continually positive 
HBsAg serum tests. For 9 of the patients with persisting HBsAg-positive serum 
the histological changes in follow-up biopsies could be studied. In 4 cases the 
second biopsy, taken approximately six months after the first, still showed the 
histological pattern of acute hepatitis. However, one year after the first biopsy, 
all 9 follow-up biopsies indicated chronic hepatitis (some chronic persistent, 
some _chronic active). 
A diffuse fluorescence pattern was seen in the first biopsy of 9 and a mixture 
of the diffuse and focal fluorescence patterns in 2 of the 11 patients whose liver 
disease progressed from acute to chronic hepatitis. All but 2 of these patients 
were clinically anicteric. Of the 31 patients with acute self-limiting hepatitis 29 
were icteric, while the other two experienced a period of doubtful icterus. 
The next table (VI.8) gives the combined results of the histological and fluor-
escence studies of the follow-up study. From these data it is clear that the 
fluorescence pattern remained constant, despite the factthatthe histology of the 
liver disease changed in sequential biopsies from these patients. 
Of the 13 cases graded histologically as acute hepatitis and a diffuse fluores-
cence pattern only three included a sporadic hepatocyte with cytoplasmic HBsAg 
fluorescence. HBcAg could only be demonstrated in 2 biopsies. 
Vl.3.11 FOLLOW-UP STUDY OF PATIENTS WITH HISTOLOGICALLY GRADED CHRONIC 
HEPATITIS 
Chronic persistent or chronic active hepatitis was diagnosed in 30 and 43 of 
the 165 liver biopsies, respectively. These biopsies were obtained from 60 
patients. All patients remained HBsAg-positive during a follow-up period of at 
least four years. Twelve follow-up biopsies were obtained from 7 patients. The 
fluorescence pattern for the first biopsy was of the diffuse type in all cases and 
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Table V1.8 Histological and fluorescence results fort he first and follow-up biopsies 
from 9 HBsAg-positive patie-nts. Note: constant HBsAg expression, 
changing histological diagnosis 
Patients 1e biopsies 
A hi st. AH CPH 
Fl. diff diff 
GG. + 
HBc + 
B hi st. AH CPH 
Fl. diff diff 
GG. + 
HBc + 
c hi st. AH AH CAH 
Fl. diff diff diff 
GG. + + 
HBc + 
D hist. AH AH CAH 
Fl. diff diff diff 
GG. + 
HBc + + 
E hi st. AH AH 
Fl. diff diff 
GG. 
HBc + 
F hi st. AH CAH 
Fl. diff diff 
GG. + 
HBc + 
G hist. AH AH 
Fl. diff diff 
GG. + 
HBc + 
H ~i~t. ~/# ~fttH 
GG. + 
HBc + 
hi st. AH CAH(mild) CAH(mod) 
Fl. diff diff diff 
GG. + + 
HBc + + + 
months ____ .,.. 0 2 4 6 8 10 12 16 20 24 
hist. =histology Fl. =fluorescence pattern diff = diffuse fluorescence pattern 
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this pattern remained diffuse later. However, the histological diagnosis changed 
during follow-up in 4 cases from CAH to CPH or from CPH to CAH. 
It HBcAg was found in-one biopsy, HBcAg could nearly always be detected in 
subsequent biopsies from the same patient. Ground-glass cells were found 
scattered throughout the liver tissue in 14 of the 19 biopsies. 
One patient with CAH who exhibited a diffuse fluorescence pattern sub-
sequently developed cirrhosis, similarly associated with a diffuse fluorescence 
pattern. One year later the patient died as a result of a hepatocellular carcinoma. 
The follow-up biopsies never revealed a change from one type of fluorescence 
pattern to another. 
Vl.4 DISCUSSION 
HBsAg could be demonstrated in 161 of the liver biopsies from HBsAg sero-
positive patients and none of those from HBsAg seronegative patients. We could 
not confirm the observation of Ray et al. (1974, 1976) that the immunofluores-
cence technique tor liver tissue is more sensitive tor detection of HBsAg than 
radioimmunoassay of serum. HBcAg was, however, found in 1 biopsy from a 
HBsAg seronegative patient. Also immunofluorescence may be enhance the 
detection of HBV infections slightly. The liver biopsies from tour HBsAg 
seropositive patients in our study gave negative HBsAg fluorescence. One of the 
4 liver biopsies from HBsAg seropositive patients with negative HBsAg fluores-
cence was characterized by late-phase acute hepatitis. In this patient HBsAg 
cleared from the serum a few weeks after the biopsy was taken. Thus, in this case 
the negative HBsAg immunofluorescence should not be considered as a false 
negative result but as a predictor of the benign course of the HBV infection. 
Therefore, as seen in the liver biopsies from all patients with an acute self-limiting 
hepatitis, HBV is as a rule cleared from the liver long before the serum becomes 
negative. The second case with negative immunofluorescence was a patient with 
chronic active hepatitis. HBsAg was detected in one serum sample but all other 
sera were negative (a false-positive serological result?). The sera of the third and 
fourth patients with negative HBsAg immunofluorescence remained HBsAg-
positive during follow-up. The biopsies from both patients showed only limited 
aspecific histological changes. The absence of HBsAg in liver tissue is in these 
cases unlikely: sampling errors due to the focal distribution of HBsAg (which is 
consistent with this type of histological change) seems to be a more probable 
explanation of the negative results. 
HBsAg was found in the cytoplasm of hepatocytes, particularly ground-glass 
hepatocytes, but also along the cell membranes of hepatocytes, in Kupffer's cells 
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and sometimes in the walls of vessels in the portal tracts. HBsAg was never found 
in hepatocytic nuclei. The most sensitive method for detection of HBsAg in liver 
tissue is the fluorescence method using air-dried or acetone-fixed frozen 
sections. Sublimate-fixed, trypsin-treatedfrozen sections yield better morphology 
with retention of the specific fluorescence. For rapid detection of HBsAg in liver 
tissue microwave stimulated incubation can be used,which yields good fluores-
cence results within 5 minutes. 
Immunofluorescence studies of paraffin-embedded formalin-fixed material 
show intracytoplasmic HBsAg in ground-glass and buttonhole cells. In contrast 
cell membrane-bound HBsAg fluorescence of hepatocytes was detected only 
sporadically: with this method we would have missed 34 patients with pure cell 
membrane-bound fluorescence staining of the liver biopsy. The peroxidase-
labelled anti body method for formalin-fixed paraffin-em bedded liver tissue allows 
detection of intracytoplasmic HBsAg and also, according to some authors, 
membrane-bound HBsAg in cell membranes of hepatocytes (Busachi, 1978). 
Only 43 of the 161 patients with HBsAg fluorescence exhibited core antigens 
(± 27 per cent). In our study core antigens always existed, except in one patient, 
in combination with cell membrane-bound HBsAg.Aisothe studyofGudat(1977) 
revealed that HBcAg may in rare cases occur without detectable HBsAg. In 
hepatocytes with a marked accumulation of HBsAg, as seen in HFH or ground-
glass hepatocytes, HBcAg could be demonstrated only sporadically. 
Probably these ground-glass cells harbor the genetic material of the virus in 
a hidden form, possibly incorporated in the genome of the host hepatocyte. The 
incorporation of viral DNA in the cellular genome differs from patient to patient 
and is possibly dependent on the rate at which the infected hepatocyte is de-
stroyed. In general the destruction of hepatocytes cannot be attributed to a direct 
toxic effect of the virus itself, because there is no direct relation between the 
concentration of HBcAg and liver cell damage. Sometimes, especially in immuno-
suppressed patients, enormous accumulations of HBcAg are found without men-
tionable liver cell necrosis. 
Accumulations of HBsAg in the hepatocytes too cannot be the cause of liver 
cell damage; on the contrary a reverse relation between the levels of HBsAg in 
the liver and liver cell necrosis seems to exist, as suggested by the findings for 
liver tissue from HBsAg carriers. The data seem to indicate that damage of the 
liver tissue is related instead to host factors. But also location of HBcAg in the 
hepatocyte may be an important factor for liver cell necrosis, as shown for re-
currence of hepatitis Bin liver grafts (see chapter XI). Dysfunction of the immune 
reaction ·of the patient, in particular, which causes infected hepatocytes to be 
eliminated, seems to lead to liver cell necrosis. An essential factor in this process 
appears to be the incorporation of HBsAg in the liver cell membrane. All of our 
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material from patients with chronic hepatitis contained hepatocytes with cell 
membrane-bound fluorescence. Moreover very early stages of acute hepatitis 
are characterized by small groups of hepatocytes with cell surface fluorescence. 
Obviously these smaller groups of hepatocytes can disappear, presumably via 
the host's immune reaction, as was the case in the 3 patients with early acute 
hepatitis combined with a cell membrane-bound fluorescence pattern. 
When acute hepatitis was associated with the presence of HBsAg on the cell 
membranes of all hepatocytes, causing a diffuse honeycomb-like fluorescence 
pattern, the acute hepatitis always changed into a chronic type of hepatitis. 
Thus, all 15 patients with acute hepatitis and a diffuse fluorescence pattern in 
the liver biopsy developed chronic hepatitis, as seen in the follow-up biopsies. 
HBsAg immunofluorescence is therefore an important tool for prediction of the 
outcome of an acute hepatitis. 
Chronic active or chronic persistent hepatitis was the diagnosis for 66 of the 
73 patients with a diffuse membrane-bound HBsAg fluorescence pattern. This 
pattern is characterized by scattered hepatocytes with intracytoplasmic fluores-
cence (ground-glass cells). However, the HFH only appeared in the diffuse 
fluorescence pattern after the infection had been present for some time. The 
shortest time interval between onset of hepatitis B and detection of HFH was 
three months. Since HFH seem to appear some time after acquisition of hepatitis 
B infection, HFH or ground-glass cells can only be used sporadically to predict 
transition of acute hepatitis to chronic hepatitis. A diffuse fluorescence pattern 
with some scattered HFH can persist for many years, independent of therapeutic 
intervention. 
As already mentioned, these scattered HFH exhibited HBcAg only sporadi-
cally and probably generally incorporated in the genome of HFH. Because of 
the solitary localization of these HFH cells they obviously are not capable of 
extending this genetic constitution by replication. 
In contrast in patients with minimal or aspecific hepatic lesions and a focal 
fluorescence pattern showing compact fields of HFH, this transfer seems to occur 
by clonal proliferations. In such cases HBcAg might be incorporated in the 
genome of the host hepatocyte with preservation of the potency of the hepato-
cytes to replicate. In this focal pattern the virus appears to be tolerated not only 
by the immune system but also by the hepatocytes of the patient. One might 
speculate that changes in hepatocyte DNA induced by incorporation of viral DNA 
may be the cause of lupus erythematosus in association with persistent hepatitis 
B (Looi, 1982). 
In our material two patients graded histologically as chronic persistent hepatitis 
exhibited the focal fluorescence pattern. 
Based on this focal HBsAg fluorescence pattern chronic persistent hepatitis 
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as seen in these two cases should be differentiated from chronic persistent hepa-
titis associated with a diffuse HBsAg fluorescence pattern, as observed in the 
other 28 patients with chronic persistent hepatitis. This diffuse HBsAg pattern 
has been shown to be closely associated with chronic active hepatitis. 
In view of these differences in viral expression pattern within the histological 
group of patients with chronic persistent hepatitis, there is evidence that chronic 
persistent hepatitis is an non-entity and only a histological receptacle. On the 
same grounds the 6 patients with a histological diagnosis of minimal or aspecific 
lesions but a diffuse fluorescence pattern have to be considered as a separate 
group with the viral expression pattern of chronic active hepatitis; 5 of these 6 
patients were on immunosuppressive therapy and 2 developed chronic hepatitis 
after withdrawal of these drugs. The patterns of viral expression in the liver, which 
are similar for chronic persistent and chronic active hepatitis, suggest that the 
two types of hepatitis are basically the same. 
Deposition of immunoglobulins along the cell membranes of hepatocytes in 
liver tissue sections and on hepatocytes in suspensions with the same pattern 
as HBsAg suggests that not only cellular but also humoral immune mechanisms 
play a role in the destruction of hepatocytes. The cellular immune reaction is 
reflected histologically in piecemeal necrosis in chronic active hepatitis. 
There is strong evdence that immunoglobulin deposits in the nuclei of 
hepatocytes in HBsAg seropositive subjects represent an in vitro induced 
phenomenon. Deposits of immunoglobulins were only found in biopsies in which 
core particles were revealed by ultrastructural examination and HBcAg in the 
nuclei were demonstrated by immuno-histochemical examination. No nuclear 
immunoglobulin deposits were found in HBcAg-negative biopsies. Nuclear 
immunoglobulin deposits were never accompanied by deposits of complement 
in the nuclei. 
However, incubation of the HBcAg-positive slides with fresh human serum 
produced complement fixation on the same place as the immunoglobulin de-
posits which suggests the formation of antigen antibody complexes in these 
places. 
The nuclear immunoglobulins could be removed from the nuclei by elution 
with KSCN (4M) and citrate acid (pH 3.2). The eluates revealed anticore activity, 
as demonstrated by the core-positive liver tissue from a patient with minimal 
anticore serum antibody titers. 
The results of these experiments indicate that anti-HBc antibodies diffuse from 
the sinusoidal blood spaces during the incubation period and bind in the second 
instance to nuclear core antigens that happen to be present (fig.V1.9). 
Immunoglobulin deposits were found by the same in vitro mechanism in liver 
biopsies which revealed nuclear Delta antigen in patients with HDV superinfec-
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Fig.VI.9 Schematic drawing showing the mechanism of immune complex formation 
in frozen tissue sections during the immunohistochemical incubation 
procedure. Circulating antibodies present in the sinusoidal spaces (e.g. 
aHBcAg or aHDAg): 
1. dissolve in the incubation droplet during the incubation procedure. 
2. bind to the corresponding antigens (e.g. HBcAf! or HDAg) which are 
hidden in the tissue cells before tissue cuttmg. The mechanism 
explains the simultaneous detection of various known and unknown 
antigens of viral or tissue origin and the correspondent circulating 
antibody. 
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tion.ln these cases serum anti-delta-antibodies binds to the Delta antigen present 
in the nuclei of hepatocytes. 
The same phenomenon can be demonstrated in tissues from patients with 
lupus erythematosus and a high titer of circulating antinuclear antibodies. These 
biopsies exhibit nuclear fluorescence by binding of anti-nuclear antibodies to the 
DNA present in the nuclei of the hepatocytes; a granular fluorescence is present 
in all nuclei in these cases in contrast to the nuclear fluorescence in scattered 
groups of hepatocytes observed in HBV-infected livers. 
The fine granular cytoplasmic lgG andjor lgM fluorescence of hepatocytes in 
liver tissue from patients with primary biliary cirrhosis (ten Kate, 1981) can also 
be explained by this in vitro mechanism. In these liver biopsies anti mitochondrial 
antibodies from serum in the sinusoidal spaces diffuse into incubation fluids and 
bind to the cytoplasmic mitochondria. 
In HBsAg seropositive patients this phenomenon reveals not only the presence 
of HBcAg in liver biopsies but also the presence of circulating anti core antibodies. 
In our series there was only one case out of the 43 patients with detectable 
HBcAg in the liver without detectable lgG fluorescence. This was a renal trans-
plant recipient on high-dose immunosuppressive therapy with very low anti core 
antibody titer. 
By using antibodies against the various immunoglobulin classes, we could 
also determine the immunoglobulin class of the anticore antibodies. In 42 cases 
these antibodies were of the lgG class; only 2 were of the lgG and lgM classes. 
In fact, this phenomenon enhances the possibility of discovering new antigen 
antibody systems, e.g. in the case of persistent non-A, non-B hepatitis. 
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Fig Vl.6 Diffuse HBsAgfluorescence pattern (direct one-step immunofluorescence, 
(150x). 
Fig Vl.7 Focal HBsAg fluorescence pattern (r;Jirekt one-step immunofluorescence, 
(150x). ' 
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CHAPTER VII 
THE GROUND-GLASS HEPATOCYTE 
Its value in light microscopical diagnosis of hepatitis B infection 
Vll.1 SUMMARY 
The presence of ground-glass hepatocytes (GGH) was studied in routinely 
stained hematoxylin-azophloxin (HA) sections of 1850 consecutive paraffin-
embedded liver biopsies. 
To determine the staining characteristics of GGH as well as the value of special 
staining methods for the detection of hepatitis B surface antigen (HBsAg) in liver 
tissue, additional sections of all liver biopsies consecutive to the HA sections 
were also stained with aldehyde thionin and in most cases orcein. The specificity 
of each positive staining result for the presence of HBsAg was determined by 
immunohistochemical detection techniques for both frozen and paraffin-
embedded sections. Hepatocytes with a ground-glass appearance were seen in 
150 HA stained sections of liver biopsy specimens obtained from both HBsAg 
seropositive and HBsAg seronegative patients with various liver diseases. 
However GGH positive for aldehyde thionin and orcein were only present in 
liver biopsy specimens from patients with HB antigenemia of more than three 
months duration. Aldehyde thionin and orcein-positive GGH were never found 
in liver tissue from either HBsAg seronegative patients or patients with acute self-
limiting hepatitis B infection. The number and distribution of GGH varied with the 
clinicopathological type of the HBV liver disease. In order to be able to judge 
those liver changes caused by hepatitis B virus in biopsies from patients with liver 
disease caused by more than one etiological factor, knowledge of the presence 
and distribution of GGH is important. A large percentage (93 per cent) of the 
biopsies from HBsAg seropositive patients with minimal liver changes were posi-
tive for GGH; in these biopsies the GGH were distributed in large clusters (focal 
pattern). Ofthe biopsies from patients with chronic persistent, chronic active and 
aspecific reactive hepatitis, nearly two-thirds contained GGH. In chronic persis-
tent and chronic active hepatitis the number of GGH was low; the GGH appeared 
in liver tissue as isolated cells surrounded by normal hepatocytes (solitary 
pattern). Weak positive staining of hepatocytes by aldehyde thionin and orcein 
was sometimes also seen in biopsies from HBsAg seronegative patients, without 
however concomitant ground-glass appearance on routine HA-stained slides. 
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Therefore not only a positive staining of the hepatocytes by aldehyde thionin 
or orcein but also ground-glass appearance on HA-stained slides are mandatory 
for a histological diagnosis of HBV infection. 
It is concluded that GGH that are positive to the aldehydethionin and/or orcein 
stain are specific for the presence of a persistent HBV infection. As confirmed by 
follow-up biopsies, their number and distribution during the natural course of the 
liver disease remain fairly constant over many years. On the other hand their 
number and distribution can be an important tool to the histological diagnosis 
and classification of hepatitis B liver disease. 
Vll.2 INTRODUCTION 
Hepatocytes are known as hepatocytes with a ground-glass appearance, i.e. 
ground-glass hepatocytes, if the cytoplasm in hematoxylin and azophloxin 
(eosin) stained sections contains a very finely granular, weakly eosinophilic 
material, usually as a cytoplasmic inclusion body. GGH were noted by many 
pathologists (Desmet, Scheuer, Popper) before their nature, pathogenesis and 
significance were known. 
Hadziyannis et al. (1973) discovered that hepatocytes with a cytoplasm that 
was proven to contain abundant HBsAg by immuno-histochemical methods 
exhibit the ground-glass aspect in routinely stained liver sections. 
In (immuno)electron microscopy studies these hepatocytes showed prolifer-
ation oftheendoplasmicreticulumwith dilated cisternae, which contained tubular . 
and circular structures that were identical to the HBsAg containing particles 
found in the serum of HBsAg seropositive subjects (Ahamed, 1971; Stein, 1972; 
Gerber, 1974; Huang, 1974; Trump, 1976). 
The material in these GGH has special histochemical staining characteristics 
and can easily be identified by the Gomori's aldehyde fuchsin, aldehyde thionin 
(ten Kate, 1974), orcein (Shikata, 1974; Kostich, 1977) and trichome (Gubetta, 
1974) stains. 
The results for sections of paraffin-embedded liver tissue stained with aldehyde 
fuchsin, aldehyde thionin and orcein appear to correlate well with specific 
immunofluorescence and immune-peroxidase stains for HBsAg (Nayak, 1975; 
Afroudakis, 1976). 
Furthermore hepatocytes with the ground-glass aspect are in themselves 
neither specific nor pathognomonic for the presence of HBsAg since they have 
also been found in liver tissue from HBsAg seronegative patients with drug-
induced and other liver diseases (Harriman, 1955; Klinge, 1968; Gerber, 1981; 
Callea, 1986). However these latter GGH do not appear to have the same histo-
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chemical staining characteristics as the ground-glass hepatocytes found in 
HBsAg-positive biopsies. The number and distribution of GGH in liver tissue 
obtained from HBsAg seropositive patients appear to vary with the histopatho-
logical category of the hepatitis. 
In biopsies from patients with HBV infections different authors have found 
varying percentages of biopsies positive for GGH (Shikata, 100 per cent; 
Deodhar, 55 per cent; Gerber 27 per cent). To determine the number of biopsies 
with GGH in various liver diseases and to appraise the diagnostic significance of 
these cells, 1850 consecutive liver biopsies from HBsAg seropositive and sero-
negative patients were screened for the presence of GGH. 
Moreover, to evaluate the value of special histochemical stains tor the detection 
of specific hepatitis B infections, adjacent sections of all biopsies were stained 
with aldehyde thionin and, in most cases, orcein. The findings were compared 
with the results of immunohistochemical staining methods, using immunofluor-
escence and immunoperoxidase techniques. 
Vll.3 MATERIAL AND METHODS 
The material consisted of 1850 consecutive formalin-fixed paraffin-embedded 
liver biopsies received for evaluation during the period 1973-1977. Forty biopsies, 
were too small (less than 0.5 em) or not properly fixed and were excluded from 
the study. 
The remaining biopsies ( 181 0) came from patients with all kinds of liver 
disease. The age of the patients ranged from 2 months to 97 years. Sera from 
750 patients were tested for the presence of HBsAg, including the sera from all 
150 patients with GGH in their liver biopsies. The remaining patients exhibited 
no clinical or morphological evidence of an HBV infection, therefore there was 
no reason for testing the serum for the presence of HBsAg. 
Serial sections of all liver biopsy specimens were stained with hematoxylin 
azophloxin, hematoxylin azophloxin saffron, periodic acid Schiff, periodic acid 
Schiff after diastase digestion, Gomori's reticulin, Azan, and, in most cases, 
orcein (see chapter Ill). Moreover all biopsies from HBsAg seropositive patients 
weretestedforthe presence of HBsAg by immunofluorescence and immunoper-
oxidase techniques (see chapter Ill). 
Moreover a fresh sample from 252 of the 181 0 liver biopsy specimens was 
separated before formalin fixation and snap-frozen in liquid nitrogen. A small 
piece of the same 252 biopsies was also prepared for electron microscopy 
studies. Sections of the snap-frozen as well as formalin-fixed material were 
investigated for the presence of HBsAg by immunofluorescence and immunoper-
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oxidase techniques (see chapter Ill). Sera from all252 patients, were examined 
for the presence of HBsAg. The HA-stained sections were screened for the 
presence of hepatocytes with the ground-glass aspect The number of G G H in the 
liver biopsies was scored semi-quantitatively as +, + +, + + +: + less than 1 
ground-glass hepatocyte per mm2 ; + + 1-1 0 ground-glass cells per mm2 ; and 
+ + + more than 1 0 ground-glass cells per mm2 • 
Determination of the range of the scores was based on the experience about 
the range of GGH in liver tissue. Ground-glass hepatocytes were defined as 
normal-sized hepatocytes with a very finely granular, almost homogeneous, 
weakly eosinophilic aspect in all or part of the cytoplasm. This aspect of the 
hepatocytes contrasts with the irregular coarsely granular cytoplasm of normal 
hepatocytes. Hepatocytes with oncocytic changes in the cytoplasm were ex-
cluded (diffuse granular deeply eosinophilic). 
Vll.4 RESULTS 
Vll.4.1 PREVALENCE 
Ground-glass hepatocytes were detected in 150 (±8 per cent) of the 181 0 liver 
biopsies. 
Fig.VII.1 Ground-glass hepatocyte in liver tissue from a HBsAg seropositive patient 
(Hand A, 500x) 
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Fig.VII.2 Large group of ground-glass hepatocytes in liver tissue of a HBsAg 
seropositive subject. Note the accumulation of preexistent cytoplasmic 
organelles on the biliary pole and the binucleation (Hand A, 360x). 
Fig.VII.3 Ground-glass hepatocytes in a liver biopsy from a HBsAg seronegative 
patient (Hand A, 360x). 
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Out of these 150 biopsies 1 03 were obtained from patients who were HBsAg 
seropositive; the other 47 biopsies came from HBsAg seronegative patients. 
In biopsies from HBsAg seropositive patients the GGH appeared as smaller 
and larger groups (focal pa~tern) or isolated cells distributed irregularly through-
out the liver parenchyma (solitary pattern). 
Table Vll.1: Distribution pattern and number of ground-glass cells in liver tissue from 
HBsAg seropositive and seronegative patients. 
HBsAg seropositive 
HBsAg seronegative 
biopsies 
n 
103 
47 
+ 
ground-glass cells 
focal solitary 
++ +++ + ++ +++ 
35 
45 
31 31 
2 
6 
+ = < 1, + + = 1-10, + + + = > 10 ground-glass cell per mm2 • 
In the focal pattern the groups of GGH were not restricted to a special area of 
the hepatic lobulus. The number of GGH in the focal pattern was almost always 
scored as + + +. In the solitary pattern the GGH were found in varying numbers 
(table Vll.l). In some biopsies only an occasional ground-glass cell could be 
detected. In biopsies from HBsAg seronegative patients the number of GGH was 
in general larger and they were nearly always grouped in large clusters. Solitary 
GG H were rarely seen in biopsies from HBsAg seronegative. patients (table VII. 1 ) . 
Vll.4.2. MORPHOLOGICAL ASPECTS: 
Cytologically the typical ground-glass cell in biopsies from HBsAg seropositive 
patients was characterized by a circumscribed mass of very finely granular, 
nearly homogeneous, eosinophilic material, lying as an inclusion body in the 
cytoplasm and separated from the cell membrane by a halo of optically clear 
material (fig.VII.1 and fig.VII.2). Sometimes fine vacuolization was seen in the 
center ofthe homogeneous material. The nucleus was displaced toward the peri-
phery of the cytoplasm, usually to the biliary pole. Moreover, in the periphery of 
the cell and close to the eccentric nucleus the preexisting coarse granular 
cytoplasmic organelles had clumped together in small areas (fig.VII.1 and 2). 
Frequently the GGH were binucleate. Mitotic figures were never seen in GGH. 
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The cytological aspect of the GGH in biopsies from HBsAg seronegative 
patients varied. In most cases the cytoplasm showed a more diffuse eosinophilic 
change without displacement of the nucleus. This eosinophilic change was 
mostly pale. GGH were found in liver biopsies from patients with all kinds of liver 
disease, predominantly however in those with cirrhosis. An explanation for the 
ground-glass change was not clear in most cases. Sometimes the patient was 
known to have used a drug that has been reported to cause ground-glass trans-
formation ofhepatocytes, e.g. chlorpromazine and diphenylhydantoin ( Jezequel, 
1972; Mullick, 1972; Ishak, 1982). Only 4 biopsies from HBsAg seronegative 
patients contained GGH that were nearly identical cytologically to those found in 
liver biopsies from HBsAg seropositive patients. In some of these cases the 
eosinophilic material appeared as a sharply circumscribed mass in the cytoplasm 
of the hepatocyte (fig.VII.3). 
Vll.4.3 ULTRASTRUCTURAL ASPECTS OF GROUND-GLASS CELLS 
In some of the biopsies the GGH could be detected as a result of their homo-
geneous structureless cytoplasm. Ultrastructurally liver tissue from both HBsAg 
seropositive and HBsAg seronegative patients contained hepatocytes with an 
excessive increase in smooth endoplasmic reticulum. In proven HBsAg-positive 
liver tissue typical circular and tubular structures were found in this endoplasmic 
reticulum (fig.X.1 ). 
These structures were not detected in the GGH present in liver biopsies from 
HBsAg seronegative patients. 
Vll.4.4 SPECIAL STAINING CHARACTERISTICS OF GROUND-GLASS CELLS STAINED 
WITH ALDEHYDE THIONIN OR ORCEIN 
Only GGH in biopsies from HBsAg seropositive patients reacted positively to 
the aldehyde thionin and orcein stains, whereas GGH in biopsies from HBsAg 
seronegative patients were consistently negative (fig.VII.4 and 5). 
With the aldehyde thionin or orcein staining methods, GGH in liver tissue from 
HBsAg seropositive patients were detected much more easily than on HA-stained 
slides, especially when only a sporadic cell was present (fig.VII.6). With these 
special staining methods, positive cells were found in 7 additional biopsies from 
HBsAg seropositive patients. Three of these 7 biopsies contained only a sporadic 
ground-glass cell, which was missed in the HA-stained sections; in the other 4 
biopsies some scattered hepatocytes or groups of hepatocytes gave a positive 
orcein and aldehyde thionin reaction only in the periphery of the cytoplasm. 
Although typical GGH were not detected in HA-stained sections, the presence of 
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Fig.VII.4 
Fig.VII.5 
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Large group of aldehyde thionine positive ground-glass hepatocytes in 
otherwise norma/liver tissue (120x). 
Large group of ground-glass hepatocytes, positive with orcein staining 
method (360x). 
Fig.VII.6 
Fig .VII.? 
Liver tissue from a Has-seropositive patient with an isolated ground-glass 
hepatocyte, easely detected by the positive reaction for aldehyde thionin 
(380x). 
Ground-glass hepatocyte in consecutive sections of frozen liver tissue, 
positive for both aldehyde thionin (right) and monospecific anti-HBsAg 
antibodies, using immunofluorescent method (left) (300x). 
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a finely granular eosinophilic change in the periphery of the cytoplasm of these 
hepatocytes was scored as "possibly present". Aldehyde thionin and orcein stain 
not only the ground-glass material in HBsAg-positive hepatocytes but also other 
structures, especially elastin, lipofuchsin and copper-binding protein. Weakly 
positive staining was sometimes seen in hepatocytes which did not exhibit the 
ground-glass aspect in HA-stained sections. This weak staining, which was 
encountered in biopsies from both seronegative and seropositive patients, was 
localized especially along the margins of the biopsy specimens. 
A disadvantage of both the aldehyde thionin and orcein stains was the incon-
sistency of staining results, that varied with the brand and lot of the dye as well as 
the maturity of the solutions. In addition to the aldehyde thionin and orcein 
staining procedures, GGH were also easily recognized in Azan-stained sections; 
in contrast these cells were not recognized, or only with great difficulty, in PAS, 
PAS after diastase digestion, Gomori's, EG and Fe-stained sections. 
TableVII.2 Distribution pattern and number of ground-glass cells in different types 
of hepatitis B liver disease 
n 
ground-glass hepatoc~es 
solitary pattern foca pattern 
+ ++ +++ + ++ +++ 
acute hepatitis that 
has transformed into 6 2 3 0 0 0 
chronic hepatitis 
chronic persistent 
hepatitis 24 12 7 1 0 0 4 
chronic active 
hepatitis (mild) 25 13 11 0 0 0 1 
chronic active 
hepatitis (moderate) 11 2 6 0 0 0 3 
cirrhosis 14 2 4 0 0 7 
aspecific reactive 
hepatitis 9 0 1 1 0 0 7 
minimal lesions 14 0 2 0 0 0 12 
total 103 31 31 6 0 0 35 
+ = < 1, ++ = 1-10, +++ > 10 ground-glass cells per mm2 • 
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VII .4.5 GROUND-GLASS HEPATOCYTES AND THE DIFFERENT CATEGORIES OF HBV 
HEPATITIS 
Ground-glass cells were found in liver biopsies from patients with chronic hepa-
titis, cirrhosis, minimal lesions and aspecific reactive inflammatory changes and 
sometimes (prolonged) acute hepatitis that progressed to chronic hepatitis. In 
chronic persistent, chronic active and prolonged acute hepatitis the GGH oc-
curred mainly as solitary cells and very rarely exhibited the focal pattern, whereas 
liver biopsies with minimal lesions or aspecific reactive hepatitis, were charac-
terized by GGH in the focal pattern (fig.VII.2 and fig.VII.4). In cirrhosis both 
patterns were observed (table Vll.2). In cirrhotic livers the number of GGH and 
sometimes the distribution often varied from nodule to nodule. 
Vll.4.6 DETECTION OF HBSAG BY THE IMMUNOFLUORESCENCE AND IMMUNO-
PEROXIDASE METHODS 
The presence of HBsAg in GGH in the biopsies from HBsAg seropositive 
patients could be confirmed by immunofluorescence and immunoperoxidase 
techniques, using serial sections ofthe paraffin-embedded and frozen liver tissue 
(fig.VII.7 and 8). On the other hand HBsAg could not be demonstrated by 
immunofluorescence and immunoperoxidase methods in the GGH present in 
biopsies from HBsAg seronegative patients. 
In the biopsies from HBsAg seropositive patients the number of hepatocytes 
positive for HBsAg according to the immunological methods was in general 
slightly higher than the number of hepatocytes positive for aldehyde thionin and 
orcein. The increase in the number of positive hepatocytes obtained by immuno-
logical techniques could be explained by the presence of hepatocytes w.ith faint 
HBsAg cytoplasmic staining but without an evident ground-glass aspect in the 
HA-stained sections. The HBsAg-positive material was localized in hepatocytes 
mainly in the periphery of the cytoplasm. 
The specificities of the immunofluorescence and immunoperoxidase methods 
for detection of HBsAg were nearly the same, being strongly dependent on suf-
ficient blocking of non-immunological binding of antibodies to the tissue sections. 
When sections of the 252 snap-frozen liver biopsy samples were examined for 
the presence of HBsAg by the immunofluorescence technique, more biopsies 
were found to be HBsAg-positive than when the formalin-fixed embedded parts 
of these biopsies were tested. 
The more sensitive detection of HBsAg in frozen liver tissue can be attributed 
to the detection of cell membrane HBsAg localization, which could detected 
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Fig.VII.8 
Fig.VII.9 
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Liver tissue with two hepatocytes with extensive accumulation of HBsAg, 
demonstrated by anti-HBsAg antibodies using indirect immunoperoxidase 
method (500x). 
Presence of HBsAg and HBcAg indifferent hepatocytes, using FJTC-Jabeled 
(HBcAg) and TRITC-Jabeled (HBsAg) antibodies (200x). 
easily in frozen liver tissue and only sporadically in liver tissue fixed in formalin 
and embedded in paraffin (see chapter VI). 
Vll.4.7 PREVALENCE OF GROUND-GLASS HEPATOCYTES IN THE VARIOUS MORPHO-
LOGICAL CATEGORIES OF HEPATITIS 8 INFECTION 
The clinical evaluation of 750 patients with liver disease included serological 
tests for the presence of HBsAg. Because there was no clinical or morphological 
evidence of hepatitis 8 infection in the remaining cases, serological testing was 
not carried out. 
Out of the above-mentioned 750 patients, 145 had a positive serum reaction 
to HBsAg; 189 biopsies were obtained from these 145 patients. 
In 1 03 of these biopsies (55 per cent) GGH were found in the HA-stained 
sections while 11 0 biopsies (59 per cent) reacted positively to the aldehyde 
thionin and orcein stains. 
Table Vll.3 Prevalence of ground-glass ce!ls in different types of hepatitis 8 liver 
disease 
biopsies ground-glass hepatocytes 
n negative positive 
acute hepatitis 48 42 6 
self-limiting 32 32 0 
transition 
into chronic 16 10 6 
chronic persistent 
hepatitis 35 11 24 
chronic active 
hepatitis 56 20 36 
minimal lesions 15 14 
aspecific hepatitis 13 4 9 
cirrhosis 22 8 14 
None of the patients with an acute self-limiting hepatitis exhibited GGH. 
However 6 of the 16 biopsies from patients with an acute hepatitis that 
progressed to chronic hepatitis contained GGH usually only a few scattered 
throughout the biopsy. 
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The percentage of biopsies positive tor GGH was the highest for the group with 
minimal lesions, namely 93 per cent (13 out of 14). In the other groups, i.e. a-
pecific reactive hepatitis, chronic persistent hepatitis, chronic active hepatitis 
and cirrhosis, the percentages of biopsies that stained positive for GGH were 
approximately the same, ranging from 65.5 per cent for the group with chronic 
active hepatitis to 70.5 per cent for the group with chronic persistent hepatitis 
(fig.VII.1 0). 
However in these last groups the distribution pattern of the GGH varied (table 
VII. 3). In the group with aspecific reactive hepatitis the focal pattern with clusters 
of positive cells predominated, while in the group with chronic persistent and 
chronic active hepatitis the solitary pattern was usually encountered. 
Vll.4.8 GROUND-GLASS HEPATOCYTES IN SERIAL BIOPSIES FROM HBSAG SERO-
POSITIVE PATIENTS 
More than 1 biopsy were obtained from 30 patients during the period of the 
study (1973-1977): 2 biopsies from 19 patients, 3 biopsies from 8 patients and 
4 biopsies from 3 patients. The histological diagnosis and the presence or 
absence of ground-glass hepatocytes in these serial biopsies are shown in 
fig.VII.11. GGH could not be detected in either the initial or the follow-up biopsies 
from 7 patients ( 1, 3, 9, 14, 24, 34, 41 ). One of these patients (3) had a severe 
acute self-limiting hepatitis with bridging necrosis. The first biopsy was taken 
during the acute phase of the hepatitis, the second biopsy six months later when 
the liver function tests had nearly normalized and HBsAg had been cleared from 
the serum. 
In two cases (1, 9) the first biopsy revealed an acute hepatitis. In the next 
biopsy from one of these patients (9) the acute hepatitis had changed to a histo-
logical picture of a chronic persistent hepatitis; however at the time of this second 
biopsy the serum had just converted from HBsAg positive to anti-HBs (self-
limiting hepatitis). In the other case ( 1) the histological findings for the next 
biopsy remained the same; however according to biopsies taken after the end of 
the study period transition of the acute hepatitis to chronic active hepatitis 
occurred. Both the initial and the follow-up biopsy (biopsies) showed chronic 
active hepatitis in two cases ( 14, 24 ), chronic persistent hepatitis in one ( 41) and 
active cirrhosis in the other case (34). 
The two serial biopsies from one patient (20) contained doubtful ground-glass 
cells in HA-stained sections, but small numbers of positive cells were evident in 
both the orcein and aldehyde thionin-stained sections. A chronic active hepatitis 
was demonstrated in the first biopsy and an active cirrhosis in the second. 
Both the first and subsequent biopsies from 11 patients contained GGH (2 
162 
Fig.VII.1 0 Schematic representation of the percentages of biopsies positive for 
ground-glass hepatocytes in the different morphological categories of 
hepatitis 8 
acute 
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Fig.VII.5 HBsAg positive patients (n = 30 vertical axis) subdivided according to histological diagnosis for the first 
biopsy.White dots: biopsies without ground- glass cells, dark dots: biopsies with ground-glass cells. Follow-up 
biopsies are shown in relation to time and histological changes (reaction pattern) 
As pH 
CPH 
Cirrhosis 
CAH 
AH 
26 - \ '\ I / ./: C C 
2
2
5
4 != 1 \ sr z ---:;:5 z z - • • \ ' I 7 ::;:;> 7 7 ,...-,., 
1 --41 o ,-::;. ...........--=,<"' ..._ e+ 
Jill. >'" GD++ 
Jol-++ 
9 
8 
7 
6 
5 
4 
3 
2 ++••t---------~~------~ 1' 611 
,------..-----...,.------r----.,..-------,--- I-- - I 
3 6 9 12 15 18 21 24 mnd 
+ < 1, + + 1-5, + + + = > 5 ground-glass cells per mm2 
+tl-
biopsies each from 7 patients and 3 biopsies each from 4 patients): For two of 
these 11 patients (2, 1 O) the initial diagnosis was an acute hepatitis while the 
subsequent biopsy was indicative of an acute hepatitis for the second time in 
one case (2) and a chronic active hepatitis in the other (1 0). For four of these 11 
patients (16, 21, 22, 25) chronic active hepatitis was diagnosed on the basis of 
the initial biopsy as well as the subsequent biopsy (biopsies) while two patients 
(19, 23) exhibited chronic active hepatitis in the first and a chronic persistent 
hepatitis in one of the follow-up biopsies. The first and the subsequent biopsies 
from two patients (32, 33) reveiled active cirrhosis. In one case ( 45) the first 
biopsy exhibit the picture of aspecific reactive hepatitis while a chronic persistent 
hepatitis was seen in the second biopsy. 
In another 11 cases one or more biopsies contained no GGH, while GGH could 
be detected in the rest of the serial biopsies. For 5 of these 11 patients acute 
hepatitis without GGH was seen in the first biopsy (biopsies); the acute hepatitis 
changed in one case (8) into a chronic persistent and in 4 cases (4, 5, 6, 7) to a 
chronic active hepatitis in the follow-up biopsies. One or all of these follow-up 
biopsies contained GGH. 
In 4 patients (15, 17, 18. 26) the diagnosis for the first biopsy was chronic 
active hepatitis, a picture that did not change in the follow-up biopsies. In one of 
the serial biopsies from these 4 patients no GGH could be detected, while the 
others contained small numbers of GGH. For one patient ( 40) the first biopsy 
yielded a diagnosis of chronic persistent hepatitis, the second biopsy showed the 
histologic picture of a chronic active hepatitis and the third biopsy was again 
indicative of a chronic persistent hepatitis. In the last case ( 44) the first biopsy 
showed an aspecific hepatitis without GGH, while the histological picture of the 
second biopsy had changed to chronic active hepatitis with many scattered GGH, 
a picture that persisted in the third biopsy. The fourth biopsy, however, was 
indicative of chronic persistent hepatitis. 
Vll.5 DISCUSSION 
For many years ground-glass hepatocytes in H and A/E stained sections have 
been related to the presence of a hepatitis B viral infection (Hadziyannis, 1974). 
However GGH with a nearly similar cytological aspect have been demonstrated 
in livers from HBsAg seronegative individuals. In most cases this phenomenon 
could be linked to the use of a pharmaceutical drug, such as Antabuse (Bruquera, 
1986). 
This ground-glass appearance is characterized byfinely granular to homogene-
ous, weak eosinophilic changes in the liver cell cytoplasm. This cytoplasmic as-
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pect contrasts with that of the surrounding hepatocytes on routine hematoxylin, 
eosin or azophloxin-stained slides. These GGH must be distinguished from oxy-
philic granular hepatocytes (Lefkowitch, 1980) or hepatic oncocytes (Gerber, 
1981 ). The oxyphilic granular or oncocytic aspect is caused by an extraordinary 
increase in cytoplasmic mitochondria, while the ground-glass aspect is caused 
by a proliferation of smooth endoplasmic reticulum (Klinge, 1 968; Hadziyannis, 
1 973). 
An oncocytic change in the hepatocytes is also encountered in HBsAg sero-
positive patients with chronic active hepatitis and cirrhosis (Lefkowitz, 1 980) and 
in patients with cirrhosis of all etiologies (Gerber, 1981 ). 
GGH were detected in 150 of the 1810 liver biopsies in this study. The largest 
proportion (1 03) of these biopsies were obtained from HBsAg seropositive 
patients, the others ( 4 ?)from HBsAg seronegative patients. GGH in biopsies from 
HBsAg seropositive patients usually differed morphologically from the GGH in 
biopsies from HBsAg seronegative patients. 
The morphological aspect of the former is typified by a eosinophilic change in 
a circumscribed part of the hepatocytic cytoplasm and the eccentric position of 
the nucleus, together with the presence of pre-existing cytoplasmic organelles 
in the hepatocyte (fig.VII.1 ). 
In addition GGH in liver tissue from HBsAg seropositive patients could be 
distinguished from GGH in liver biopsies from HBsAg seronegative patients by 
their specific staining reactions to orcein (Shikata, 197 4) and aldehyde thionin 
(Klinge, 1 973; ten Kate, 1 973). Moreover all biopsies with GGH that were positive 
after orcein and aldehyde thionin staining showed accumulation of cytoplasmic 
HBsAg, as demonstrated by immunochemical detection methods using serial 
sections, whereas orcein and aldehyde thionin-negative GGH were HBsAg-
negative. These observations, which are in agreement with the results of the 
studies of Shikata (1 974) and Deodhar (1975), demonstrated that the presence 
of orcein and/or aldehyde thionin-positive hepatocytes indicates the existence 
of an HBV infection. These staining characteristics seem to be based on the 
binding of the dyes by disulfide bands, present in the excessive accumulated 
HBsAg (Vyas, 1972; Sukena, 1972; Shikata, 1974), in cisternae of smooth 
endoplasmic reticulum. 
The detection of GGH in liver tissue from HBsAg seropositive patients was 
easier with the earlier mentioned special stains as compared with the HA stain. 
When only a few randomly distributed ground-glass cells are present, they will 
easily be missed in HA-stained sections. 
In our material, GGH were detected by orcein and aldehyde thionin staining in 
only three additional cases. In these cases the GGH were missed in HA stained 
slides even after careful screening. In all three cases the liver tissue contained 
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only a sporadic ground-glass cell. Moreover, by using these special stains, 
hepatocytes with insufficient HBsAg in the cytoplasm to cause the typical ground-
glass aspect in HA-stained sections could also be demonstrated. In this study 7 
(3.5 per cent) of the 189 biopsies from HBsAg seropositive patients were found 
to contain HBsAg only after orcein and aldehyde thionin staining. In 4 cases the 
positive hepatocytes did not exhibit the typical ground-glass aspect in the HA-
stained sections. 
In most biopsies from HBsAg-positive patients the number of aldehyde thionin 
or orcein-positive cells was greater than the number of ground-glass hepatocytes 
in the HA-stained sections. This increase in number can be explained partly by 
the presence of insufficient quantities of HBsAg in the cytoplasm to induce the 
typical ground-glass aspect. From this observation it is concluded that only when 
HBsAg has accumulated in bulk in the endoplasmic reticulum the antigen will 
cause the ground-glass appearance. The small difference in number between 
ground-glass cells in HA-stained sections and in orcein-stained sections in this 
study is in sharp contrast with the findings of Gubetta (1977). He found that of his 
orcein-positive cases, less then one-half exhibited ground-glass hepatocytes in 
HA-stained sections. 
Although these special staining procedures offer the advantage of detecting 
small quantities of ground-glass hepatocytes, both orcein and aldehyde thionin-
stained slides are difficult to interpret in many cases. There are several 
explanations for these difficulties. Firstly, the orcein and aldehyde thionin stains 
are not specific for HBsAg but also react with other structures in the liver biopsy, 
e.g. elastin, lipofuchsin and copper-binding protein. Secondly, both stains 
produce aspecific reactions, especially along the margins of the biopsies and in 
particular when fixation is not optimal. Thirdly, both orcein and aldehyde thionin 
vary considerably in staining properties from lot to lot, which makes it difficult to 
obtain consistent staining results. For these reasons many variations in the orcein 
staining procedure have been suggested (Masachika, 1982) and alternative 
staining procedures have been proposed (Gubetta, 1977). For these reasons, it 
is essential for the diagnosis of a HBV infection that hepatocytes not only give a 
positive reaction with orcein and aldehyde thionin stains but also show in HA-
stained sections a typical ground-glass aspect. Despite the greater specificity, the 
sensitivity of the immunofluorescence and immunoperoxidase staining methods 
for detection of HBsAg on sections of paraffin-embedded liver tissue was only 
slightly better than thatfor the histochemical aldehyde thionin and orcein stains, 
confirming the results of the studies of Gerber {1975) and Afroudakis ( 1976). We 
did not see an increase in the number of positive biopsies, only that the number 
of hepatocytes detected with the immunological method was greater than the 
numberofaldehydethioninandorcein-positivehepatocytes.Theimmunofluores-
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cence and immunoperoxidase methods for paraffin-embedded liver tissue were 
nearly similar in results and sensitivity. The staining results were highly dependent 
on effective blocking of aspecific binding of the antisera on the slides. However 
with respect to the specificity of the immuno-peroxidase method for detecting 
HBsAg, the study of Ornata ( 1980) showed that positive staining of HBsAg is not 
only caused by specific binding of the HBs antibodies to HBsAg but also by non-
immunological binding of horse-rabbit peroxidase to HBsAg. 
In this particular case this phenomenon has no implications for the detection 
of HBsAg, only for the detection of other antigens in HBsAg-positive liver tissue 
by means of the immunoperoxidase technique. Moreover, in addition to the affin-
ity of horse-rabbit peroxidase for HBsAg, other investigators have shown a non-
immunological binding of horse-rabbit peroxidase to alcoholic hyalin (Sim and 
French, 1976) and lymphocyte cell membrane (Molin, 1978). 
Ground-glass hepatocytes were detected in all types of hepatitis B liver 
disease, except acute self-limiting hepatitis, however the quantity and distribution 
pattern of the ground-glass hepatocytes differ from one type of liver disease to 
the other. The focal pattern, with many ground-glass cells arranged in clusters, 
is typical for HBV carriers with minimal histological changes, indicating that the 
presence of virus surface protein is not necessarily hepatotoxic. 
As already mentioned in chapter V, HBcAg cannot be demonstrated in these 
cases, despite the abundant production of HBsAg; the viral genome seems to 
be incorporated in the DNA of the host, as shown by Shafritz ( 1981) for HBV liver 
disease and hepatocellular carcinoma. During this integration specific HBcAg 
expression is deleted. The focal distribution pattern suggests a clonal prolifer-
ation of GGH in these cases. 
Due to the presence of overwhelming numbers of ground-glass cells, HBV 
carriers with minimal lesions are seldom missed, as shown in this study and the 
studies of Gerber (1975) and Deodhar (1975). If sufficient biopsy material is 
present (>0.5_cm), sampling errors, whereby GGH can be missed, are not likely 
because of the homogeneous distribution of the ground-glass cells throughout 
the whole liver, as indicated by the study of Nakaso ( 1982). 
The solitary distribution of GGH is a pattern seen specifically in biopsies of 
chronic hepatitis (both chronic persistent and chronic active) or prolonged acute 
hepatitis that progresses to chronic hepatitis. This similarity in the number and 
distribution of HBsAg among these different morphological categories of hepa-
titis suggests that these types of hepatitis basically belong to one group, and that 
the histological differences are an expression of small differences in immune 
reactivity of the host against viral antigens. In biopsies with the solitary pattern of 
GGH, variable amounts of HBcAg could often be detected in the nuclei of varying 
numbers of hepatocytes (see chapter V)(fig.VII.9). However, HBcAg could be 
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detected in only a minority of GGH and the solitary distribution suggests an 
inability of these cells to proliferate in these cases. In the solitary pattern the 
scattered ground-glass cells are surrounded by normal-looking hepatocytes. The 
number of GGH varies in most cases from + to + +, with a tendency toward 
increasing numbers as the activity of the chronic liver disease increases. This ob-
servation contrasts with the observations of Gubetta (1977) and Paradinas 
( 1981 ). Paradinas found more ground-glass hepatocytes in inactive liver disease 
than in active liver disease. However these differences, which were not 
significant, can be explained by the fact that the group of inactive liver diseases 
was composed of both minimal lesions and chronic persistent hepatitis. In most 
of their cases of chronic persistent hepatitis, Paradinas found also only a few 
GGH and the high mean value can be attributed to the large number of GGH in 
biopsies, showing minimal lesions. 
In this study the percentages of biopsies with GGH in the chronic active and 
chronic persistent hepatitis groups were nearly identical, 65.5 per cent and 70.5 
per cent, respectively. These percentages are in agreement with the findings of 
Deodhar (1975), who used orcein stain. He found GGH in 7 out of 11 biopsies 
with chronic persistent hepatitis and in 27 out of 40 biopsies with chronic active 
hepatitis or with cirrhosis. The study of Gubetta ( 1977), who used orcein as well 
as trichrome, also showed that 70 per cent of the biopsies with chronic persistent 
hepatitis contained GGH. However he found GGH in only 22 per cent of the liver 
biopsies with chronic active hepatitis. 
With the exception of the group of patients with acute self-limiting hepatitis, 
who exhibited in the liver tissue no ground-glass cells at all, GGH were detected 
in all histological categories. The lowest percentage of GGH was found for the 
group that underwent transition from (prolonged) acute hepatitis, to chronic 
hepatitis (37.5 per cent). However during histological follow-up of all cases of 
acute hepatitis that progressed to chronic active hepatitis, GGH could always be 
detected in one of the later biopsies. From these findings it is concluded that in 
acute hepatitis the detection of GGH with special affinity for aldehyde thionin or 
orcein forecasts transition of this acute hepatitis to a chronic hepatitis. The 
development of GGH (incorporation of viral DNA in the hepatocyte genome) 
takes some time; in our series the shortest time within which GGH were detected 
was nearly 3 months after the onset of acute hepatitis. However the assessment 
of the exact date of the onset of the acute hepatitis was very difficult, because the 
liver disease in nearly all patients with the histological features of acute hepatitis 
that progresses to chronic hepatitis is, according to the findings of Sherlock 
(1976), clinically anicteric and in some cases subicteric. Reinfected liver grafts 
for which the exact date of infection was known, exhibited ground-glass cells six 
months later (see chapter XI). 
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As shown in chapter V immunofluorescence studies using of frozen liver tissue, 
provide in a much earlier stage of the acute hepatitis an indication of an un-
favorable course by the presence of a cell membrane-bound HBsAg fluorescence 
pattern of all hepatocytes in these cases. This cell membrane-bound fluorescence 
pattern is lost in most cases after formalin fixation, as was also reported by 
Gubetta (1977). 
From follow-up biopsies there is some evidence that the number and distri-
bution of GGH in one patient remain quite constant, at least for some years. In 
many cases the number and especially the distribution pattern of GGH are more 
constant than the histological diagnosis of the liver disease. We could not 
demonstrate an increase in the number of GGH during the course of the disease. 
Although screening of liver tissue for the presence of ground-glass hepatocytes 
is not a sensitive method for detection of hepatitis B infection, the presence of 
these cells has some prognostic value in acute hepatitis and is an essential tool 
for the grading hepatitis B liver disease. This is especially important when more 
than one etiological factor seems to be responsible for the changes in the liver. 
In conclusion, as far as the assessment of an HBV infection by various stainings 
on formalin fixed liver biopsy material is concerned, it can be stated that: 
1. No histochemical and immunochemical reactions diagnostic for an HBV 
infection are found in acute self-limiting HBV hepatitis. 
2. In chronic HBsAg-positive patients precise light microscopic diagnosis of 
an HBV infection is possible of a maximum of± 90 per cent in the category 
of minimal histological changes. In the other clinico-pathological categories 
lower percentages of biopsies, in which a diagnosis of an HBV infection can 
be established, were found. 
3. Most of these diagnoses can be established on the basis of routinely stained 
hematoxylin azophloxin (eosin) slides. 
4. Specific immunohistochemical detection methods do not lead to an 
increase in the number of diagnosis, but are indispensable for specification 
of the definitive diagnosis. 
5. There are few arguments that support the routine use of histochemical 
staining methods to detect an HBV infection. 
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CHAPTER VIII 
EXPRESSION OF THE DETERMINANTS OF HEPATITIS B 
SURFACE SUBTYPES IN LIVER TISSUE 
Vlll.1 SUMMARY 
The presence of different HBsAg determinants in HBV-infected liver tissue was 
demonstrated by means of the immunofluorescence technique using mono-
specific antisera against the "a", "d" and "y" determinants. These experiments 
proved that liver tissue from HBsAg ("ad") seropositive patients contains the "a" 
determinant as well as the "d" determinant. Similarly liver tissue from HBsAg 
("ay")-seropositive patients contained the "a" and the "y" determinant. 
By using the double labelling immunofluorescence technique it was shown 
that the different determinants have the same localization in liver tissue. It is 
concluded that these determinants are formed by the same mechanism and that 
none of the determinants are liver cell-derived. 
Vlll.2 INTRODUCTION 
The determinants of hepatitis B surface antigen (HBsAg) have been inves-
tigated by several authors (Le Bouvier, 1971; Courouce, 1974). Studies on 
HBsAg-positive serum have resulted in the detection of several antigenic deter-
minants, indicated by the letters "a", "d", "y", "w" and "r". In this system the "a" 
determinant has been found to be the obligatory group-specific determinant, 
which in turn can be classified according to the presence of four 
subdeterminants (Courouce, 1974). The "d" and "y" as well as the "w" and "r" 
determinants re-present two pairs of mutually exclusive determinants, giving rise 
to the following hepatitis B surface subtypes: "adr", "adw", "ayw", "ayr" (Le 
Bouvier, 1971; Bancroft, 1972). 
The presence of the different determinants in liver tissue has barely been 
documented. Most HBsAg studies were performed with antisera against HBsAg 
"ad" or "ay". Houthoff ( 1976) suggested that the "a" determinant is not present in 
liver tissue. Our studies on the localization of HBsAg in liver tissue, reported in 
the previous chapters, were based on the use of an antiserum against HBsAg 
subtype "ad" that contained antibodies against both the "a" determinant (high 
titers) and the "d" determinant (low titers). 
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In this chapter the results of a study on the specific localizations of the "a", "y" 
and "d" determinants in liver tissue from both HBsAg (subtype "ad" and "ay") 
seropositive and HBsAg seronegative patients are given; antisera against the "a", 
the "y" and the "d" determinants, respectively, were used (chapter Ill). 
Vlll.3 MATERIALAND METHODS 
Liver biopsy tissue from 20 HBsAg seropositive and 8 HBsAg seronegative 
patients was tested with monospecific antisera against "ad", "a", "d" and "y" 
determinants of the hepatitis B surface antigen, using direct and indirect 
immunofluorescence techniques (see chapter Ill). 
Experiments were completed by blocking and double staining procedures. 
Vlll.4 RESULTS 
Anti "ad" 
In 19 of the 20 liver biopsies from HBsAg seropositive patients one of the pre-
viously described fluorescence patterns (focal or diffuse) was observed. The 
solitary pattern was not seen. None of the liver biopsies from the 8 HBsAg 
seronegative patients were positive for the "ad" determinants. 
Table Vlll.1: Localization of HBsAg "a", "d" and "y" determinants in liver tissue from 
20 HBsAg "ad" and "ay" seropositive patients. 
serology immunofluorescence 
lladll "ay" uau "dll llyll 
15 14/15 12/15 0/15 
5 5/5 0/5 3/5 
Anti "a" 
The immunofluorescence results with antiserum against the "a" determinant of 
HBsAg were identical to those found with the anti "ad" antiserum. Reactivity was 
completely abolished by preincubation of the anti "a" antiserum with HBsAg 
("adr"), HBsAg ("adw") or HBsAg ("ayw"). 
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Anti "d" 
Of the liver biopsies from HBsAg ("ad") and HBsAg ("ay") seropositive patients 
tested with anti "d" antiserum only those from HBsAg ("ad") seropositive patients 
exhibited (in most cases) fluorescence. The fluorescence pattern was the same 
as that found with HBsAg ("ad") and HBsAg ("a") antisera. However, two HBsAg 
("ad") seropositive patients reacted positively to anti "ad" and anti "a" antisera but 
negatively to anti "d" antiserum. Moreover in a few cases there was some dif-
ference in the intensity of fluorescence obtained with anti "ad" antiserum, on one 
hand, and anti "d" antiserum, on the other. By double staining of the liver slides 
with rabbit anti "a" antiserum and guinea pig anti "d" antiserum, using TRITC and 
FITC-Iabelled anti-rabbit and anti-guinea pig antisera, respectively, as second 
layer, the localizations of the "a" and "d" determinants were shown to be exactly 
the same. Both were found in the cytoplasm as well as along the cell membranes 
of the hepatocytes. No fluorescence was found after preincubation of the anti "d" 
antiserum with HBsAg ("ad")-positive serum. Preincubation of the anti "d" anti-
serum with HBsAg ("ay") sera did not influence the outcome of the fluorescence 
studies. 
Anti "y" 
Anti-HBsAg ("y") antiserum only stained liver tissue from HBsAg ("ay")-sero-
positive patients. However, liver biopsies from 2 of the 5 HBsAg ("ay")-sero-
positive patients reacted negatively to the anti "y" antiserum, although both 
biopsies exhibited fluorescence with anti "ad" and anti "a" antisera. In the other 
biopsies the localization of the "y" determinant was identical to that of the "a" 
determinant. Both could be demonstrated along the cellular membrane a11d in 
the cytoplasm of hepatocytes. Preincubation of the anti "y" antiserum with 
HBsAg ("ay") serum abolished the reactivity, whereas preincubation with HBsAg 
("ad") serum did not alter the results of the fluorescence studies. 
Vll1.5 DISCUSSION 
The results of these fluorescence experiments demonstrate that both the 
common group-specific "a" determinant as well as the "y" and "d" determinants 
of HBsAg are present in liver tissue from HBsAg seropositive patients. This 
conflicts with the results of Houthoff and Houwen ( 1 976) who could not find the 
"a" determinant in liver tissue from either "ad" or "ay" seropositive patients and 
suggested that proteins derived from liver cell membranes participate in the 
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formation of HBsAg. This suggestion seems unlikely in view of the fact that our 
rabbit anti "a" antiserum, which contained high titers against the "a" determinant 
and low titers against the "d" determinant, yielded positive fluorescence in liver 
tissue from both HBsAg "ay" and "ad" seropositive subjects. The "a", "d" and "y" 
determinants were found both in the cytoplasm of hepatocytes and along the cell 
membranes. Double staining techniques revealed the identical localizations of 
these determinants. Although the "a", "d" and "y" determinants were found at the 
same localization in the liver tissue, the quantity of the "a" determinant, on the 
one hand, and the "d" and "y" determinants, on the other, varied, as estimated 
from the intensity of the fluorescence. In two HBsAg ("ad") and two HBsAg ("ay") 
seropositive patients the "d" and "y" determinants could not even be detected in 
the liver tissue, while these tissues were positive for the HBsAg ("a") determinant. 
This is in accordance with the studies of Van Elven (unpublished), which showed 
a variation in the ratio of "a" to "d" antigens in HBsAg "ad" positive sera and of "a" 
to "y" antigens in HBsAg "ay" positive sera. Although the common "a" determi-
nant is always combined with the "d" or the "y" determinant in HBsAg, the free 
capsid material of HBV does not seem to have a fixed "a", "d" and "y" 
composition. When using immunological techniques for the detection of HBsAg 
in liver tissue it is recommended that an antiserum with a high anti "a" activity be 
used because antisera with anti "d" and "y" activity tend to produce false-
negative results. 
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CHAPTER IX 
HBeAg AND anti-HBe 
Localization of HBeAg in liver tissue; relation between HBeAg 
and anti-HBe in serum and hepatitis B antigens in liver tissue. 
A light microscopical and immunohistochemical study. 
177 

CHAPTER IX 
HBeAg AND anti-HBe 
Localization of HBeAg in liver tissue; relation between HBeAg 
and anti-HBe in serum and hepatitis B antigens in liver tissue. 
A light microscopical and immunohistochemical study. 
IX.1 SUMMARY 
Sixty-three serum samples from 62 patients with histologically graded hepatitis 
B liver disease were examined for the presence of HBe-antigen (HBeAg) and 
HBe-antibody (anti-HBe). The incidence of HBeAg and anti-HBe in serum was 
estimated for the various histological types of liver disease. The presence and 
localization of HBeAg, HBsAg, HBcAg and immunoglobulins in liver tissue were 
studied by immunofluorescence and compared with the presence of HBeAg and 
anti-HBe in serum. 
HBeAg was found mainly in chronic hepatitis B infection. A relation existed 
between the activity of chronic hepatitis B and the presence of HBeAg in serum 
and in liver tissue. Of the patients with cirrhotic liver disease, however, only 3 out 
of 1 0 were HBeAg-seropositive. The only patient with minimal histological 
changes and HBeAg-positive serum was on immunosuppressive therapy, indi-
cating that the presence of HBeAg in itself does not cause active liver disease. 
Sera from 3 out of 13 patients with acute self-limiting hepatitis exhibited HBeAg. 
However, HBeAg was found in 5 out of 6 patients with an acute hepatitis that 
progressed to chronic liver disease. 
All but four HBeAg seropositive patients exhibited HBcAg in the nuclei of hepa-
tocytes versus one out of 7 patients with anti-HBe-positive serum and 2 out of 21 
patients with neither HBeAg nor anti-HBe in the serum. 
Immunofluorescence studies of liver tissue showed identical nuclear local-
izations for HBeAg and HBcAg. In all HBeAg seropositive patients HBsAgfluores-
cence was found along the cell surface of the hepatocytes. 
From this it was concluded that: 
a high level of HBeAg in the serum is an indicator ofthe presence of chronic 
hepatitis B infection; an early preicteric stage of acute self-limiting hepatitis 
B infection has to be excluded. 
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HBsAg-positive patients with cirrhosis are relatively infrequent HBeAg 
positive. This low prevalence of eAg in cirrhosis is probably due to e-
conversion, which may occur after long-term HBsAg carriership. 
the presence of HBeAg is related to the severity of chronic hepatitis. 
there is a close relation between HBeAg and HBcAg in the liver as far as 
both incidence and localization are concerned. 
there is no direct relation between the numbers of HBeAg and HBcAg-
positive hepatocytes and the level of HBeAg in serum. 
twenty-three out of twenty-six (88 percent) patients with HBcAg and HBeAg 
in the liver tissue were found to have HBeAg in the serum. 
IX.2 INTRODUCTION 
In 1972 Magnius and Espmark described a new antigen-antibody system, 
designated HBe antigen (HBeAg) and HBe antibody (anti-HBe), in hepatitis B 
surface antigen (HBsAg) positive sera. They found HBeAg in sera from both 
persistent carriers of HBsAg and patients in the incubation period of a hepatitis 
B infection (Magnius, ·1975). HBeAgwasfound exclusively in HBsAg-positive sera 
and is therefore apparently linked to the HBV. HBeAg did not appear to be a 
subtype of the hepatitis B surface antigen from which it differed both immuno-
logically and biochemically (Magnius, 1975). 
Not only the observation that the presence of HBeAg in patient sera seemed to 
be closely associated with the occurrence of Dane particles and DNA polymerase 
activity, but also the finding that HBeAg in serum was associated with hepatitis 
B core antigen (HBcAg), strongly suggests that HBeAg is a component of the 
Dane or core particle. In their study, Takahashi et al. ( 1979) confirmed this 
hypothesis by demonstrating the masked presence of HBeAg in the cores of the 
Dane particles. Since the Dane particle is known to represent the complete virion 
of HBV, the presence of HBeAg in serum is considered to be an important marker 
of the infectivity of HBsAg-positive serum. 
The exact nature of HBeAg, which seems to exhibit antigenic polymorphism 
(Budkowska, 1979), was however far from clear (McAuliffe, 1976). Studies of 
Neurath et al. ( 1977) showed that HBeAg has the physicochemical and immuno-
logical properties of an immunoglobulin, predominantly of the lgG4 subclass. 
Specific antigenic sites, designated as HBe determinants, do however differen-
tiate HBeAg from other immunoglobulins. 
Clinical studies (Nielson, 197 4; Trepo, 1976; Smith, 1976; Eleftheriou, 1976) 
indicate that the presence of HBeAg is associated with the activity of hepatitis, 
and that HBeAg may be used as a prognostic marker for acute hepatitis (Thamer, 
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1976). In accordance with the findings of these studies, several other studies 
have indicated that chronic active hepatitis 8 may improve after seroconversion 
from H8eAg to anti-H8e and is then usually associated with a favorable outcome 
of the disease, as shown by a sustained biochemical and histological remission 
(Realdi, 1980; Fattovich, 1986). In contrast Fattovich (1988) has shown that 
patients with anti-H8e positive chronic hepatitis 8 infection may have continuing 
inflammatory activity and a poor prognosis. This continuing inflammatory activity 
in anti-H8e positive patients seems to be caused by low level H8V replication 
(Lok, 1984). 
As far as the localization of H8eAg in liver tissue is concerned, two completely 
conflicting reports exist. Trepo ( 1976) demonstrated H8eAg in the cytoplasm of 
hepatocytes, whereas Arnold ( 1977) localized the H8eAg exclusively in hepatic 
nuclei. Therefore the presence of H8eAg and anti H8e was studied in a series of 
H8sAg seropositive patients with various histopathological types of liver disease. 
In addition the localization of H8eAg in liver tissue and the relation of H8eAg in 
serum with the localization of H8cAg, H8sAg and immunoglobulins in liver tissue 
were investigated. 
IX.3 MATERIAL AND METHODS 
.IX.3.1 LiVER TISSUE 
Sixty-three liver biopsies were obtained from 62 H8sAg seropositive patients 
with a True-cut needle (TravenoiA). All liver biopsies were prepared as described 
in chapter Ill and graded histologically as described in chapter IV. 
IX.3.2 SERA 
Serum samples from all62 patients were acquired on the same day as the liver 
biopsy specimen and tested for the presence of H8sAg by radioimmunoassay 
(Abbott Laboratories, IL, USA). The presence of H8eAg and anti-H8e antibodies 
was determined by both by a double immunodiffusion method and radioimmuno-
assay (Abbott Laboratories, IL, USA). 
IX.3.3 ANTISERA 
Slides of the snap-frozen part of the liver biopsies were tested with antibodies 
against H8sAg, H8cAg and H8eAg and with H8e-positive sera (see chapter Ill). 
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IX.4 RESULTS 
HBeAg and anti-HBe in sera from patients with different histological types of 
hepatitis B, measured by the immunodiffusion method 
HBeAg was detected in the sera of 5 out of the 19 patients with histologically 
graded acute hepatitis (26 per cent), 2 out of 9 patients with chronic persistent 
hepatitis (22 per cent) and 9 out of 16 patients with chronic active hepatitis 
without cirrhotic changes (56 per cent). One out of 1 0 patients with cirrhotic liver 
changes and 1 out of 9 subjects with minimal or aspecific reactive liver changes 
had HBeAg in their serum. 
Anti-HBe was found in the serum of only 1 of the 19 patients (5 per cent) with 
acute hepatitis, 2 of the 9 patients (22 per cent) with chronic persistent hepatitis, 
2 of the 16 patients ( 13 per cent) with chronic active hepatitis, 3 of the 9 subjects 
(33 per cent) with minimal or aspecitic liver disease and 2 of the 1 0 patients {20 
per cent) with cirrhosis. 
HBeAg and anti-HBe in sera from patients with different histological types of 
hepatitis B, measured by radioimmunoassay 
Three sera from patients with histologically graded acute hepatitis, one serum 
from a patient with chronic persistent hepatitis, three sera from patients with 
chronic active hepatitis and one serum from a patient with cirrhosis, all negative 
for both HBeAg and anti-HBe according to the immunodiffusion technique, were 
HBeAg-positive according to the radioimmunoassay. 
In addition to the anti-HBe positive cases found by the immunodiffusion 
technique, anti-HBe could be detected by radioimmunoassay in sera from tour 
patients with acute hepatitis and two patients with minimal or aspecitic liver 
disease (table IX.1 ). 
Of the 19 patients with histologically graded acute hepatitis, 13 normalized 
biochemically and serologically. In contrast 6 patients developed a chronic liver 
disease. Initially five of these 6 patients were serologically positive for HBeAg, 
while only three of the 13 patients with acute self-limiting hepatitis were positive 
tor HBeAg. Two of these three patients were blood donors who were found to be 
HBsAg-positive by chance in the pre-icteric phase of an acute hepatitis B; in one 
patient a liver biopsy and a serum sample were taken during this period whereas 
the others were biopsied in the early icteric phase. One of these patients had both 
HBeAg and anti-HBe in the serum. 
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Table IX.1 Presence of H8eAg and anti-H8e in sera from patients with different 
histological types of hepatitis 8, as assessed by the immunodiffusion 
technique and radioimmunoassay (in parentheses) 
HBeAg anti-HBe 
histological type n n % n % 
acute hepatitis 19 5 (8) 26(42) 1(5) 5(26) 
chronic persistent 
hepatitis 9 2 (3) 22(33) 2(2) 22(22) 
chronic active 
hepatitis 16 9(12) 56(75) 2(2) 13(13) 
cirrhosis 10 1 (3) 1 0(30) 2(2) 20(20) 
minimal or 
aspecific 
liver changes 9 1 (1) 11(11) 3(5) 33(55) 
The patients in the acute hepatitis group with anti-HBe positive-serum proved 
to have a self-limiting acute icteric hepatitis. At the time of the fiver biopsy these 
patients had had jaundice for more than 1 0 days. 
Table IX.2 H8eAg and anti-H8e in histologically graded acute hepatitis 8 
self-limiting hepatitis 
acute hepatitis with transition 
to chronrc hepatitis 
n 
13 
6 
HBeAg anti-HBe 
3 5 
5 0 
Out of the group of 16 patients with chronic active liver disease, 7 patients had 
a mild degree of chronic active hepatitis with transaminase levels no more than 
3 times the normal value. Four of these patients were serologically positive for 
HBeAg. Nine patients had moderate or severe chronic active hepatitis. For 8 of 
these 9 patients HBeAg could be demonstrated in the serum. 
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Table IX.3 HBeAg and anti-HBe in serum related to the various grades of chronic 
active hepatitis 
chronic active hepatitis n 
mild 
moderate I severe 
total 
7 
9 
16 
HBeAg 
n % 
4 57 
8 90 
12 75 
anti-HBe 
n % 
2 
0 
2 
28 
0 
13 
The only patient with minimal liver changes and HBeAg in his serum was a renal 
transplant recipient receiving high doses of immunosuppressive agents. 
In .the group of 10 patients with cirrhosis of the liver, cirrhosis was combined 
with a chronic active hepatitis in 8 cases (active cirrhosis). The three patients in 
this group of 1 0 patients with HBeAg detectable in the serum had cirrhosis with 
a mild degree of chronic active hepatitis in two cases and with a severe degree 
of CAH in the third. One of the patients with mild CAH was on immunosuppressive 
therapy. The two patients with positive anti-HBe serum exhibited a moderate and 
severe chronic active hepatitis component, respectively. The two patients with 
inactive cirrhosis had neither HBeAg nor anti-HBe. 
Correlation of HBeAg and anti-HBe in serum with HBsAg distribution in liver 
tissue 
This study of 63 biopsies revealed that HBsAg occurred in three distinct 
patterns (see also chapter IV). 
a. A solitary pattern, in which only a few scattered Kupffer's cells and portal 
macrophages are positive for HBsAg, as indicated by a granular cytoplasmic 
fluorescence; this pattern was seen in 12 of the 63 biopsies. 
b. A diffuse pattern, in which all hepatocytesshowcell membrane-bound linear 
fluorescence. In this pattern varying numbers of scattered hepatocytes also 
exhibit intracytoplasmic fluorescence; this pattern was seen in 34 of the 63 
biopsies. 
c. A focal pattern, in which clusters of hepatocytes show bright intracyto-
plasmic HBsAg fluorescence. The remaining hepatocytes in the liver tissue 
eitherexhibitfaintcell membrane-bound HBsAgfluorescence or are negative 
for HBsAg. 
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HBeAg could be detected in 27 of 63 serum samples tested from HBsAg-
positive patients. In 25 of the 27 cases HBeAg in serum was associated with a 
diffuse HBsAg pattern in the liver tissue. These 25 liver biopsies represented all 
histological types of hepatitis B liver disease. The other two cases, both patients 
with acute self-limiting hepatitis, exhibited a solitary pattern. 
Anti-HBe was found together with the solitary pattern in 5 cases, the diffuse 
pattern in 5 cases and the focal pattern in 6 cases. 
Table IX.4 Correlation of HBsAg fluorescence pattern in liver tissue and HBeAg or 
anti-HBe in serum. 
n focal pattern diffuse pattern solitary pattern 
HBeAg 27 25 2 
anti-HBe 16 6 5 5 
Correlation of HBeAg and anti HBe in serum with the presence of HBcAg in liver 
tissue 
Liver biopsy specimens from all patients were tested for the presence of HBcAg 
by the immunofluorescence technique and, in a few cases, by electron micros-
copy. HBeAg was found in 27 of the 63 samples tested. In 23 of these cases the 
corresponding liver biopsies revealed HBcAg. In four cases HBeAg was found in 
the serum without HBcAg in the corresponding liver biopsy. Two of these four 
HBcAg-tissue-negative, HBe-seropositive cases were patients with an acute self-
limiting hepatitis. 
Table IX.5 Correlation of HBeAg and anti-HBe in serum with the presence of HBcAg 
in liver biopsies. I, 
HBcAg 
HBeAgjanti-HBe n 
HBeAg positive 27 
HBeAg negativejanti-HBe negative 21 
anti-HBe positive 16 
HBcAg 
pos. 
23 
2 
neg. 
4 
19 
15 
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The sera from 21 of the 62 patients contained neither HBeAg nor anti-HBe while 
core particles could be detected in the corresponding liver biopsies from 2 of 
these 21 patients. In one case anti-HBe in serum was associated with the 
presence of HBcAg in the liver tissue. Table IX.6 shows the relation between 
HBeAg and anti-HBe in serum and the presence of HBcAg in liver tissue for the 
various histological groups of hepatitis B. 
Table IX.6 Correlation between HBeAg and anti-HBe in serum and HBcAg in liver 
tissue for various histological types of hepatitis. 
n 
acute hepatitis 
self limiting 13 
acute hepatitis 
with transition 
into CH 6 
chronic persistent 
hepatitis 9 
chronic active 
hepatitis 16 
minimal lesions 4 
reactive hepatitis 5 
cirrhosis 10 
total 63 
HBeAg 
pas 
core+ core-
2 
5 
3 
10 2 
3 
23 4 
HBeAg neg 
anti-HBe neg 
core+ core-
6 
4 
1 
1 
2 
4 
2 19 
anti-HBe 
pas 
core+ core-
5 
2 
2 
2 
3 
1 15 
Of the group of patients with acute self-limiting hepatitis three had HBeAg-
positive serum; only one of these three patients was also positive for HBcAg in the 
liver biopsy. Of the 6 cases of acute hepatitis that progressed to chronic hepatitis 
only one was negative for both HBcAg in liver tissue and HBeAg in serum. 
In the histological group of chronic persistent hepatitis, 3 of the 9 patients were 
positive for both HBeAg in serum and HBcAg in liver tissue. Two of the nine 
patients had anti-HBe in serum and no detectable HBcAg in the liver tissue. 
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In the group with chronic active hepatitis 1 0 of the 16 patients were positive for 
both HBeAg in serum and HBcAg in the liver. In 2 cases the serum showed anti-
HBe without HBcAg in the liver tissue. Of the 2 patients negative for HBeAg and 
anti-HBe, one, however, showed HBcAg in the liver tissue. 
In the group of 9 patients with minimal lesions or aspecific reactive hepatitis 
one patient, a renal transplant recipient on high-dose immunosuppressive 
therapy, exhibited HBeAg in the serum as well as HBcAg in the liver specimen. 
Five of the 9 patients were anti-HBe seropositive without detectable HBcAg in the 
liver, while 3 patients were negative both for HBeAg and anti-HBe in serum and 
HBcAg in the liver tissue. 
Table IX.? RelationbetweenthepercentageofHBcAg-positivehepatocyticnuc/eiand 
HBeAg in serum as determined by immunodiffusion and radioimmuno-
assay. 
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For 3 of the 10 patients with cirrhosis HBeAg could be detected in the serum, 
while 4 patients were positive for HBcAg. Two patients showed anti-HBe, 1 with 
and 1 without HBcAg in the liver tissue. Four patients were negative for HBeAg 
and anti-HBe in the serum as well as for HBcAg in the liver tissue. 
The percentage nuclei positive for HBcAg in the liver biopsy ranged from 
sporadic to 80 per cent, with a mean value of ± 20 per cent, for the group of 
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patients with HBeAg-positive serum as measured by the immunodiffusion tech-
nique and from 5 per cent to 60 per cent, with a mean value of 30 per cent, for the 
group of patients who were HBeAg-positive only with the sensitive radioimmuno-
assay (table IX.7). 
Localization of HBeAg in liver tissue 
All 63 liver biopsy specimens were tested with HBeAg and anti-HBe-positive 
sera using the indirect and direct immunofluorescence technique. In most cases 
HBeAg was only detected in the nuclei of hepatocytes; in some cases, however, 
nuclear HBeAg localization was combined with localization in the cytoplasm of 
hepatocytes. All 26 biopsies positive for HBc antigen also exhibited positive 
fluorescence with anti-HBe antisera and HBeAg-positive sera; the latter yielded 
a distribution identical to that seen for HBcAg. Preincubation of the slides with a 
monoclonal mouse anti-HBcAg antiserum before incubation ofthe slides with the 
human HBcAg antiserum resulted into complete blocking of the specific HBcAg 
fluorescence. On the other hand incubation of slides with anti-HBe antisera after 
preincubation with monoclonal mouse HBcAg-antiserumyielded nuclearfluores-
cence. 
IX.5 DISCUSSION 
Sixty-three HBsAg-positive sera from 62 patients with various types of liver 
disease were tested for the presence of HBeAg and anti-HBe. The results of the 
serological tests were correlated with the results of immunofluorescence studies 
to demonstrate the presence of HBcAg in the liver biopsies. These biopsies were 
taken on the day the sera were sampled. 
Twenty-seven of the tested sera were positive for HBeAg and 16 for anti-HBe. 
Twenty-one (33 per cent) of the sera, however, were negative for both HBeAg and 
anti-HBe. When the immunodiffusion technique was used 35 of 63 sera were 
negative; this number dropped to 21 with the radioimmunoassay. The relatively 
low percentage of cases positive for anti-HBe or HBeAg (68 per cent) is in 
contrasttotheresultsreported byMushawar, 1978, Tabor, 1980,Aidersville, 1980 
and Mushawar, 1981, who detected either HBeAg or anti-HBe in about 90 per 
cent of the HBsAg-seropositive serum samples. The low numbers of either HBeAg 
or anti-HBe may partly be explained by the relatively large group of patients with 
acute self-limiting hepatitis. 
In our material there was a close positive correlation between the presence of 
HBeAg in the serum and HBcAg in the nuclei of hepatocytes in the liver biopsy, 
188 
a correlation that was als9 found by Murphy (1976) and Trepo (1976). In only 
four cases was a patient positive for HBeAg in the serum and negative for HBcAg 
in the liver tissue. Two of these patients had a self-limiting acute hepatitis. Two 
patients, however, had a chronic active hepatitis. In a follow-up biopsy obtained 
two years later from one of these patients HBcAg could be detected. Because 
HBcAg is found mostly in foci of hepatocytes, the absence of HBcAg in the first 
biopsy probably represents a sampling error. Despite the close correlation 
between the presence of HBcAg in liver tissue and HBeAg in serum, remarkable 
differences in HBeAg titers and the number of HBcAg-positive hepatocytic nuclei 
were found. Although this discrepancy can be partly attributed to sampling of the 
liver tissue, because the positive nuclei are irregularly distributed, the differences 
in HBeAg serum levels and the number of HBcAg-positive nuclei are too frequent 
and too striking for this to be the only explanation. In one case more than 80 per 
cent of the nuclei in the biopsy were positive for HBcAg whereas the HBeAg 
serum titer was very low. On the other hand 3 patients with sparse HBcAg-
positive nuclei had a high HBeAg titer. Moreover, for 2 patients without detectable 
HBeAg in the serum, the number of HBcAg-positive nuclei ranged from 5 to 60 
per cent. The mean number of HBcAg-positive nuclei for the group with HBeAg 
detected by the immunodiffusion technique was lower than that for patients with 
HBeAg detected only by radioimmunoassay. The discrepancy between the quan-
tity of HBeAg and HBcAg in tissue and serum may be explained by differences in 
the excretion of core particles from the hepatocytes or by differences in the 
degree of lysis of hepatocytes loaded with viral particles. HoweVer in this study 
no direct relation was found between hepatocyte necrosis and HBeAg titer. 
Although the core particle contains the genetic information and the potency of 
the HBV, our observations on the close correlation between the presence of 
HBeAg in serum and core particles in liver tissue confirm the value .of the 
demonstration of HBeAg in serum as a sign of infectious potency and viral 
replication. In addition, however, our data also indicate that demonstration of 
HBeAg and HBcAg in liver tissue is supplementary to the detection of HBeAg in 
serum for the assessment of infectivity and viral replication activity; anti-HBe in 
serum does not exclude the possibility of ari infectious type of hepatitis B liver 
disease. For example in one patient with active cirrhosis, HBcAg in the liver · 
biopsy was accompanied by the presence of anti HBe in serum. Follow-up 
biopsies from this patient confirmed this simultaneous presence of HBcAg in liver 
tissue and anti HBe in serum, thusexcludingthe possibilitythattheinitial samples 
were taken during conversion of HBeAg to anti-HBe with the subsequent 
disappearance of HBcAg. In contrast to the study of Murphy (1976) our results 
demonstrate that a strong correlation exists between HBcAg in liver tissue and 
the presence of HBeAg in serum. 
189 
The studies of Okada (1976), Beasly (1977) and Mushahwar (1981) on the 
vertical transmission of hepatitis B from mothers to their children and our own 
observation of infection of a liver graft by the hepatitis B virus in an anti-HBe 
seropositive patient prove that not only HBeAg-positive subjects but also anti-
HBe-positive subjects have to be considered as potentially infectious. Only 
patients with a focal HBsAg fluorescence pattern have been shown to be con-
sistently negative for HBcAg and HBeAg in both serum and liver tissue. 
Of the patients with histologically graded acute hepatitis and HBeAg in the 
serum, 5 out of 8 underwent transition to chronic active hepatitis. Only 1 of the 6 
patients with acute hepatitis that progressed to chronic hepatitis was negative for 
HBeAg in the serum. In contrast all but three patients with acute self-limiting 
hepatitis were negative for HBeAg. This confirms the predictive significance of 
HBeAg in late stage acute hepatitis for the natural course of the disease, as 
already mentioned by Nielsen (1974). Moreover, in cases of acute hepatitis per-
sistent high serum titers of HBeAg are shown to be highly predictive of transition 
to chronic hepatitis (van Hattum, 1986). 
In our study a strong correlation was found between the severity of chronic 
hepatitis B infection and the presence of HBeAg. HBeAg-positive serum was 
found for 3 of the 9 patients with chronic persistent hepatitis, 4 of the 7 patients 
with mild chronic active hepatitis and 8 of the 9 patients with severe chronic 
active hepatitis. Only in liver cirrhosis was there a lack of correlation between 
activity of the inflammation and the presence of HBeAg. Eight of the 1 0 patients 
with cirrhosis revealed a mild or· more severe chronic active hepatitis component, 
while only 3 patients were positive for HBeAg. One ofthese two patients was also 
on immunosuppressive therapy. Another patientwith cirrhosis and chronic active 
hepatitis was positive for anti HBe, a serum profile that was also found in 1 case 
by Mushahwar (1981) and for several patients in the study of Fattovich (1988). 
These results suggest that long-standing hepatitis B has a tendency to correlate 
with declining HBeAg titers and sera-conversion from HBeAg to anti HBe. 
Minimal and aspecific lesions in liver tissue were accompanied by the presence 
of HBeAg in only 1 of the 9 patients. This patient was the only one in this group 
on immunosuppressive therapy, indicating that positive HBeAg and HBcAg titers 
are not in themselves related to inflammatory infiltrates. 
Striking was the close relation between the cell membrane bound HBsAg 
pattern and the presence of HBeAg in serum and HBcAg and HBeAg in liver tissue 
and the severity of the liver disease. On the other hand a focal HBsAg pattern was 
found for patients without evidence of liver cell necrosis, a HBeAg-negative 
serology and a HBcAg-negative liver biopsy. 
This study on the localization of HBeAg in liver tissue demonstrates the close 
relation between HBeAg and HBcAg on the cellular level. HBeAg was only found 
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in nuclei and cytoplasm from liver tissue specimens which also contained HBcAg. 
In most HBcAg-positive liver biopsies, the numbers of HBcAg and HBe-containing 
hepatocytes were equal. These results are in agreement with those of Arnold 
(1977) who found, using specific FITC and rodamine-labelled antisera against 
HBcAg and HBeAg, a nuclear localization for both HBc and HBeAg. In our studies 
it was impossible to purify human anti-HBe antisera of anti-HBc antibodies using 
an immunoabsorbenttechnique. This phenomenon is also mentioned by Neurath 
(1977), which leads to the supposition that HBeAg itself is an immunoglobulin. 
Immunofluorescence experiments using HBeAg-positive sera yielded the same 
results as those obtained with anti-HBe and HBcAg antisera. However, this 
cannot result from immunoglobulin activity of HBe alone although it may pointto 
the presence of anti-HBc antibodies in the test sera. A special difficulty, not 
mentioned by Arnold (1977), is the presence of anti-HBc antibodies in the serum, 
and thus in the biopsy itself, which could also bind to the core particles in 
hepatocytes during the immunofluorescence procedure. During the testing of 
biopsies for the presence of HBeAg and HBcAg by means of a double immuno-
fluorescence method, some of the core particles could be masked by intrinsic 
anti-HBc. Therefore the conclusion that HBeAg and HBcAg are not always 
present simultaneously in the nuclei of hepatocytes is not proven. 
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CHAPTER X 
HEPATITIS B 
An electron microscopical study 
X.1 SUMMARY 
Twenty-five liver biopsies randomly selected from a series of 165 liver biopsies 
from HBsAg seropositive patients were investigated immunohistochemically for 
the presence of hepatitis B antigens and ultrastructurally for the presence of viral 
particles. In all biopsies in which HBcAg was demonstrated by immunochemical 
methods, 23-27 nm particles could be detected in the hepatocytes. These 
particles were found mainly in the nuclei in large clusters scattered among the 
nuclear chromatin.ln contrast, all HBcAg-negative biopsies lacked 23-27 nm viral 
particles. In some biopsies scatt_ered hepatocytes were found with extensive 
accumulations of round and filamentous particles in widened cisternae of the 
endoplasmic reticulum. The presence of these particles in hepatocytes correlated 
with the presence of HBsAg-positive ground-glass hepatocytes seen in light 
microscopy. Ultrastructurally no viral structures could be found that correlated 
with the HBsAg detected immunohistochemicallyalong the cell membranes of the 
hepatocytes. 
X.2 INTRODUCTION 
Ultrastructural studies of liver tissue obtainedfrom H BsAg-seropositive patients 
have disclosed hepatitis B viral structures and a variety of cytoplasmic and 
nuclear alterations in hepatocytes and sinusoidal lining cells (Schaffner, 1966; 
Lapis and Schaff 1979; Yamada, 1982; Phillips, 1981 ). 
The core of the Dane particle, the complete HB virus, was identified ultra-
structurally as an uncoated 21 - 25 nm particle, distributed mostly within the 
nucleus in a diffuse pattern or in large or small aggregations (Huang, 1971; 
Gerber 197 4 ). Sometimes core particles were found in the cytoplasma of hepato-
cytes (Huang, 1974). The structural substrate of HBsAg could be identified as 
characteristic filamentous structures lying within widened cisternae of the 
proliferating smooth endoplasmatic reticulum (Stein, 1972). In transverse 
sections the intracisternal filaments appeared as small ring-like structures with a 
diameter of 35 nm. Sometimes these filamentous structures were found to be 
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continuous with the outer covering of the coated particles, like the Dane particle 
in serum (Huang, 1974). 
In acute hepatitis B the ultrastructural aspects essentially do not differ from 
those seen in other types of acute viral hepatitis. Generally the hepatocytes show 
degenerative-necrotic and regenerative changes simultaneously. Rounded 
necrotic dark cells with barely identifiable organelles, sometimes with nuclear 
fragments (Councilman bodies) (Kiion and Schaffner, 1966), are seen together 
with swollen hepatocytes characterized by marked distension of the endo-
plasmatic reticulum (balloon cells), swollen mitochondria and aspecific 
degenerative changes in the nucleus (Schaffner, 1966; Ruebner, 1968). Lytic 
necrosis of ballooning hepatocytes is often preceeded by marked swelling of the 
vascular pole and bleb formation. Sinusoidal lining cells (Kupffer's cells and 
endothelial cells) are enlarged and contain lipofuscin, ceroid hemosiderin, bile 
and necrotic hepatocytic debris. Only in early acute H8V infection can nuclear 
core particles be found ultrastructurally. The presence of core particles in later 
stages of acute hepatitis is an indication of on-going HBV infection (transition to 
chronic hepatitis). 
In chronic hepatitis 8 both intracisternal filamentous H8sAg and nuclear core 
particleswerefound, whereas asymptomatic hepatitis 8 carriers usually exhibited 
only filamentous HBsAg (Sun, 1 974). Structural substrates of membrane-bound 
HBsAg have not been described. 
In this study the presence of viral particles was investigated in 25 of the 165 
liver biopsies and compared with the presence of viral antigens detected by 
means of immunochemical methods. 
X.3 RESULTS 
The results of the ultrastructural study of the presence of viral particles in liver 
biopsy material from 25 H8sAg seropositive patients are summarized in table X.1 
Table X.1 Presence of viral particles detected by electron microscopy in 25 liver 
biopsies from HBsAg-positive patients 
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23-27 nm particles 
(nuclear) 
filamentous/round 
cytoplasmic particles 
negative 
10/25 
8/25 
11/25 
In 8 of the 25 liver biopsies the cytoplasm of a few scattered hepatocytes 
contained accumulations of filamentous and round structures in widened 
cisternae of the smooth endoplasmatic reticulum (fig.X.1 ). These hepatocytes 
could be already detected easily in the semi-thin sections by their typical 
cytoplasmic aspect in thetoluidin blue stain (fig.X.2).1n all8 cases thatpartofthe 
tissue used for light microscopical evaluation showed HBsAg-positive ground-
glass hepatocytes. No cytoplasmic viral structures were found in 17 biopsies; in 
8 of these 17 cases HBsAg-positive ground-glass cells were found in the part 
prepared for light microscopy (table X.2). 
Table X.2 Correlation between groundglass cells and filamentous and circular viral 
structures in the cytoplasm of hepatocytes 
Ground-glass 
hepatocytes 
present 
absent 
filamentous/circular particles 
present absent 
8 
0 
8 
9 
In 1 0 of the 25 biopsies large and small clusters of 23-27 nm particles were 
detected. These particles were localized mainly in the nuclei, between the nuclear 
chromatin (fig.X.3 andX.4). In all1 0 cases HBcAg (and lgG in the same location) 
were detected immunohistochemically in frozen and formalin-fixed sections of 
the biopsies. In contrast neither HBcAg nor 23-27 nm particles were detected in 
the 15 other biopsies. 
Table X.3 Correlation between 23-27 nm nuclear particles and HBcAg in nuclei of 
hepatocytes 
HBcAg 
present 
absent 
± 27 nm particles 
present absent 
10 
0 
0 
15 
In only 4 biopsies could filamentous structures be found in the cytoplasm 
together with± 23-27 nm particles in the nuclei. In only one case were 23-27 nm 
particles detected in the nucleus of a hepatocyte with filamentous particles in the 
cytoplasm. 
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Fig.X.1 Hepatocyte with many filamentous structures within dilated cisternae of 
proliferated smooth endoplasmic reticulum. In cross sections the endo-
plasmic reticulum is seen to contain one or more of these filaments ( 52.000x) 
Fig.X.2 Semi-thin section of epon-embedded liver tissue, showing many hepatocytes 
with faint staining homogeneous cytoplasm, corresponding to the 
accumulation of HBsAg-re/ated filamentous structures (tofu Tdin blue, 150x) 
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Fig.X.3 Electron micrograph of the nucleus of a hepatocyte, showing clusters of 
loosely arranged uncoated 18-27 nm core-particles (22.000x) 
Fig.X.4 Electron micrograph of clusters of core particles within the nucleus of a 
hepatocyte (52. OOOx) 
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X.4 DISCUSSION 
As described by several authors (Stein, 1972; Huang, 1974; Yamada, 1977; 
Lapis, 1979), viral particles can be found in liver cells from HBsAg seropositive 
patients in the nucleus, as ± 23 nm particles, as well as the cytoplasm. Most 
cytoplasmic viral structures are detected in widened cisternae of the rough and 
smooth endoplasmic reticulum. These particles are round or filamentous, the 
length of which can vary, and structurally are comparable to the round and 
filamentous particles found in the sera of HBsAg seropositive patients. Only 
HBsAg antigenic determinants, representing non-infectious surplus viral coat 
material, are present on these particles. 
The results of this study are in accordance with these earlier studies. In contrast 
to some other studies 23-27 nm particles were not seen in the cytoplasm, 
probably as a result of selection of the investigated material. The main purpose 
of this study was to determine the sensitivity of the ultrastructural detection 
method for hepatitis B viral infections. Because no structural substance is known 
for cell membrane-bound HBsAg, which is the most sensitive immunochemical 
sign of a chronic hepatitis B infection (see chapter VI), only 14 of the 25 biopsies 
exhibited ultrastructural signs of hepatitis B viral infection. The ultrastructural 
method for detection of core particles was not better and much more complicated 
than immunohistochemical methods for detection of HBcAg antigen. Moreover, 
by immunoelectron microscopy, HBcAg determinants were displayed not only by 
the core particles but also in nuclear and cytoplasmic ground substance 
(Yamada, 1982). In only half of the biopsies was there a correlation between the 
presence of intracytoplasmic viral structures as demonstrated by electron 
microscopy, and intracytoplasmic HBsAg as demonstrated by immunohisto-
chemical methods. The discrepancy could be explained by tissue sampling. It is 
concluded that for the detection and diagnosis of hepatitis B infections, ultra-
structural studies of liver tissue are not a valuable tool. 
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CHAPTER XI 
COURSEOFHEPATITISBANDDELTAINFECTIONINUVERS,AUXIUARY 
TRANSPLANTED IN HEPATITIS B POSITIVE PATIENTS 
A light microscopic and immunochemical study 
Xl.1 SUMMARY 
Four patients who received a heterotopic auxiliary liver graft for decom-
pensated liver cirrhosis due to hepatitis B, associated in two cases with hepatitis 
delta virus(HDV) superinfection, were studied. The consecutive appearance of 
hepatitis Band D antigens in the grafts was investigated in serial liver biopsies by 
immuno-histochemical methods and compared with the viral antigenic profiles 
in the host livers. The histological changes in the livers were studied in relation to 
the viral expression patterns. 
One week after transplantation HBsAg could already be detected in two grafts; 
this was accompanied by a minimal amount of HBcAg in the graft of the only 
patient with HBcAg in the host liver. HDAg was detectable in both patients with 
HDV cirrhosis; in one case HDAg was present in the absence of HBsAg. In the 
three-week graft biopsy HBsAg was observed in a linear pattern along the cell 
membranes of all hepatocytes in all patients. This HBsAg pattern was associated 
with nuclear and especially cytoplasmic localization of HBcAg in two patients and 
nuclear and to a lesser extent cytoplasmic localization of delta antigen in the 
other two. At three months, widespread delta expression with extensive coex-
pression of HBcAg was observed in the grafts of the two HDV positive patients. 
All patients developed a mild lobular hepatitis, histologically demonstrated 
between the 47th and 1 07th posttransplantation day. In the two HBV-positive, 
HDV-negative patients the hepatitis B infection induced cirrhotic transformation 
in the graft within one year. In the HDV-positive patients the hepatitis Band D 
infection persisted, with transition of the acute hepatitis to a mild chronic active 
hepatitis with slight or moderate fibrosis after one year. 
It is concluded that HBV and HDV infection in livers, auxiliary transplanted in 
HBV or HDV positive patients is demonstrable by immunological methods within 
1-3 weeks after transplantation; HBV infection in liver grafts appears to be a 
rapidly progressive disease; coinfection with HDV does not aggravate the acute 
hepatitis and may even suppress the aggressiveness of the hepatitis B infection. 
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There is evidence that liver cell damage may be due to direct cytopathic effects 
of HBV while cytopathic effects of HDV plays a minor role. It should be empha-
sized, however, that these observations are made in effectively immuno-
suppressed patients. 
Xl.2 INTRODUCTION 
Liver transplantation has become a feasible form of treatment for patients with 
acute and chronic liver failure of various etiologies. 
Cirrhosis due to hepatitis B is one of the generic indications for liver trans-
plantation (Corman, 1970; Maddrey, 1988). A complication of liver transplan-
tation for chronic hepatitis B is the frequent recurrence of hepatitis B or D in the 
transplanted liver, despite passive immunization or antiviral therapy (Demetris, 
1986; Portman, 1986; Lauchart, 1987; van Thiel, 1987; Rizzetto, 1987; Samuel, 
1988). The clinical implications of recurrence of the hepatitis B or D infection are 
not well known since preliminary reports range from excellent tolerance 
(Lauchart, 1987; Samuel, 1988) to an aggressive disease in which histological 
cirrhosis develops within less than a year (van Thiel, 1987). 
A program for auxiliary partial liver transplantation was started in our hospital 
in October, 1986 (Terpstra et al). Five chronic hepatitis B patients with decom-
pensated cirrhosis received a heterotopic liver graft, four of whom survived 
beyond 1 month. This transplantation technique is such that the host liver and 
thus the source of the hepatitis B infection remains in situ; therefore serological 
viral parameters cannot be used to monitor viral events in the grafted livers. 
In this prospective study, we used serial liver biopsies to assess the evolution 
of hepatitis B infection in the auxiliary transplanted livers. For this purpose the 
various markers of hepatitis Band D infection as well as the accompanying histo-
logical changes in the liver tissue were investigated. The mechanisms of liver 
damage due to the viral infection will be discussed. 
Xl.3 PATIENTS AND METHODS 
Xl.3.1 PATIENTS 
Pretransplant demografic data, liver disease and viral HBV and HDV markers 
are given in table Xl.1. Two patients (II and Ill) had an HDV superinfection. One 
ofthe other two showed signs of active viral replication {IV), whereas the other (I) 
did not. 
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Table Xl.1 ?retransplant demographic data, liver disease. and viral HBV and HDV 
markers 
viral markers 
liver serum 
pretransplant 
Patient agej liver disease 
sex HBs HBc HDAg HBs HBe DNAp aHD 
36/M cirrhosis + 
(micro)+CAH 
moderate hepato-
cellular atypia 
II 41/M 
Ill 32/M 
cirrhosis 
(macro) + CAH 
severe hepato-
cellular atypia 
cirrhosis 
(macro) + CAH 
moderate hepato-
cellular atypia 
IV 51 /M cirrhosis 
(macro)+CAH 
moderate hepato-
cellular atypia 
DNAp = DNA-polymerase 
Patient I 
+ 
+ 
+ 
+ 
+ + + 
+ + + 
+ + + + 
CAH chronic active hepatitis 
A 35 year old, HBs- and HBe-seropositive male with a liver cirrhosis was admitted 
twice for hepatic coma and intractable ascites in 1985. One year before trans-
plantation HBeAg and HBV -DNA polymerase became negative. The pre-operative 
liver biopsy then revealed a macronodular cirrhosis with signs of a mild chronic 
active hepatitis component and moderate hepatocellular atypia. HBsAg was 
found in a linear pattern along hepatocyte cell membranes; HBcAg, HBeAg and 
HDAg could not be detected. 
Patient II 
A 40 year old male suffered from a decompensated liver cirrhosis due to a chronic 
hepatitis B and D infection. Intractable ascites and muscle wasting were the 
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indication for liver transplantation. The serum was and remained positive for 
HBsAg, anti-HBe and anti-HD; HBeAg, and HBV-DNA polymerase could not be 
detected. A preoperative liver biopsy showed a cirrhosis with a moderate chronic 
active hepatitis component. Focally moderate atypia of hepatocytes was seen. 
HBsAg was present in a diffuse pattern along the cell membranes of the hepa-
tocytes. HDAg was found in about 5 per cent of the hepatocytes; HBcAg and 
HBeAg could not be detected. 
Patient Ill 
A 32 year old male was admitted for ascites. Liver cirrhosis due to chronic 
hepatitis B with D superinfection was diagnosed. Persistent ascites associated 
with continued inflammation was the indication for liver transplantation. Serum 
was positive for HBsAg, anti-HBe and anti-HD, negative for HBeAg and HBV -DNA 
polymerase. Liver biopsy showed macronodulair cirrhosis with moderate atypia 
of hepatocytes and a mild chronic active hepatitis. HBsAg was detected both 
along cell membranes and in the cytoplasm of the hepatocytes. In a sporadical 
hepatocyte delta antigen was detected in the nucleus. 
Patient IV 
A 52 year old male, with intractable ascites was found to be HBsAg positive 15 
months prior to transplantation. Additional serum tests were positive for HBeAg, 
HBV-DNA polymerase and HBV-DNA, and remained so till the day of transplan-
tation. A liver biopsy showed a macronodular cirrhosis with a moderate chronic 
active hepatitis. Focally the liver parenchyma showed a moderate hepatocellular 
atypia. HBsAg was found in a linear pattern along the cell membranes of all hepa-
tocytes in all nodules and in the cytoplasma of a few hepatocytes. HBcAg was 
found in more than 50 per cent of the hepatocytes in the nuclei and focally also 
in the cytoplasm; HDAg was not detectable. 
Xl.3.2 LIVER TRANSPLANTATION 
All four patients received a heterotopic auxiliary partial liver transplant, as 
described by Terpstra (1988). The liver grafts were reduced in size by segment 
resection of the left lobe. Transplantation was performed with both arterial and 
portal inflow and venous drainage throughout the suprahepatic vena cava of the 
graft into the recipient vena cava as craniad as possible. Biliary drainage was by 
choledochojejunostomy with a Raux-and-Y loop. 
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Xl.3.3 IMMUNOSUPPRESSIVE REGIMEN 
Prednisolone (25 mg) was administered intravenously prior to surgery and 
every 6 hours during the first 24 hours; it was then tapered off to a maintenance 
dose of 15 mg orally on the 14th postoperative day. Equine antilymphocyte 
globulin (Institute Merieux, Lyon, France; 425 lymphocytotoxic unitsjkgjday) 
and azathioprine (1 mgjkg i.v.) were given untill the 7th postoperative day. 
Cyclosporine A was started on the 6th postoperative day in a dosage of 3 
mgjkg/24 h via a continuous intravenous infusion and adjusted to plasma levels 
of 200 ngjl (conventional radioimmunoassay, Sandoz, Basle). After withdrawal 
of the biliary drainage catheter on the 1Oth postoperative day, cyclosporine A was 
administered orally in a dosage of 4 times the daily intravenous dose, divided into 
2 daily portions and adjusted to trough plasma levels of 1 00-200 ngjl. 
Xl.3.4 LIVER BIOPSIES 
Needle (Tru-Cut R) biopsies of the transplanted livers were taken according 
to protocol, 30 minutes after implantation of the graft and one week, three weeks, 
three months, six months and one year after transplantation. At the time of trans-
plantation a needle biopsy of the recipient liver was also taken. Additional 
biopsies were only obtained in the event of clinical or biochemical signs of graft 
dysfunction. Light microscopical and immunohistochemical procedures are 
carried out as described in chapter Ill. An overview of the immunohistochemical 
techniques and the antibodies used, are given in table Xl.2. 
Table Xl.2 Antibodies and techniques used for the immunohistochemical studies on 
liver biopsies 
Antigens Method 
HBsAg diF 
HBsAg iiF/iiP 
HBcAg iiF/iiP 
HBeAg iiF ~iiP 
HDV dl /diP 
lgG diF 
diF: direct fluorescence method 
iiF: indirect fluorescence method 
Pab: polyclonal antibody 
Antibody Source 
Pab C.L.B. 
Mab Organon 
Mab Organon 
Mab Thomas 
Mab Rizzetto 
Mab Kallestad 
diP: direct immunoperoxidase method 
iiP: indirect immunoperoxidase method 
Mab: monoclonal antibody 
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HBsAg antibodies were tested against positive and negative controls. The 
monoclonal anti-HBe antibody was negative for anti-HBc activity in the standard 
radioimmunoassay (Corab, Abbott, U.S.A.). Similarly the monoclonal anti-HBc 
antibody was negative in the radioimmunoassay for anti-HBe activity (Abbott, 
U.S.A.). Non-immune serum was substituted for the primary antibody to obtain 
a negative control for each staining procedure; no staining occurred. 
Liver tissue from seropositive patients with chronic hepatitis Band D was used 
as the positive control. 
Xl.4 RESULTS 
Xl.4.1 RECIPIENT LIVER BIOPSIES 
Biopsies taken from the recipient's liver during the auxiliary liver transplantation 
procedure showed a mixed microjmacro-nodular cirrhosis combined with a 
chronic active hepatitis component in all cases. In all four livers moderate to 
severe atypia was seen in the hepatocytes in some parenchymal nodules. 
Immunohistochemical studies on frozen liver tissue revealed HBsAg expression 
along the membranes of nearly all hepatocytes in the liver tissue of all four 
biopsies; in three of the four patients (patients I, II, IV) the liver biopsies revealed 
also intracytoplasmic HBsAg expression in some nodules. 
HDAg could be detected in about 5 per cent of the hepatocytic nuclei in the 
liver tissue of two patients (patients II, Ill). Neither HBcAg nor HBeAg could be 
demonstrated in either of these biopsies. One biopsy (patient IV) contained 
HBcAg and HBeAg, mainly in the cytoplasm but also in the nuclei of the hepato-
cytes. HBcAg, HBeAg and HDAgwere not detected in the biopsy from patient I. 
Xl.4.2 30-MINUTE BIOPSIES 
The biopsies taken from the liver graft 30 minutes after recirculation showed 
only minor light microscopic changes. HBsAg, HBcAg, HBeAg and HDAg could 
not be detected in any of these biopsies. 
Xl.4.3 ONE-WEEK BIOPSIES 
The one-week protocolled biopsies were actually taken on the fifth, seventh, 
eight and ninth days after transplantation. 
Light microscopically all biopsies showed an acute cholangiolitis with moder-
ate centrilobular hepatocellular and canalicular cholestasis in all cases. Only mild 
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liver cell necrosis with scattered acidophil bodies was present; characteristic 
signs of acute rejection (Snover 1 984) were not found. 
Hepatitis B surface antigens could be detected in two of the four biopsies 
(patients Ill and IV, fig.XI.1 ). Only patient I, who exhibited no signs of active viral 
replication before transplantation, did not test positive for any of the hepatitis B 
or hepatitis D antigens. 
In patients II and Ill, who were positive for HDAg prior to transplantation, HDAg 
was already present in 50 and 1 per cent of the hepatocytic nuclei, respectively, 
one week after transplantation; HBcAg was not detected in either biopsy. In the 
biopsy from patient IV, who exhibited active hepatitis B replication prior to trans-
plantation, a weak nuclear HBcAg fluorescence was detected in a sporadic hepa-
tocyte. 
lgG deposits were detected in the biopsy, which revealed HDV in 50 per cent 
of the nuclei, in an identical pattern and localization of the HDV antigen as result 
of binding of intrinsic HDV antibodies to HDV antigen in the liver tissue. 
Xl.4.4 THREE-WEEK BIOPSIES 
The three-week biopsy of the protocol was taken on days 20, 20, 21 and 24, 
respectively. 
In all cases a mild acute cholangiolitis was still present, together with a mild 
lobular cholestasis. In one biopsy round cell infiltration of some bile ductules 
was consistent with the development of grade I graft rejection (patient II). 
All biopsies revealed viral antigens. HBsAg was detected in a linear pattern 
along the cell membranes of all hepatocytes in all four liver grafts. In patients II 
and Ill this HBsAg pattern was combined with nuclear accumulation of delta 
antigen; HBcAg could not be detected in these cases. In the other two cases 
(patients I and IV) HBsAg occurred in combination with HBcAg and HBeAg, 
localized in the nucleus of a sporadic hepatocyte in patient I and in the cytoplasm 
of about 40 per cent of the hepatocytes in patient IV (fig.XI.1 ). 
Xl.4.5 THREE-MONTH BIOPSIES 
Histologically three out offour biopsies were characterized by a lobular (acute) 
hepatitis with necrosis of many scattered mainly centrilobular hepatocytes. In 
one biopsy (patient I) only minimal changes were observed. None of the biopsies, 
however, contained ground-glass hepatocytes. In all four biopsies a bright linear 
cell membrane-bound HBsAg fluorescence was seen (fig.VI.6 page 145), ac-
companied in two cases (patients I and IV) by mild cytoplasmic staining (fig.XI.1 ). 
In the two HDV-positive patients HDAg was detected in about 50 per cent of 
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Schematic drawing of HBV and HOV expression patterns in serial liver 
biopsies from livers, transplanted in two HBV-positive (I and IV) and two 
HOV-positive (II and Ill) patients. I 
the hepatocytes, mainly in the nuclei. HDAg expression was combined with 
HBcAg expression in both the nucleus and the cytoplasm in patient II and only 
in the nucleus in patient Ill (fig.XI.1 and X1.2). 
The two HBV-positive, HDV-negative patients showed HBcAg and HBeAg ex-
pression in more than half of the hepatocytes, partly in the nucleus and partly in 
the cytoplasm. 
Xl.4.6 SIX-MONTH BIOPSIES 
The biopsies of the HBV-positive, HDV-negative patients showed an ongoing 
acute hepatitis, with focal and extensive centrilobular (patient I) hepatocyte 
necrosis (fig.XI.3). In patient IV this acute (lobular) hepatitis was combined with 
periportal hepatitis, indicating a transition to chronic hepatitis. Biopsies from the 
HDV-positive patients revealed a transition from acute hepatitis to mild chronic 
active hepatitis in patient II and a mild cholangiolitis in patient Ill. The biopsies of 
the HBV-positive, HDV-negative patients exhibited both mild and severe fibrotic 
changes, whereas the HDV-positive patients showed only minimal or mild fibrosis 
(table Xl.3). 
In all biopsies linear HBsAg deposits were found along the cell membranes of 
all hepatocytes. In the biopsies of patient I and IV, this pattern was combined with 
intracytoplasmic HBsAg expression. In the HBV-positive, HDV-negative patients 
HBcAg and HBeAg were detected in more than 50 per cent of the hepatocytes, 
in the nucleus but also in the cytoplasm. The biopsies from the HDV-positive 
patients revealed HDAg together with nuclear and cytoplasmic (patient II) HBcAg 
and HBeAg. HDAg was present in 50 per cent of the hepatocytes but restricted 
to the nucleus in patient II; in patient Ill HDAg expression was found in only a 
small percentage of the hepatocytes, both in nucleus and cytoplasm (fig.X1.4). 
lgG was demonstrated in sections of the frozen liver tissue in a distribution 
pattern identical to HBcAg andjor HDAg, and due to in vitro binding of intrinsic 
anti-HBc and anti-HDV antibodies to their complementary antigens. 
Xl.4.7 ONE-YEAR BIOPSIES 
The biopsies from both HBV-positive, HDV-negative patients (I and IV) showed 
severe fibrosis with cirrhotic transformation of the hepatic parenchyma (table 
Xl.3. and fig.XI.5 and Xl.6). The fibrous septa contained only an inconspicuous 
aspecific inflammatory infiltrate. In the parenchymal nodules most hepatocytes 
were enlarged due to the abundant finely granular cytoplasm, that reacted faintly 
positively to HBsAg anti bodies. HBsAg-positive "ground-glass" hepatocyteswere 
present sporadically in patient I and in abundance in patient IV. There was exten 
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sive HBcAg and HBeAg expression located in the nucleus as well as the cyto-
plasm of about 80 per cent of the hepatocytes in patient I and mainly in the 
nucleus of about 40 per cent of the hepatocytes in patient IV. This nuclear 
localization of HBcAg and HBeAg in patient IV is in contrast to the mainly 
cytoplasmic localization in the six-month biopsy (fig.XI.1 ). 
In contrast to the cirrhotic transformation found for both HBV-positive, HDV-
negative patients, only a minimal or mild fibrosis was seen in the HDV-positive 
patients (fig.XI.7 and Xl.8). Both HDV-positive patients exhibited signs of a mild 
chronic active hepatitis (fig.XI.9). Ground-glass hepatocytes could not be 
detected. HBsAg was found along the cell membrane of the hepatocytes and not 
in the cytoplasm. 
For patient Ill the numbers of HBeAg- and HDAg-positive cells and the antigen 
distribution patterns were essentially-the same as in the six-month biopsy. In 
patient II the number of HDAg-positive hepatocytes had clearly diminished, while 
the HBcAg and HBeAg expression remained constant (fig.XI.1 ). 
Table Xl.3 Evolution of liver histology in serial liver biopsies from four liver grafts 
HBV-positive patients HDV -positive patients 
Patient I Patient IV Patient II Patient Ill 
fibrosis hepatitis fibrosis hepatitis fibrosis hepatitis fibrosis hepatitis 
one 
week 
three 
weeks 
three 
months 
six 
months 
AH 
+ AH 
+ AH 
+++ CAH 
one 
year + + + + CAH + + + + CAH 
AH = acute hepatitis 
+ = mild fibrosis 
+ 
+ AH + 
+ CAH + /- CAH 
+ CAH + /- CAH 
CAH = chronic active hepatitis 
+ + = moderate fibrosis 
+ + + = severe fibrosis + + + + = cirrhosis 
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Fig.XI.2 Three-month biopsy from HDV-positive patient Ill: more than half of the 
hepatocytes reveal HDV mainly in the nuclei (anti-HDV; direct peroxidase 
method, 120x) 
Fig.XI.3 Six-month biopsy from HBV-positive, HDV-negative patient I. Extensive 
centrilobular necrosis of hepatocytes. Only slight inflammatory infiltrate 
present (PAS, 150x.) 
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With the same localization and distribution pattern of HBcAg and HDAg, lgG 
was detected in sections of all frozen liver biopsies. 
Xl.4.8 INCIDENTAL BIOPSIES 
Because of a rise in the bilirubin and/ or serum aminotransferase levels of un-
known cause, four non-protocol biopsies were obtained from three of the four 
patients (II, Ill and IV). 
A 65-day biopsy from HDV-positive patient II showed histological signs of a 
mild (grade I) rejection based on a mild cholangiolitis combined with venous 
endothelialitis. In addition the hepatic parenchyma contained several scattered 
acidophil (Councflman) bodies. Beside HDV-antigen, this biopsy showed HBcAg 
in about 1 0 per cent of the hepatocytes, mainly in the nucleus, but sometimes 
also in the cytoplasm. HDV-positive patient Ill underwent biopsies on days 51 
and 69. On day 51 the mild light microscopic changes in the hepatic lobules were 
consistent with an early acute hepatitis, whereas on day 69 the picture had pro-
gressed to a lobular hepatitis with many scattered acidophil bodies. 
Fig.X1.4 
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Six-month biopsy from HDV-positive patient Ill: scattered hepatocytes 
exhibit HDV-ant1gen, both in the nucleus and in cytoplasm (anti-HDV 
antibody; direct immunoperoxidase method, 380x) 
Fig.XI.5 One-year biopsy from HBV-positive, HDV-negative patient IV. Cirrhotic 
transformation of the liver parenchyma (PAS 60x). 
Fig.XI.6 One year biopsy of HBV-positive, HDV-negative patient IV. High powerfield: 
only minimal infiltrate in the fibrous septa. In the liver nodule (left) many 
hepatocytes with ground-glass aspect (HAS, 150x). 
215 
Fig.XI. 7 One year biopsyfrom HDV-positive patient /11.1 ntact liver architecture. Only 
slightly enlarged portal tracts (PAS, 60x). 
Fig.XI.8 One year biopsy from HBV-positive, HOV-positive patient II. Intact archi-
tecture; irregular enlarged portal tracts (mild periportalfibrosis )( HA, 60x). 
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Fig.XI.9 One year biopsy from HBV-positive, HDV-positive patient II: periportal hepa-
titis: roundce/1 infiltrate extending into the liver parenchyma (HA, 150x). 
On day 51 nuclear HDV expression in about 70 per cent of the hepatocytes was 
combined with nuclear and cytoplasmic localization of HBcAg and HBeAg in 
about 30 per cent of the hepatocytes. On day 69 HBcAg had increased and was 
present in the cytoplasm of about 40 per cent and the nucleus of about 70 per 
cent of the hepatocytes. HDV was slightly diminished, being present in about 50 
per cent of the hepatocyte nuclei. A 47-day biopsy from patient IV showed not 
only cholangiolitis but also a mild lobular hepatitis component. HBsAg appeared 
as a bright fluorescence pattern along the cell membranes ofthe hepatocytes and 
occasionally in the cytoplasm. 
Xl.4.9 RELATION BETWEEN SERUM TRANSAMINASE LEVELS, HISTOLOGY AND VIRAL 
ANTIGENS IN LIVER TISSUE 
In fig.XI.1 0,11,12 and 13 liver transaminase levels in the four patients are given 
in relation to the time of the post-transplantation biopsies and the presence of 
viral antigens in the biopsies. Despite the presence of HBsAg along the cell 
membranes of the hepatocytes and HDV-antigen (patient II and Ill) in the one-
week and three-week biopsies, transaminase levels are not elevated. Simul-
taneouslywith the appearance of HBcAg in the liver tissue, transaminase levels 
are elevated. 
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related to the time of the biopsies and the viral antigens, present in the 
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Fig.XI.13 HDV-positive patient Ill: posttransplantation levels of SGOT and SGPT, 
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Xl.5 DISCUSSION 
Within the framework of an auxiliary partial liver transplant (A.P.L.T.) program 
five HBsAg-positive patients with decompensated cirrhosis underwenttransplan-
tation. Four out of the five survived for more than one month and were followed 
for at least one year; serial liver biopsies of the grafts were taken and special 
attention was directed toward appearance and evolution of the viral infection as 
well as the accompanying histological changes in the grafts. 
At the time of transplantation one patient exhibited signs of active HBY 
replication, as indicated by positive HBeAg and DNA-polymerase activity in the 
serum. The other three patients showed no signs of active HBY replication, 
although two had an active HOY superinfection. 
After transplantation the liver grafts of all four patients exhibits signs of active 
HBYinfection together with active HOY infection in the two HOY-positive patients. 
The infection of the graft in the HBY-positive patient with signs of active viral 
replication could be expected on forehand. The infection of the liver grafts by 
HBY, however, in the HBeAg-negative patient and by both HBYand HOY in the 
HOY-positive patients is not self-evident, but consistent with the findings after 
orthotopic liver transplantation. In these latter patients "dormant" HBY is 
presumably reactivated. In three of the four patients viral infection of the graft was 
already apparent in the one-week biopsy, For the HBY-positive, HBeAg-negative 
patient (case 1), however, the graft infection could not be demonstrated until the 
three-week biopsy. This difference in time point of graft infection may be 
explained by the time necessary for reactivation of the silent HBY infection. In one 
of the HOY-positive patients viral graft infection was demonstrated only by the 
presence of HD viral antigen in 40 per cent of the hepatocytic nuclei without 
concomitant HBY markers. 
One of the early signs of an HBY or HOY infection of the liver grafts comprise 
localization of HBsAg along the cell membrane of all hepatocytes. This early 
diffuse HBsAg expression along the cell membrane of the hepatocytes may be 
explained by different mechanisms. Firstly, HBsAg circulating in the serum of the 
patient binds immediately after transplantation to specific receptors on the cell 
surface of the hepatocytes. In support of this possibility specific binding of HBsAg 
to the liver cell surface has been shown to occur intermediated by poly-albumine 
and is assumed to be the first step in the penetration and infection of hepatocytes 
(Thung, 1 984; Gerber, 1 985; Wright, 1 987). This specific binding of viral antigens 
to antigens on the cell surface is also demonstrated to play a role by other viral 
infections (Philipson, 1981 ). The difference in the time of appearance of HBsAg 
in the HBeAg positive and in the HBe-negative patient might then be explained by 
higher HBsAg levels in the HBeAg-positive than in the HBeAg-negative patient. 
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Another more acceptable explanation for the early appearence of the diffuse 
HBsAg expression is a nearly simultaneous HBsAg production in all hepatocytes 
following infection of the hepatocytes by the hepatitis B virus. In that case the 
synthesis of HBsAg proteins by the replicating virus would proceed more rapidly 
or be more abundant than the synthesis of HBc and HBeAg proteins. In support 
of the synthesis hypothesis of the cell membrane HBsAg is the fact that HBsAg 
has been shown to be already detectable on the third day after inoculation of 
experimentally infected duck siblings (Freiman, 1988). 
Moreover Krugman et al, 1979, who studied the natural history of hepatitis B 
infection in children inoculated with the MS-2 strain hepatitis virus, found an 
interval of only six days between exposure and the appearance of HBsAg in 
serum. 
In the early stage of infection the hepatocyte cell membrane apparently is a 
predilection locus for the newly synthesised HBsAg antigens, thus probably 
changing the antigenic composition of the cell membranes of all hepatocytes. 
This altered antigenic cell surface composition is suggested in many studies 
(Gerber, 1985; Alberti, 1984; Mondelli, 1984) as a putative mechanism for cell-
mediated immune cell lysis and viral clearing. 
The diffuse expression of HBsAg on the hepatocyte cell surface was obviously 
not accompanied by increased destruction of hepatocytes, as indicated by the 
absence of hepatitis in these early biopsies. 
On the contrary the liver cells exhibited high regenerative activity, as indicated 
by the numerous mitotic figures in the hepatocytes (Willemse, 1989). However, 
it has to be stressed that these patients were on effective immunosuppressive 
therapy, with suppression of immune mechanisms. Although HBsAg was de-
tected mainly along the cell membranes of the hepatocytes in the early infection 
phase (one-and three-week biopsies), later it also appeared together with HBc in 
a faintly diffuse pattern in the cytoplasm of the hepatocytes of the HBV-positive, 
HDV-negative patients. In the six-month biopsies from both HBV-positive, HDV-
negative patients typical HBsAg-positive ground-glass cells could be detected. 
In the two HDV-positive patients, HDAg appeared before or simul-taneously with 
HBsAg and long before HBcAg; HDAg was already present on the 7th-9th post-
transplantation day (fig.XI.1 ). This observation, also reported by others (Rizzetto, 
1987), suggests infection and replication of HDV in liver cells without obvious 
help from the hepatitis B virus. In one case (patient II), on the 9th 
posttransplantation day, 40 per cent of the hepatocytes stained positive for HDAg 
without HBsAg along the cell membrane and without detectable HBcAg in the 
cytoplasm or nucleus of the hepatocytes. 
In the 3 month-biopsies HDAg was detected together with HBcAg. In these 
patients the time lag between the appearance of HBsAg on one hand and HBcAg 
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and HBeAg on the other was even more impressive. 
The very early appearance of excessive amounts of HDAg in the liver trans-
plants was not associated with major morphological changes. This observation 
does not support a direct toxic effect of HDV on the hepatocyte. 
The frozen but not the paraffin sections of all liver biopsies revealed lgG in the 
same distribution pattern as HBcAg and HDAg indicating in vitro immune 
complex for-mation between HDAg and HBcAg antigens in liver tissue and 
intrinsic anti-HD and anti-HBcAg in sinusoidal serum (Rizzetto, 1981 ). 
All livers revealed an acute hepatitis, demonstrated light microscopically 
between day 47 and 107, with slight (patient I) to moderate (patient II, Ill, IV) 
elevation of SGOT and SGPT ranging from 70 to 1010 i.u.jl (fig.XI.1 0, 11, 12 and 
13 ). The onset of abnormal transaminases, obvious related with the HBVinfection 
of the graft was detected as early as 35 days and as late as 56 days after trans-
plantation. The appearance of these abnormal serum transaminases after HBV 
exposure differs only slightly from the time of appearance of abnormal trans-
aminases after exposition of HV in the children in the study of Krugman ( 1 979). 
In all livers the acute lobular hepatitis coincided with the appearance in the liver 
tissue of HBcAg located in three of the four biopsies mainly in the cytoplasm and 
less obviously in the nuclei. This distribution pattern differs from that seen in most 
livers with untreated chronic persistent and chronic active hepatitis, in which 
HBcAg occurs predominantly in the hepatocytic nuclei and less in the cytoplasm 
(see chapter VI). 
Possibly of major interest is the observation that the hepatitis was accompanied 
by an unusually mild inflammatory infiltrate. The concomitant appearance of 
HBcAg and the lobular cell damage and the virtual absence of an inflammatory 
infiltrate suggest that a direct toxic effect of cytoplasmic HBcAg rather than 
immunological events plays a role in the pathogenesis of viral hepatitis B. Cellular 
immunological mechanisms are also less likely, because rejection phenomena 
were· not prominent in any of the biopsies, indicating adequate suppression of 
the cellular immune system. 
In all patients the acute hepatitis ultimately changed into a mild chronic active 
or chronic persistent hepatitis although it took 6 months in 3 cases and 12 
months in the other for this to happen. Despite the fact that the patients' immuno-
logical system had already been sensitized by the hepatitis B virus and despite 
the use of immunosuppressiva the naturally occurring sequence of lobular hepa-
titis to portal/periportal hepatitis, as seen by a first infection appeared not to be 
changed essentially. Also this is not in favor of an immunological mediate 
disease. Similar to the finding of a progressive hepatitis B infection in many 
immunosuppressed renal (Parfrey, 1984, 1 985) and liver (van Thiel, 1 987) 
transplant recipients, the two HBV-positive, HDV-negative patients in this study 
222 
developed liver cirrhosis within one year. It seems likely that enhanced replication 
of the hepatitis B virus especially with the expression of HBcAg and HBsAg in the 
cytoplasm of the hepatocytes is an important factor in hepatocyte necrosis and 
may be due to a direct toxic effect of the virus on the hepatocyte. The importance 
of cytoplasmic localization of HBcAg in patients with aggressive disease was also 
stressed in the study of Hsu, 1988. 
Since there is strong evidence that, in the natural course of a hepatitis B 
infection, a T cell-mediated immune mechanism against membrane-bound 
HBsAg and HBcAg also plays an important role in hepatocyte destruction, we 
suggest that hepatocyte necrosis might be attribute to two different mechanisms; 
firstly to an immune mediated mechanism and secondly to a direct cytotoxic 
effect of HBV. 
The mild course of the hepatitis D infection makes a direct toxic effect of HDV 
improbable. The two HDV-positive patients in this study (especially patient Ill who 
showed minimal HBcAg expression) exhibited little architectural liver damage 
after one year. This relatively favorable course can be explained by suppression 
of HBV by HDV (Chen, 1988). Nevertheless, the course of the HBV /HDV coinfec-
tion in these immunosuppressed patients is in marked contrast to the relatively 
severe natural course of an HDV infection. Immunological mechanisms may play 
a role during the HDV infection, and immunosuppression may need to be 
reevaluated, despite the findings of Rizzetto {1983) who could not demonstrate 
a beneficial effect of standard immunosuppression in HDV-positive patients. 
As complication of the chronic HBV-infection one ofthe delta negative patients 
(I), who was HBeAg negative before transplantation, died two years after trans-
plantation of hepatocellular carcinoma which replaced the recipient liver totally 
and had invaded the liver graft extensively. 
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GENERAL REMARKS 
The studies in this thesis have demonstrated the close relationship between 
viral expression and pathological changes in liver tissue from HBsAg-positive 
patients. The patterns of viral expression have been shown to play an important 
role in the classification of hepatitis B liver disease as well as assessment of 
prognosis of the disease. 
Broadly speaking, three patterns could be distinguished: 
A. A pattern, characteristic of (late-phase) acute self-limiting hepatitis with 
only minimal HBsAg in some scattered macrophages and degenerated 
hepatocytes. HBcAg is not present (state of viral inacceptance with viral 
elimination). 
B. A pattern characterized by minimal or slight aspecific histological changes 
and large clusters of hepatocytes with excessive cytoplasmic accumula-
tions of HBsAg; light microscopically these cells are recognized as ground-
glass hepatocytes. Despite the presence of excessive HBsAg, no HBcAg 
can be detected. Incorporation of HDV-DNA in the hepatocyte genome and 
clonal proliferation of these hepatocytes are apparent in this pattern (state 
of viral acceptance). 
C. A pattern characterized by a diffuse cell membrane-related HBsAg 
expression (honeycomb pattern), indicative of all types of chronic hepatitis 
as well as an acute hepatitis which will eventually progress to chronic 
hepatitis. In many cases HBcAg is present in this pattern. Varying numbers 
of scattered hepatocytes with intracytoplasmic HBsAg accumulation may 
be detected; they are the ground-glass cells in light microscopy. Only a few 
of these ground-glass hepatocytes contain HBcAg.ln this pattern there are 
no signs of clonal proliferation of the ground-glass hepatocytes, nor is there 
a relation between the number of ground-glass cells and the activity of the 
chronic hepatitis (state of viral inacceptance without viral elimination). 
Viral expression remains constant over prolonged periods, whereas clinical 
histological activity changes. 
The results of the studies demonstrate that it is not the quantity of HBsAg and 
HBcAg in liver tissue that is related to activity and progression of the liver disease 
but their localization. 
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Our findings suggest that HBsAg localization in the cell membrane of hepato-
cytes causes immune-mediated liver disease, as indicated by portal piecemeal 
necrosis in light microscopy. The degree of piecemeal necrosis is dependent on 
host factors. The localization of HBcAg in the cytoplasm of hepatocytes can be 
related to lobular hepatocyte necrosis. 
Studies of reinfected liver grafts show that extensive liver cell necrosis can 
occur without the presence of lymphocytes. This finding suggests a direct cyto-
pathic effect of HBcAg on the liver cell. 
These findings provide evidence that liver cell necrosis is due to both immuno-
logical processes, depending upon localization of HBsAg in the cell membrane 
of hepatocytes, and direct cytopathogenic mechanisms, arising from viral repli-
cation and cytoplasmic localization of HBcAg. 
The immunological aspect of chronic hepatitis, the severity of which is 
determined by host factors, presents as periportal hepatitis with piecemeal 
necrosis. The direct cytopathogenic effect becomes manifest as lobular hepato-
cytic necrosis and determines to a large extent the prognosis of the chronic 
hepatitis. 
The findings reported in this thesis provide a basis for a strategy for anti-viral 
treatment of chronic hepatitis B. 
Theoretically several approaches to the treatment of a viral infection exist. 
Because there is strong evidence for a direct relation between viral replication 
and activity of the liver disease, one therapeutic possibility may be to achieve 
suppression of viral replication and thus amelioriation of disease activity. 
For this purpose drugs that interfere with both viral RNA transcription and the 
production of viral proteins can be administered in order to suppress replication 
of the virus. 
At present however such drugs are. not available. Moreover the infection will not 
be cured: instead only the effects will mitigated. Such a drug may suppress both 
the immune mechanism, by diminishing protein (HBsAg) production, and the 
toxic effects, by reducing proliferation of the virus. 
Elimination of the potential of an infected cell to produce a virus is another 
possibile approach. 
To accomplish this aim, drugs can be used that eliminate ali infected hepato-
cytes from the liver. As shown in chapter VI, in chronic hepatitis all hepatocytes 
appear to be infected by the virus, as demonstrated by the diffuse cell membrane-
bound HBsAg localization, so that such a therapy would imply elimination of all 
hepatocytes. 
If this elimination were to occur rapidly, the result would be massive liver cell 
necrosis and death of the patient. 
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A more realistic way to eliminate the potential of infected cells to produce virus 
would be to cure infection of the hepatocyte. 
Such a therapy may be achieved by inhibition of viral DNA synthesis. Since viral 
DNA formation depends on reverse transcription, drugs such as phosphono-
formic acid that interfere with reverse transcriptasewould prevent the generation 
of cccDNA. However preliminary results with this type of drug are not hopeful. A 
decline in viral replication activity is followed by rapid restoration of this activity 
after withdrawal of the drug. 
Finally, another possibility is to cure the chronic infection by creating a situation 
in which newly formed hepatocytes are protected against reinfection by the virus. 
In this way, the number of infected hepatocytes will slowly decrease, as a result 
of regeneration of the liver, and all infected cells will eventually disappear. 
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SUMMARY 
Hepatitis B represents a major public health problem of worldwide concern 
because of its frequent occurrence and severe complications. Hepatitis B 
infection is characterized by a wide range of histological changes and various 
clinical courses, which in general are caused by differences in the relation 
between the virus and the host. 
Since the discovery of the Australia antigen by Blumberg and the subsequent 
recognition of the Australia antigen as a marker for hepatitis B infection by Prince, 
significant advances in the fields of basic molecular biology and clinical research 
have been made. 
However our knowledge about the pathobiology of the virus and the molecular 
and cellular basis for the pathogenesis of the liver changes is still incomplete. In 
particular mechanisms which lead to: 
a. liver cell necrosis. 
b. evolution of acute to chronic hepatitis. 
c. persistance of a hepatitis B infection. 
d. development of hepatocellular carcinoma. 
are only partly understood and reports on these subjects are conflicting. 
In addition the interactions between the hepatitis B virus and the incomplete 
hepatitis delta virus as well as the accompanying pathological events are far from 
clear. 
By studying the expression patterns found for the hepatitis Band D virusses in 
relation to histopathological changes in liver tissue from a series of HBsAg 
seropositive individuals (both patients and apparently healthy carriers), an 
attempt has been made to contribute to a better understanding ofthe pathogene-
tic mechanisms in viral hepatitis. 
In chapter I the history of the discovery of hepatitis B virus and the subsequent 
advances in hepatitis B research, which is characterized by many serendipities, 
were reviewed. At the end of this chapter the general aims of the study were 
described: the central theme is the unravelling of the pathogenetic mechanisms 
of hepatitis B. 
Chapter II is an evaluation of the liver biopsies investigated in this thesis. A 
series of consecutive liver needle biopsies, received for histological examination 
by the Department of Clinical Pathology during a five-year period ( 1973-1977), 
was studied. 
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In this period 165 liver needle biopsies from 139 HBsAg seropositive patients 
{1 06 males and 33 females) were presented for light microscopical as well as 
immunohistochemical and electron microscopical examination. 
The group of 139 HBsAg seropositive individuals was composed of: 
a. apparently healthy asymptomatic HBsAg positive subjects (51) 
b. patients with a hepatitis B infection demonstrated during evaluation of a 
clinically manifest liver disease or other internal diseases partly caused by 
liver disease {88). 
In this chapter demographic data and the possible mode of infection were 
considered; 41 of the 51 apparently healthy HBsAg positive individuals came 
from a group of 128 blood donors who were found to be HBsAg positive upon 
routine screening. 
From this finding a prevalence for HBsAg in the Netherlands (Rotterdam) of 
roughly 0.2 per cent was calculated with a malejfemale ratio of 4:1. This 
prevalence for HBsAg is in agreement with prevalences reported for other West 
European countries and the USA and is far less than the 6-15 per cent found for 
some Asian and African countries. 
All 128 HBsAg-positive blood donors were admitted for clinical evaluation of 
their HBsAg carriership; a liver biopsy was obtained from 41 (± 25 per cent) blood 
donors. 
In chapter Ill, the methods used for the investigation of the liver biopsy 
material were described. 
Chapter IV focussed on the light microscopical aspects of hepatitis, and in 
particular hepatitis B. The criteria for and difficulties of the classification of the 
broad spectrum of microscopical changes were discussed. The relation between 
light microscopical characteristics and prognosis was considered in detail. 
Chapter V dealt with the analysis of liver biopsies from 139 HBsAg positive 
patients, classified according to the system, described in chapter IV. 
The histological findings were compared with clinical and biochemical 
parameters and the course of the hepatitis B infection. A histological diagnosis 
of acute hepatitis was established for 43 patients, 1 0 of whom belonged to the 
group "apparently healthy individuals". The acute hepatitis was anicteric in 9 
cases. All anicteric versus only two cases of icteric acute hepatitis progressed to 
chronic hepatitis, with prolonged persistence of HBsAg. This provides strong 
evidence that acute hepatitis with an anicteric course transforms into chronic 
hepatitis; in contrast of the patients with the clinically more severe icteric acute 
hepatitis only a few (in this series 6 per cent) underwent progression to chronic 
hepatitis. 
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This finding is in agreement with the fact that patients with chronic hepatitis 
rarely have a history of jaundice. 
Light microscopically acute hepatitis could be subdivided roughly into early, 
fully developed and late phase acute hepatitis, which correlated well with the 
biochemical and clinical features. No consistent histological features that predict 
an unfavorable course of acute hepatitis, i.e. transition to chronic hepatitis, were 
found. Prominent infiltrates in the portal tracts, sometimes with features of 
piecemeal necrosis, and the absence of cholestasis gave the best correlation with 
transition to chronic hepatitis. 
All cases of acute hepatitis that transformed into chronic hepatitis were of the 
late-phase type. 
In contrast with reports in the literature, biopsies from patients with acute 
hepatitis contained only minimal iron deposits in this series. 
In general asymptomatic individuals with chronic hepatitis exhibited, as was 
expected, less severe liver changes than the symptomatic ones. On the other 
hand, the biopsies from 9 asymptomatic blood donors exhibited the pattern of 
acute hepatitis, 6 of whom ultimately remained anicteric. 
Five blood donors had chronic active hepatitis and 1 an incomplete septal 
cirrhosis. 
Seventeen of the 88 symptomatic hepatitis B carriers exhibited severe fiver 
changes with cirrhosis. Cirrhosis developed for the most part in the older age 
group. 
Not only the differentiation of acute self-limiting hepatitis from acute hepatitis 
which progresses to chronic hepatitis but also the differentiation of chronic 
persistent hepatitis from chronic active hepatitis, on the one hand, and aspecific 
reactive hepatitis and the residual phase of acute hepatitis, on the other, was 
sometimes problematic. 
In chapter VI the results of immunohistochemical studies for determination of 
the presence and localization of hepatitis Band D antigens and immunoglobulins 
were reported. 
In the hepatocyte HBsAg could be detected along the cell membrane or in the 
cytoplasm in a diffuse pattern or as inclusion body. The intracytoplasmic 
localization of HBsAg correlated in most cases with the presence of ground-glass 
hepatocytes in Hand A-stained formalin-fixed sections of liver tissue. In contrast 
to the intracytoplasmic HBsAg localization, the membrane localization in general 
could not be demonstrated in formalin-fixed material. 
Using isolated liver cells in suspension it was demonstrated that HBsAg was 
present along the cell membrane with expression on the outer surface, and that 
HBsAg was mobile in this cell membrane, as indicated by the capping 
phenomenon. 
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HBcAg was demonstrated mainly in the nucleus of the hepatocytes. In some 
cases this nuclear localization was combined with diffuse localization in the 
cytoplasm, indicative of active viral replication. HBcAg occurred in nearly all 
cases in combination with a cell membrane-related HBsAg localization. 
Sporadically HBcAg was found in hepatocytes with the ground-glass aspect, 
which correlated with cytoplasmic accumulation of HBsAg. 
The localization of HBeAg in liver tissue was identical to that of HBcAg, both 
being distinct from HBsAg. This finding is also indicative of the close relation, 
probably involving the same particles, between HBeAg and HBcAg in liver tissue. 
Delta antigen was also detected mainly in the nuclei of the hepatocytes, 
sometimes combined with cytoplasmic localization. In individuals with chronic 
hepatic disease only a few hepatocytes revealed delta antigen and never in 
combination with HBcAg. 
Concerning the localization of immunoglobulins, the most striking finding for 
HBsAg-positive patients was the presence of I gG and in some cases I g M deposits 
in the nuclei of hepatocytes. 
Occurrence and localization of these immunoglobulin deposits were identical 
to those for HBcAg and core particles, as demonstrated by electron microscopy. 
The phenomenon was shown to be caused by binding of intrinsic antibodies 
present in the serum in the sinusoidal spaces to core antigen in the nucleus. 
In the same way HBeAg and delta antigen could be demonstrated in eAg or 
delta antigen-positive liver tissue in patients with anti-HBe and anti-delta activity, 
respectively, in the serum. 
On the basis of the different localizations of the various viral antigens, three viral 
expression patterns could be distinguished. Localization of HBsAg is the most 
important for differentiation of the three patterns: 
a. solitary pattern: only a few scattered cells (macrophages or degenerated 
hepatocytes) are present in the liver tissue without concomitant HBcAg. 
This pattern correlates with and is only present in acute self -limiting hepatitis. 
b. focal pattern: in this pattern large clusters of hepatocytes show extensive 
accumulation of HBsAg in the cytoplasm. No HBcAg can be detected. This 
pattern correlates with a nearly normal liver tissue with the striking aspect 
of large groups of ground-glass hepatocytes. This pattern suggests a viral 
acceptance state with viral DNA incorporated in the viral genoom. 
c. diffuse pattern, which correlates with chronic hepatitis. A cell membrane-
bound HBsAg localization is seen in all hepatocytes. Some hepatocyteswith 
intracytoplasmic HBsAg (ground-glass cell) can be found dispersed 
throughout the liver tissue. In this pattern HBcAg can be demonstrated in 
some hepatocytes (a viral inacceptance state). 
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On the basis of the presence and especially on the localization of HBcAg, this 
pattern was subdivided. Cytoplasmic HBcAg localization correlates with rapid 
progression of the chronic hepatitis. 
It is concluded that the localization of viral antigens correlates well with 
histological patterns and plays an important (prognostic) role in the exact 
classification of HB disease. 
Localization of HBsAg along the cell membrane of hepatocytes is presumed to 
bean importantfactor in immune-mediated liver changes? manifested as piecemal 
necrosis in light microscopy. Aetive viral replication, with expression of HBcAg 
in the cytoplasm of hepatocytes, is an important factor in lobular necrosis of 
hepatocytes and is probably caused by direct hepatotoxic effects. 
In chapter VII attention was focussed on hepatocytes with the ground-glass 
aspect in routine HA-stained sections of formalin-fixed paraffin-embedded liver 
tissue. Ground-glass hepatocytes in routinely stained liver sections are known 
to occur in association with different liver diseases, hepatitis B viral liver disease 
being possibly the most important. In these cases the cytoplasm is loaded with 
hepatitis B surface antigen and shows special affinity for histochemical dyes. The 
occurrence of ground-glass cells, their staining characteristics, the specificity 
for a hepatitis B infection and their value for classification of hepatitis B liver 
disease were investigated. 
Ground-glass hepatocytes were found in± 8% of a series of 181 0 liver biopsies. 
In most cases {1 03 of the 150) the biopsies came from HBsAg-seropositive in-
dividuals. The presence of HBsAg in these ground-glass cells was proven by 
specific immunohistochemical staining methods. These hepatocytes stained 
positive with aldehyde thionin and orcein, whereas the hepatocytes in biopsies 
from HBsAg-negative patients were negative. Except for acute self-limiting hepa-
titis, groun~d-glass cells were detected in all variants of HBsAg liver dise~se in 
clusters (focal pattern) or scattered throughout the liver tissue (solitary pattern). 
The solitary pattern was seen in many cases of prolonged acute hepatitis (37.5 
per cent), chronic persistent hepatitis and chronic active hepatitis. The focal 
pattern was detected in cases of minimal liver changes and in most cases of 
aspecific reactive hepatitis. These expression patterns were shown to be quite 
constant in serial liver biopsies. It was concluded that the ground-glass 
hepatocyte, with its special staining characteristics, forms the hallmark for light 
microscopical diagnosis of a chronic hepatitis B infection and is an essential aid 
in grading hepatitis B liver disease, especially when more etiologic factors are 
responsible for the light microscopical liver changes. 
The results of a study on the presence and localization in liver tissue of the 
determinants characteristic for the different subtypes of HBsAg are reported in 
chapter VIII. 
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In liver tissue, the "a" as well as the "d" and "y" determinants were demonstrated 
atthe same localization, such that the "a" determinantwasalways presenttogether 
with either the "d" or the "y'' determinant. 
Dissociation ofthe different determinants of HBsAgwas not found in any of the 
biopsies. 
Chapter IX describes the presence of and the relation between HBeAg and anti 
HBe in serum and HBeAg in liver tissue. 
HBeAg was always detected together with and at the same localization as 
HBcAg. HBeAg and HBcAgwasfound in liver biopsies from all except four HBeAg-
seropositive patients. 
In the contrast two patients with HBeAg and anti-HBe-negative serum and one 
patient with anti-HBe-positive serum revealed HBeAg and HBcAg in the liver 
tissue. 
There was no clear correlation between the titer of HBeAg in serum and the 
amount of HBcAg and HBeAg in the liver tissue. 
It was concluded that an anti-HBe-positive serum may not be used as marker 
for the absence of infectivity of a patient. This statement was confirmed by the 
reinfection of an liver graft transplanted into an anti-HBe-positive patient (see 
chapter XI). 
Chapter X presents the results of an electron microscopical study on the 
presence of viral structures in liver tissue from HBsAg seropositive patients. For 
all patients with immunohistochemically demonstrated HBcAg, small and large 
groups of circular structures consistent with core particles were found. No 
structural counterpart for HBsAg localization along the cell-membrane could be 
shown. 
In chapter XI the development and course of hepatitis B and hepatitis delta 
infections in auxiliary heterotopic liver grafts in patients suffering end-stage 
(cirrhotic) hepatitis B liver disease are discussed. Serial biopsies from the liver 
grafts were used to investigate the consecutive appearance of the various hepatitis 
B and delta antigens and the accompanying histological events in four patients. 
Prior to transplantation two of these patients were HBV-positive HDV-negative, 
while the other two had delta superinfection without accompanying signs of active 
HBVreplication. One of the HBV-positive HDV-negative patients exhibited active 
viral replication, as indicated by HBeAg and HBV-polymerase-positive serum and 
HBcAg in the liver tissue. The other HBV-positive HDV-negative patient had no 
signs of active viral replication. 
According to the experience in other centers with orthotopic liver grafts in 
HBsAg-positive patients, the hepatitis Band D virus recurred, in all four liver grafts. 
The one-week biopsies from the grafts already revealed hepatitis B or D antigens 
in three out of four patients. Only in the HBV-positive, HDV-negative patient 
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without signs of active viral replication was recurrence of hepatitis B delayed until 
the three-week biopsy. This delayed occurrence is probably attributable to the 
time needed for reactivation of the dormant viral infection. In one of the HDV-
positive patients, HDAg was demonstrated as first and only viral antigen in the 
nucleus of more than 40 percent of the hepatocytes in the one-week biopsy. 
HBsAg was present in the one-week biopsies from two of the four grafts and in 
the three-weeks biopsies from all grafts, along the cell membrane of all 
hepatocytes. Despite immunosuppressive therapy and previous activation of the 
immune system of the recipient by hepatitis B viral antigens, the sequence of 
histological events characteristic of a first hepatitis B infection, recurred in all 
grafts. Acute hepatitis did not occur before 47 days and progressed slowly within 
six to twelve months to a mild chronic active hepatitis. These observations suggest 
that the biological processes of the virus in the liver parenchyma determines the 
course of the disease. Despite a slight inflammatory reaction in the livers, the 
grafts from both HBV-positive HDV-negative patients exhibited cirrhotic trans-
formation within one year, whereas both HDV-positive patients showed only mild 
or moderate fibrosis, respectively, after one year. 
The appearance of hepatitis in the liver tissue was related to the appearance of 
HBcAg, especially in the cytoplasm of the hepatocytes, as a sign of marked viral 
replication. The appearance of HDV in liver tissue and HBsAg on the cell 
membranes of the hepatocytes could not be correlated with obvious hepatocytic 
necrosis in these immune-suppressed patients. 
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SAMENVATTING 
Hepatitis B vormt door zijn wereldwijd en frequent voorkomen (± 300 miljoen 
chronische hepatitis B dragers) en zi jn ernstige gevolgen een belangri jk wereld-
gezondheidsprobleem. 
Sinds de ontdekkingvan hetAustralie antigeen door Blumberg, Alter en Visnich. 
en vervolgens de onderkenning door Prince, dat de aanwezigheid van dit anti-
geen een marker van een hepatitis B virus infectie is, zijn er zeer belangrijke 
vorderingen gemaakt in het Hepatitis B onderzoek, vooral op het gebied van de 
moleculair biologische eigenschappen van het virus. 
Omtrent onze kennis van de pathobiologie van het virus en de moleculaire en 
cellulaire basis voor de pathogenese van de ziekte blijven daarentegen nog be-
langrijke gebieden onopgehelderd. Met name de mechanismen welke leiden tot: 
a. levercelnecrose. 
b. het ontstaan van acute dan wei chronische hepatitis. 
c. het persisteren van het hepatitis B virusinfectie. 
d. het ontstaan van hepatocellulair carcinoom. 
zijn slechts ten dele opgelost en worden als controversieel beschouwd. Ook de 
interactie van het Hepatitis B virus met het incomplete hepatitis delta virus en de 
hierbij optredende pathobiologische mechanismen zijn verre van duidelijk. 
Door het bestuderen van expressiepatronen van hepatitis B en delta virus, in 
relatie met histopathologische veranderingen in leverweefsel van een groep 
hepatitis B surface antigeen positieve patienten, tracht deze studie een bijdrage 
te leveren tot een beter be grip van pathogenetische mechanismen,welke een rol 
spelen bij een hepatitis B infectie. 
In hoofdstuk I wordt een historisch overzicht gegeven van de, door toevallige 
omstandigheden gekenmerkte, ontdekking van zowel het hepatitis B als het he-
patitis Delta virus en de daarop volgende ontwikkelingen. Het hoofdstuk eindigt 
met de doelstellingen van het onderzoek, waarbij ontrafeling van pathogeneti-
sche mechanismen van de door het virus veroorzaakte leveratwijkingen centraal 
staat. 
Hoofdstuk II beschrijft de herkomst van het in deze stu die onderzochte lever-
materiaal. Dit betreft hoofdzakelijk door naaldbiopsie verkregen leverweefsel, 
ontvangen op de afdeling Klinische Pathologie gedurende de jaren 1973-1977. 
In deze periodewerden 165 naaldbiopten van 139 HBsAg seropositieve patien-
ten (1 06 mannen en 33 vrouwen) aangeboden, die voor lichtmicroscopisch, 
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immunohistochemisch en electronenmicroscopisch onderzoek konden worden 
bewerkt. 
De groep van 139 patienten is samengesteld uit twee subgroepen, nl.: 
A. "gezonde" asymptomatische hepatitis B dragers {51). 
B. patienten {88) waarbij HBsAg in het serum werd gevonden in het kader van 
een klinisch manifeste leverziekte, of een andere interne aandoening, die 
gedeeltelijk het gevolg was van een leverziekte. 
Leeftijd en geslachtsverdeling en de mogelijke besmettingswijze worden van 
aile Hepatitis B dragers gegeven. In de onderzoeksperiodewerden op de Bloed-
transfusiedienstt~ Rotterdam 128 donoren HBsAg positief bevonden. Hieruit kon 
een prevalentie van HBsAg in de Nederlandse (Rotterdamse) bevolking van± 0.2 
worden berekend met een manjvrouw verhouding van± 4 : 1. Deze prevalentie 
komt goed overeen met de prevalentiewaarden in andere West-Europese Ianden 
en staat in schil contrast met de hoge prevalentiewaarden berekend in delen van 
Azie en Afrika. Aile 128 positieve donoren werden verwezen voor nader klinisch 
onderzoek van hun HBsAg dragerschap.ln het kader van dit onderzoek werd bij 
41 een leverbiopt verricht. 
Hoofdstuk Ill geeft een beschrijving van de bewerking van het leverbiopsie-
materiaal voor de verschillende onderzoeksmethoden. 
In hoofdstuk IVwordt in algemene zin uitgebreid ingegaan op de verschillende 
lichtmicroscopische reactievormen van de lever op een hepatitis B infectie. De 
classificatie van deze reactievormen wordt be Iicht, waarbi j ingegaan wordt op de 
histologische kenmerken van de verschillende groepen en subgroepen van 
hepatitis, de problemen bij de classificatie en de waarde van verschillende ken-
merken voor de prognose van hepatitis. 
In hoofdstukVworden de morfologischeveranderingen in de 1651everbiopten 
van de 139 HasAg positieve patienten geanaliseerd en volgens het in hoofdstuk 
IV beschreven classificatiesysteem ingedeeld. 
De histologische bevindingen werden vergeleken met klinische en klinisch-
biochemische parameters en met het be loop van de hepatitis B infectie, over een 
periode van minimaal 2 jaar tot maximaal 15 jaar. 
In de gehele groep patienten werd bij 43 patienten de diagnose acute hepatitis 
gesteld, waarvan 9 een anicterisch beloop en 34 een icterisch beloop hadden. 
Aile acute leverontstekingen met een anicterisch beloop gingen over in een 
chronisch hepatitisbeeld, waarbij HBsAg vele jaren positief bleef. Slechts 2 
patienten met een icterische acute hepatitis ontwikkelden een chronische hepa-
titis. Hieruitwordt geconcludeerd dat chronische hepatitis vrijwel altijd ontstaat 
via een anicterische (weinig ernstige) acute hepatitis en dat een icterische 
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hepatitis, welke in de acute phase soms tot ernstig levercelverval aanleiding kan 
geven, zelden overgaat in een chronische hepatitis. Deze bevinding is in over-
eenstemming met het feit dat anamnestisch slechts zelden icterus wordt gemeld 
bij patienten met een chronische hepatitis. Lichtmicroscopisch konden in de 
groep van patienten met acute hepatitis geen, voor het verloop van de virale 
infectiekenmerkendeprognostischeaspecten, worden gevonden. Een prominent 
portaal ontstekingsinfiltraat en de afwezigheid van cholestase tijdens de acute 
hepatitis zijn het meest significant, doch niet absoluut kenmerkend voor 
overgang in chronische hepatitis. 
In tegenstelling met literatuurgegevens werd in de groep van acute hepatitis 
patienten opvallend weinig ijzerpigmentstapeling in het leverweefsel aangetrof-
fen. 
Asymptomatische hepatitis B dragers toonden, in de lijn der verwachting, in 
vergelijking met de symptomatische hepatitis B dragers minder ernstige lever-
afwijkingen. Tach toonden 9 van de 41 asymptomatische bloeddonoren het 
histologische beeld van een acute hepatitis, waarvan 6 uiteindelijk anicterisch 
verliepen. Bij 5 van de 41 donoren werd een chronische actieve hepatitis 
aangetroffen, welke in aile gevallen·gepaard ging met leverenzymstoornissen. In 
een donor werd een z.g. incomplete septale (inactieve) cirrhose aangetroffen. 
Geconcludeerd werd dat asymptomatische hepatitis B dragers ernstige lever-
afwijkingen kunnen tonen, die dan echter altijd met serum transaminase stoor-
nissen gepaard gaan. 
Bij de chronische symptomatische hepatitis B dragers werden over het 
algemeen ernstige afwijkingen aangetroffen; bij 17 van de 88 werd het beeld van 
cirrhose gezien. De cirrhotische leverafwijkingen werden vooral gezien in de 
oudere leeftijdsgroep en gingen in de meeste gevallen gepaard met een 
chronisch actief hepatitisbeeld, welk blijkbaar de oorzaak van de cirrhose was. 
Naast de problemen bij de afgrenzing van acute hepatitis en acute hepatitis 
overgaande in chronische hepatitis, gat de diagnostiek van chronische persis-
terende hepatitis vaak moeilijkheden, aan de ene kant met betrekking tot de 
afgrenzing van niet specifieke hepatitis en hepatitisrestverschijnselen, aan de 
andere kant met betrekking tot chronische actieve hepatitis. 
In hoofdstuk VI worden de resultaten van het immunohistochemische onder-
zoek naar de aanwezigheid en de lokalisatie van de verschillendevirale antigenen 
en immunoglobulinen en complementfactoren in het ingevroren en gefixeerde 
leverweefsel van de 139 HBsAg positieve patienten beschreven. 
In de hepatocyt kan HBsAg worden aangetroffen langs de celmembraan, dif-
fuus in het cytoplasma en als insluitlichaam focaal in het cytoplasma, nooit in de 
kern. De intracytoplasmatische HBsAg lokalisatie correleert met het lichtmicros-
copisch aangetroffen groundglass aspect van hepatocyten (zie hoofdstuk VII). 
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In tegenstelling met het cytoplasmatische HBsAg is het celmembraan 
gebonden HBsAg in gefixeerd leverweefsel veelal niet of moeilijk aantoonbaar. 
Bi j onderzoek van suspensiepreparaten van HBsAg positief Ieverweefsel werd 
HBsAg op het buitenoppervlak van hepatocyten aangetoond en leek op grand 
van het gevonden "capping" fenomeen mobiel in de celmembraan aanwezig. 
HBcAg wordt voornamelijk in de kern aangetroffen en in een klein deel der 
gevallen, welke hoge virale replicatie activiteit tonen, eveneens en soms aileen 
in het cytoplasma. HBcAg wordt in de hepatocyt vrijwel altijd gecombineerd 
aangetroffen met celmembraan gebonden HBsAg en in veel mindere mate met 
de focale cytoplasmatische lokalisatie van HBsAg. Deze focaal cytoplasmatische 
Iokalisatie van HBsAg Iijkt derhalve suggestief voor een zichtbare uiting van de 
situatie, waarin viraal DNA is ingebouwd in het genoom van de gastheer. 
HBeAg lijkt wat Iokalisatie betreft niet af te wijken van de Iokalisatie van het 
HBcAg en er werden geen leverbiopten gevonden waarin er een discrepantie 
bestond tussen aanwezigheid en lokalisatie van HBcAg en HBeAg. 
Delta antigeen werd vrijwel aileen in de kernen van de hepatocyten aange-
troffen en aileen bij zeer hoge delta virus replicatie ook in het cytoplasma. Over 
het algemeen sluit de aanwezigheid van delta antigeen de aanwezigheid van 
HBcAg en HBeAg uit. Bij de HDV positieve transplantatiepatienten, waar sprake 
is van een HDV coinfectie, werden echter zowel HBcAg en delta antigeen naast 
elkaar aangetroffen. 
Wat betreft de lokalisatie van immunoglobulinen was de meest opmerkelijke 
bevinding dat in coupes van ingevroren Ieverweefsel deposities van immuno-
globuline, hoofdzakelijk IgG, werden aangetroffen op dezelfde plaats als core 
enjof delta antigeen. Dit fenomeen kon worden verklaard door een in vitro 
binding van intrinsiek in de sinusoidale vaten aanwezige antilichamen tegen core 
enjof delta antigeen, met het in de hepatocyten aanwezige core enjof delta 
antigeen. Dit verschijnsel maakt het mogelijk ook andere antigeenjantilichaam 
systemen op het spoor te komen. 
Op grand van de Iokalisatie van de verschillende virale antigenen, konden 
verschillende, voor de classificatie en de prognose kenmerkende patronen 
worden onderscheiden. De HBsAg lokalisatie speelt in deze patronen de 
belangrijkste rol: 
a. Solitair patroon: hierbijwordteen enkele zwak HBsAg positieve, veelal gede-
genereerde hepatocyt of macrofaag gezien, temidden van HBsAg negatief 
leverweefsel. Dit patroon wordt aangetroffen bij acute hepatitis, welke niet in 
een chronische hepatitis overgaat. 
b. Focaal patroon: hierbij worden naast grate aaneengesloten velden hepato-
cyten met cytoplasmatische HBsAg Iokalisatie (groundglasscellen) kleinere 
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of grotere velden hepatocyten zonder HBsAg expressie gezien.Dit patroon 
wordt aangetroffen bij chronische Hepatitis B dragers zonder noemens-
waardige lever afwijkingen. HBcAg wordt hierbij niet gedetecteerd. 
c. Diffuus patroon: in dit patroon tonen aile hepatocyten een celmembraan 
gebonden HBsAg lokalisatie (honingraat aspect in lever coupes). Dit patroon 
wordt gezien bij aile vormen van chronische hepatitis en gaat in een groat dee I 
der gevallen gepaard met HBcAg in de kern of het cytoplasma (actieve virale 
replicatie ). 
Geconcludeerd wordt dat de lokalisatie van virale antigenen duidelijk gecor-
releerd is met histologische leververanderingen en dat het virale verdelings-
patroon bij de classificatie van de leverontstekingen een belangrijke (prognos-
tische) rol speelt. 
Pathogenetisch lijkt lokalisatie van HBsAg langs de celmembraan van de hepa~ 
tocyten belangrijk voor het histologische aspect van zgn. piecemeal necrose bij 
chronische actieve hepatitis; dit verschijnsel berust op een immunologisch 
proces. Virale replicatie, vooral met HBcAg expressie in het cytoplasma, is 
gerelateerd aan de ernst van lobulair levercelverval en bepaald voor een 
belangrijk deel de snelheid van de progressie van de leverziekte. 
In hoofdstuk VII wordt ingegaan op de zgn. "groundglass" hepatocyt. Het 
"groundglass" of matglas aspect van hepatocyten is sterk geassocieerd met de 
aanwezigheid van een hepatitis B infectie. Het berust op excessieve stapeling van 
hepatitis B surface antigeen in het cytoplasma van deze hepatocyten. 
"Groundglass" veranderingen van het cytoplasma van de hepatocyten kunnen 
echter ook worden aangetroffen bij verschillende andere leveraandoeningen 
("drug induced" en cirrhose in het algemeen). 
In deze studiewerden hetv66rkomen, defrequentie, hetverdelingspatroon en 
de histochemische kleuringskarakteristieken van groundglass hepatocyten 
onderzocht in een serie van 1810 opeenvolgende leverbiopten, die in de periode 
van dit onderzoek werden ontvangen. 
HBsAg positieve groundglass hepatocyten hebben specifieke affiniteit tot 
bepaalde histochemische kleurstoffen (orceine, aldehyde thionine, aldehyde 
fuchsine), welke nietwordtaangetroffen bij HBsAg negatieve groundglasscellen. 
In 150 van de 1810 leverbiopten (± 8%) werden groundglasscellen aange-
troffen. In de meeste gevallen (1 03 van de 150) ging het hierbij om HBsAg 
seropositieve patienten. De aanwezigheid van HBsAg kon in deze groundglass-
cellen immunohistochemisch worden aangetoond. De groundglasscellen in de 
biopten van HBsAg seronegatieve patienten waren HBsAg negatief. 
Behalve in de acute genezende HBV infectie worden typische groundglass-
cellen in meer of mindere mate in aile andere histopathologische vormen van 
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chronische hepatitis B infectie aangetroffen. 
In leverbiopten van patienten met chronische hepatitis B infectie met mini male 
of geringe nietspecifieke histologische afwijkingenwerden in de meeste gevallen 
(± 90%) groundglasscellen gezien, welke hier in grate aaneengesloten velden 
gelokaliseerd zijn (focaal verdeiingspatroon). 
In ieverbiopten met chronische persisterende en chronische actieve hepatitis 
werden in ± 70% van de biopten groundglasscellen gezien, welke solitair, 
verspreid liggend tussen normale hepatocyten (solitair verdelingspatroon), 
voorkomen. Dit solitaire verdelingspatroon werd ook gezien in acute hepatitis 
overgaand in chronische hepatitis(± 47% van de gevallen), waarbij opgemerkt 
moet worden dat deze cellen niet eerder dan 6 maanden na het begin van de 
infectie verschijnen. 
De leverbiopten van HBsAg positieve patienten met cirrhose toonden in 66.5% 
van de gevallen groundglass hepatocyten. Het verdelingspatroon en het aantal 
groundglasscellen wisselt hier sterk van nodus tot nodus. 
In het solitaire verdelingspatroon is het aantal groundglasscellen veel minder 
groat dan in het focale verdelingspatroon; voor de opsporing is zorgvuldige 
screening van routinematig gekleurde HA coupes vereist. Voor het opsporen van 
sporadisch voorkomende groundglasscellen zijn de specifieke histochemische 
of immunohistochemische kleuringen waardevol. Rekening moet echter worden 
gehouden met aspecifieke immunohistochemische en histochemische kleur-
reacties. Voor de diagnose chronische HBV infectie zijn em een typisch 
groundglass aspect van het cytoplasma en een positieve kleurreactie 
noodzakelijk. 
In hoofdstuk VIII worden de resultaten van een onderzoek naar de lokalisatie 
van de determinanten van de verschillende subtypen HBsAg ("a", "d" en "y") 
gegeven. Zowel de "a", de "d" en "y" determinant wordt in leverweefsel steeds op 
dezelfde lokalisatie aangetroffen, waarbij de "a" determinant altijd aanwezig is, 
gepaard gaand~ met, of de "y", of de "d" determinant. Dissociatie in lokalisatie 
van de verschillende determinanten is hierbij niet aangetroffen. Geconcludeerd 
wordt derhalve dat aile determinanten op het HBsAg van virale afkomst zijn en 
direct in een partikel worden geassembleerd. 
Hoofdstuk IX gaat in op de lokalisatie van HBeAg in leverweefsel. De relatie 
van HBeAg in dit leverweefsel met andere virale antigenen (HBcAg, HBsAg) in 
leverweefsel en met de aanwezigheid van HBeAg en anti HBe in serum, wordt 
nagegaan. HBeAg komt altijd tesamen en in dezelfde lokalisatie voor als HBcAg. 
HBeAg en HBcAg worden steeds in combinatie met een diffuus HBsAg fluores-
centiepatroon aangetroffen. Er werd sporadisch HBeAg in het serum aangetrof-
fen, wanneer eAg en HBcAg in het leverweefsel nietkondenworden aangetroffen. 
In een enkel geval werd HBeAg in het leverweefsel aangetroffen in combinatie 
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met anti HBe in het serum. Geconcludeerd kan worden dat detectie van HBeAg 
en HBcAg in leverweefsel een gevoelige methode is voor de opsporing van 
hepatitis B infectie met actieve virale replicatie. 
In hoofdstuk X worden de bevindingen van het electronenmicroscopisch 
onderzoek weergegeven. Met name wordt hier de relatie tussen de aanwezigheid 
van viruspartikels in de hepatocyten en de histochemisch aangetoonde virale 
antigenen belicht. In aile gevallen, waar immunohistochemisch HBcAg in de 
hepatocyten werd aangetoond, konden ± 27 nm partikels in de kernen van de 
hepatocyten worden gezien. 
In hoofdstuk XI worden de resultaten beschreven van een onderzoek naar de 
ontwikkeling en het verloop van hepatitis B en delta virus infecties in heterotoop 
auxillair getransplanteerde levers bi j patienten met een gedecompenseerde HBV 
of HDV positieve levercirrhose. Met behulp van op bepaalde tijden verrichte 
leverbiopten kon de volgorde van verse hi jnen van de verschillende hepatitis Ben 
D antigenen en de daarmee gepaard gaande lichtmicroscopische veranderingen 
worden nagegaan in vier transplantaten. 
Twee van de getransplanteerde patienten waren v66r de transplantatie HBV 
positief HDV negatief, terwijl de andere twee HBV negatief, HDV positiefwaren. 
E€m van de HBV positieve patienten had tekenen van virale replicatie, de andere 
niet. Een week na transplantatie werden in drie van de vier transplantaten hepa-
titis B of hepatitis D virus antigenen aangetroffen. Aileen hettransplantaat van de 
HBV positieve, HDV negatieve patient zonder virale replicatie toonde pas in het 
protocollaire 3e week biopt viraal antigeen. 
In de twee HBV positieve HDV negatieve patienten verscheen HBsAg het eerst 
langs de celmembraan van de hepatocyt, in latere biopten gevolgd door HBcAg. 
In de HBV negatieve HDV positieve patienten was HDV het eerst aangetoonde 
antigeen, in een geval gecombineerd met HBsAg langs de celmembraan. In de 
HBV negatieve, HDV positieve patienten verscheen HBcAg later (3e week en 3e 
maand biopt) tesamen met HDV. HBcAg was gedeeltelijk of grotendeels intra-
cytoplasmatisch gelokaliseerd. 
In aile transplantaten ontstond na ± 7 weken het histologische beeld van een 
acute hepatitis. Het optreden van de acute hepatitis was niet gerelateerd aan het 
verschijnen van HBsAg en delta antigeen, maar steeds aan dat van HBcAg, vooral 
gelokaliseerd in het cytoplasma. In beide HBV positieve, HDV negatieve trans-
plantaten ontstond na een jaar een cirrhose, hetgeen een aanmerkelijk sneller 
beloop is dan bij de meeste natuurlijke hepatitis B infecties. Tegen de verwach-
ting in was de hepatitis in be ide HDV positieve patienten vee I minder progressief; 
na 1 jaar werd slechts geringe fibrose aangetroffen. 
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AH 
anti-HBc 
anti-HBe 
anti-HBs 
As pH 
Au-Ag 
BHN 
CAH 
CCC 
CH 
CLH 
CPH 
EG 
GGH 
HA 
HBAg 
HBcAg 
HBeAg 
HBF 
HBsAg 
HBV 
HCC 
HDV 
HFH 
PAS 
PAS after diastase 
SFH 
SGOT 
SGPT 
SHN 
ABBREVIATIONS 
acute hepatitis 
antibodies against hepatitis B core antigen 
antibodies against hepatitis B e-antigen 
antibodies against hepatitis B surface antigen 
aspecific hepatitis 
Australia antigen 
bridging hepatic necrosis 
chronic active hepatitis 
covalently closed-circular 
chronic hepatitis 
chronic lobular hepatitis 
chronic persistent hepatitis 
Lawson-von Giesen's technique for elastin 
ground-glass hepatocyte 
hematoxylin and azophloxin 
hepatitis B antigen 
hepatitis B core antigen 
hepatitis B e antigen 
button-hole hepatocyte 
hepatitis B surface antigen 
hepatitis B virus 
hepatocellular carcinoma 
hepatitis delta virus 
homogeneous fluorescence hepatocyte 
periodic acid-Schiff 
periodic acid-Schiff after glycogen digestion by 
diastases 
cell surface fluorescence hepatocyte 
serum glutamic oxaloacetic transaminase 
serum glutamate pyruvate transaminase 
subacute hepatic necrosis 
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WOORDEN VAN DANK 
De tot standkoming van dit proefschrift is niet in de laatste plaats te dank en aan 
en een direct gevolg van de aanwezigheid van een groep zeer enthousiaste hepa-
tologisch geinteresseeerde collega's in de Rotterdamse regia. Een enthousias-
me dat tot uitdrukking komt in vele samenwerkingsverbanden op hepatologisch 
gebied, "de Rotterdamse leverclub" en gezamenlijk onderzoek. 
Voor de jarenlange en inspirerende samenwerking dank ik allen. Klinische 
pathologie floreert niet zonder de aanwezigheid van een geinteresseerde en 
veeleisende kliniek. 
In verband hiermee moeten in de eerste plaats de pioniers van de moderne 
Rotterdamse hepatologieworden genoemd: prof.dr. M. Frenkel, prof.dr. J.H.P. 
Wilson, dr. M. de Jong, dr. M. van Blankenstein en mijn collega patholoog-
anatomen dr. S. Gratama, A.S.M. Jacobs en dr. A.P.R. Blok, in prettige samen-
werking gesteund door de kennis en ervaring van prof.dr. V. Desmet uit Leuven. 
Aan Roeland Blok ben ik mijn interesse voor de leverpathologie verschuldigd; hij 
was het oak die mij stimuleerde tot de afronding van dit proefschrift. In deze 
begin fase werd mijn belangstelling voor hepatitis B gewekt door het klinisch-
epidemiologisch onderzoek van "Australie" antigeen seropositieve patienten van 
Marek van Blankenstein en dr. F.C.H.A. Kothe, die ik met name dank voor de 
gastvrijheid op de Rotterdamse bloedbank. 
De pioniersfase werd gevolgd door een voortdurende periode van hepatolo-
gische bloei op onnavolgbare wijze gestimuleerd door prof.dr. S.W. Schalm 
samen met prof.dr. O.T. Terpstra en dr. R. Heijtink; voor de plezierige samen-
werking en hun stimulerende invloed ben ik hun veel dank verschuldigd. 
Vaak denk ik nag terug aan de plezierige samenwerking in de beginfase van het 
hepatitis onderzoek met dr. Jan Willem Steffelaar, dr. Mar ius Nap en dr. Ferry van 
Elven. Oak dank ik allen waarmee ik in de loop der jar en in prettige samenwerking 
hepatologisch onderzoek heb mogen doen. 
Mijn promotor, prof.dr. R.O. van de Heul dank ik voor de vrijheid, die ik kreeg 
om mijn werkzaamheden en onderzoek naar eigen inzicht te mogen indelen en 
voor het overdragen van een deel van zijn kennis van de (oncologische) 
pathologie. 
Dr. Th.M. Vroom dank ik speciaal voor de wijze waarop zij mij de voor dit 
proefschrift belangrijke immunohistochemische technieken bijbracht en voor 
de daaropvolgende blijvende samenwerking. 
Voor de jarenlange samenwerking en vele uren kijken en discussie achter de 
fluorescentie microscoop dank ik vooral Johan van Lier en de andere analisten, 
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waarmee ik in de loop der jaren heb samengewerkt. Dr. Vojslav Vuzevski en Piet 
van der Heul hielpen mij bij het electronenmicroscopisch onderzoek. De foto's 
werden gemaakt door Paula Delfos. Mevrouw Bominaar dank ik voor de grote 
vasthoudendheid en nauwkeurigheid bij het uittypen van mijn veelal onleesbare 
schri jveri jen. Dank voorts aan iedereen van de afdeling Pathologische-Anatomie, 
die op enigerlei wijze heeft bijgedragen aan het tot stand komen van dit 
proefschrift. 
Het proefschriftwerd op vakkundige wijze van misstappen in de Engelse taal 
gezuiverd door mw. G.P. Bieger-Smith.ln zeer prettige samenwerking kwam de 
uiteindelijke vormgeving tot stand met de deskundige hulp van Erik Davids. De 
omslag van het proefschrifiwerd getekend door dhr. van Leeuwen. 
Tenslottewas dit proefschrift nooit in drukverschenen zonder de inspanningen 
van Christine, die de P .C. en aile daaraan verbonden programma's feilloos onder 
de knie kreeg en aile tegenslagen wist op te Iossen met hulp van Peter van Vuuren 
en Sjors Beens. 
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CURRICULUM VITAE 
De schrijver van dit proefschriftwerd geboren in 1942 te Rotterdam. Hij behaalde 
in 1962 het eindexamen Gymnasium B aan het Gymnasium Erasmianum te 
Rotterdam. 
De medische studie werd gevolgd in Groningen met co-assistentschappen in 
Willemstad (Curagao). Na assistentschappen in Sittard (gynaecologie) en 
Groningen (intensive care) werd in 1970 het artsexamen afgelegd. 
Na als huisarts werkzaam te zijn geweest, werd van 1971-1975 de opleiding tot 
patholoog-anatoom gevolgd in hetAcademisch Ziekenhuis Di jkzigtte Rotterdam 
(hoofd: prof.dr.G. Wielenga) 
Sinds 1975 maakt hij dee I uit van de stat van de afdeling pathologische anatomie. 
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